细胞株Cell Lines 17-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
- 价 格：¥19200
- 货 号：Cell Line CV17
- 产 地：北京
- BioVector NTCC典型培养物保藏中心
- 联系人：Dr.Xu, Biovector NTCC Inc.
电话：400-800-2947 工作QQ:1843439339 (微信同号)
邮件：Biovector@163.com
手机：18901268599
地址：北京
- 已注册
细胞株Cell Lines
BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心
ID Dicer -/- line 27H10
AC CVCL_AW06
SY Dicer -/- (27H10)
DR GEO; GSM210972
DR GEO; GSM210973
DR GEO; GSM210974
DR GEO; GSM210975
DR GEO; GSM210976
DR GEO; GSM210977
RX PubMed=16099834;
RX PubMed=18311153;
CC Knockout cell: Method=KO mouse; MGI; MGI:2177178; Dicer.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID Dicer1-/-
AC CVCL_DC67
DR ATCC; CRL-3221
RX PubMed=22698408;
CC Knockout cell: Method=Homologous recombination; MGI; MGI:2177178; Dicer.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Dicer1tm1Bdh/J.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_DC68 ! Dicer1f/f
SX Female
CA Transformed cell line
//
ID Dicer1f/f
AC CVCL_DC68
DR ATCC; CRL-3220
RX PubMed=22698408;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: Dicer1tm1Bdh/J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Transformed cell line
//
ID DiFi
AC CVCL_6895
SY DIFI
DR BTO; BTO:0005902
DR CCRID; 3111C0002000000030
DR Cosmic; 1479628
DR Cosmic; 1519358
DR Cosmic-CLP; 1789883
DR GDSC; 1789883
DR GEO; GSM1448175
DR GEO; GSM1669732
DR KCB; KCB 2014033YJ
RX DOI=10.1007/978-4-431-68337-7_80;
RX PubMed=8385096;
RX PubMed=22270724;
RX PubMed=25926053;
RX PubMed=27397505;
CC Doubling time: ~40 hours (PubMed=8385096).
CC Microsatellite instability: Stable (MSS) (PubMed=25926053; Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 8,11
ST D16S539: 12
ST D5S818: 11,12
ST D7S820: 10,12
ST TH01: 7,9.3
ST TPOX: 8,9
ST vWA: 17,18
DI NCIt; C2955; Colorectal carcinoma
DI NCIt; C6728; Gardner syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID DIG104.10H.1
AC CVCL_J289
SY DIG 104.H10.1
DR JCRB; JCRB1213.3
RX PubMed=1364357;
CC Monoclonal antibody target: ChEBI; CHEBI:4551; Digoxin.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID DIG222.4D.5
AC CVCL_J290
SY DIG 222.4D.5
DR JCRB; JCRB1213.2
RX PubMed=1364357;
CC Monoclonal antibody target: ChEBI; CHEBI:4551; Digoxin.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID DIG64.2B.5
AC CVCL_J291
SY DIG 64.2B.5
DR JCRB; JCRB1213.1
RX PubMed=1364357;
CC Monoclonal antibody target: ChEBI; CHEBI:4551; Digoxin.
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID DII 33.1
AC CVCL_G692
SY DII33.1
DR CLO; CLO_0002780
DR ATCC; CRL-1827
CC Monoclonal antibody target: UniProtKB; P06213; Human INSR.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3940 ! NS0
CA Hybridoma
//
ID DIPG 4
AC CVCL_IP14
SY DIPG-4; DIPG4
DR BTO; BTO:0005955
RX PubMed=25366336;
CC Characteristics: Low-passage-number culture.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DIPG 6
AC CVCL_IP15
SY DIPG-6; DIPG6
DR BTO; BTO:0005954
RX PubMed=25366336;
CC Characteristics: Low-passage-number culture.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DiPS-H1.5
AC CVCL_C955
SY NYSCF-DE-1000-1000-Skin-RV-IPSC1
DR ISCR; 1760
RX PubMed=19720998;
WW http://shared.eagle-i.net/i/00000146-8fb5-ca91-b0a0-8e9480000000
CC From: Harvard University; Boston; USA.
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID DiPS-H2.1
AC CVCL_C956
SY NYSCF-DE-1005-1005-Skin-RV-IPSC1
DR ISCR; 1761
RX PubMed=19720998;
WW http://shared.eagle-i.net/i/00000146-8fb6-1bbf-b0a0-8e9480000000
CC From: Harvard University; Boston; USA.
CC Caution: It seems to be not known which of DiPS-H2.1 or DiPS-H2.4 is NYSCF-DE-1005-1005-Skin-RV-IPSC1 (personal communication of Egli D.).
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C957 ! DiPS-H2.4
SX Male
CA Induced pluripotent stem cell
//
ID DiPS-H2.4
AC CVCL_C957
SY NYSCF-DE-1005-1005-Skin-RV-IPSC1
DR ISCR; 1762
RX PubMed=19720998;
WW http://shared.eagle-i.net/i/00000146-8fb6-1bbf-b0a0-8e9480000000
CC From: Harvard University; Boston; USA.
CC Caution: It seems to be not known which of DiPS-H2.1 or DiPS-H2.4 is NYSCF-DE-1005-1005-Skin-RV-IPSC1 (personal communication of Egli D.).
DI NCIt; C2986; Type 1 diabetes mellitus
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_C956 ! DiPS-H2.1
SX Male
CA Induced pluripotent stem cell
//
ID DIT29
AC CVCL_J028
DR CLO; CLO_0051618
DR RCB; RCB2945
CC Group: Fish cell line.
OX NCBI_TaxID=8090; ! Oryzias latipes
SX Sex undetermined
CA Cancer cell line
//
ID DITRUD-1
AC CVCL_6216
SY DITRUD; Ditrud
RX PubMed=6278188;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0511 ! Raji
HI CVCL_6220 ! Daudi-TG
CA Hybrid cell line
//
ID DJA,N
AC CVCL_E563
SY DJA, N
DR dbMHC; 48757
DR ECACC; 94082224
DR IHW; IHW9125
DR IMGT/HLA; 11668
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl125.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID DJM-1
AC CVCL_1172
DR CLO; CLO_0050680
DR BCRJ; 0375
DR BioSample; SAMN03472223
DR ChEMBL-Cells; CHEMBL3308190
DR ChEMBL-Targets; CHEMBL2366264
DR Cosmic; 906841
DR Cosmic-CLP; 906841
DR GDSC; 906841
DR GEO; GSM1669733
DR RCB; RCB0736
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 10
ST D5S818: 10,13
ST D7S820: 7,8
ST TH01: 6
ST TPOX: 8,9
ST vWA: 14,17
DI NCIt; C4819; Skin squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID DJS
AC CVCL_E564
DR dbMHC; 48758
DR ECACC; 94050317
DR IHW; IHW9269
DR IMGT/HLA; 10500
WW http://bioinformatics.hsanmartino.it/ecbr/cl269.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID DJU,S
AC CVCL_E565
SY DJU, S
DR dbMHC; 48759
DR ECACC; 940822103
DR IHW; IHW9199
DR IMGT/HLA; 11740
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl199.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID DK
AC CVCL_4162
SY Dog Kidney
DR CLO; CLO_0002781
DR CLDB; cl1061
DR CLDB; cl1062
DR ATCC; CRL-6247
DR ECACC; 93120836
DR IZSLER; BS CL 36
RX PubMed=7129476;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6247; true.
CC Breed/subspecies: Beagle.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Spontaneously immortalized cell line
//
ID DK-MG
AC CVCL_1173
SY DKMG
DR CLO; CLO_0002782
DR EFO; EFO_0002161
DR BioSample; SAMN03470927
DR CCLE; DKMG_CENTRAL_NERVOUS_SYSTEM
DR ChEMBL-Cells; CHEMBL3308814
DR ChEMBL-Targets; CHEMBL1075433
DR Cosmic; 687566
DR Cosmic; 906839
DR Cosmic; 2302329
DR Cosmic; 2367524
DR Cosmic; 2516016
DR Cosmic-CLP; 906839
DR DSMZ; ACC-277
DR GDSC; 906839
DR GEO; GSM326231
DR GEO; GSM886978
DR GEO; GSM888047
DR GEO; GSM1669734
DR IGRhCellID; DKMG
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 80 hours (PubMed=25984343); ~50 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 10,11
ST D18S51: 13,17
ST D19S433: 13,15.2
ST D21S11: 29,30
ST D2S1338: 24,25
ST D3S1358: 15,16
ST D5S818: 9,11
ST D7S820: 9,12
ST D8S1179: 13
ST FGA: 19,24
ST Penta D: 9,12
ST Penta E: 7,17
ST TH01: 9.3
ST TPOX: 8
ST vWA: 18,19
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID DK0006
AC CVCL_8W07
DR ECACC; 94062421
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C84905; Muir-Torre syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID DK0064
AC CVCL_R778
SY SCKL1
RX PubMed=15496423;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID DK0099
AC CVCL_8W08
DR ECACC; 98110405
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C120083; Hereditary nonpolyposis colorectal cancer
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID DK1 [Tursiops]
AC CVCL_R774
SY CDK; Carvan dolphin kidney
RX DOI=10.1111/j.1748-7692.1994.tb00389.x;
CC Group: Cetacean cell line.
OX NCBI_TaxID=9739; ! Tursiops truncatus
SX Female
CA Finite cell line
//
ID DK1 [Human B-cell]
AC CVCL_E566
DR dbMHC; 48760
DR ECACC; 94050327
DR IHW; IHW9210
DR IMGT/HLA; 10501
WW http://bioinformatics.hsanmartino.it/ecbr/cl210.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID DK1631
AC CVCL_IU50
SY DK 1631
RX PubMed=8344493;
CC Characteristics: Heterozygous for the TP53 p.Arg248Gln mutation.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DKB
AC CVCL_E567
SY DkB
DR dbMHC; 48761
DR ECACC; 88052074
DR IHW; IHW9075
DR IMGT/HLA; 10503
RX PubMed=6417008;
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl75.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID DKC-8
AC CVCL_6896
SY DCT
DR BTO; BTO:0003950
RX CelloPub=CLPUB00159;
RX PubMed=18593564;
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID DKN1
AC CVCL_7899
RX PubMed=15003703;
CC Group: Cetacean cell line.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pSV3-neo].
OX NCBI_TaxID=9739; ! Tursiops truncatus
HI CVCL_R774 ! DK1 [Tursiops]
SX Female
CA Transformed cell line
//
ID DKO-1
AC CVCL_9798
SY DKO1
DR TOKU-E; 4094
RX PubMed=8465203;
CC Characteristics: In DLD-1 one of the two KRAS alleles has a p.Gly13Asp mutation. This cell line is KO for the normal allele.
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 6407; KRAS.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DKO-3
AC CVCL_9799
SY DKO3
RX PubMed=8465203;
CC Characteristics: In DLD-1 one of the two KRAS alleles has a p.Gly13Asp mutation. This cell line is KO for the mutant allele.
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 6407; KRAS.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DKO-4
AC CVCL_9800
SY DKO4
RX PubMed=8465203;
CC Characteristics: In DLD-1 one of the two KRAS alleles has a p.Gly13Asp mutation. This cell line is KO for the mutant allele.
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 6407; KRAS.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DKO35
AC CVCL_K036
RX PubMed=16794253;
CC Knockout cell: Method=KO mouse; MGI; MGI:96878; Blnk.
CC Knockout cell: Method=KO mouse; MGI; MGI:88319; Cd19.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID DKs-5
AC CVCL_9801
SY Dks-5; Dks5
RX PubMed=8465203;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DKs-8
AC CVCL_9802
SY Dks-8; DKS-8; DKS8; Dks8
RX PubMed=8465203;
CC Characteristics: In DLD-1 one of the two KRAS alleles has a p.Gly13Asp mutation. This cell line is KO for the mutant allele.
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 6407; KRAS.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DL [Human B-cell]
AC CVCL_E568
DR dbMHC; 48762
DR ECACC; 94050328
DR IHW; IHW9268
DR IMGT/HLA; 10505
WW http://bioinformatics.hsanmartino.it/ecbr/cl268.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Discontinued: ECACC; 94050328; probable.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID DL [Human lung rhabdoid tumor]
AC CVCL_U760
DR Cosmic; 802238
DI NCIt; C6586; Extrarenal rhabdoid tumor
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DL [Human melanoma]
AC CVCL_9V00
SY DLmel
RX PubMed=9331097;
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DL-110
AC CVCL_IR14
SY DL110
RX PubMed=9266949;
RX PubMed=9499341;
RX PubMed=10639591;
CC Characteristics: IL6 dependent.
DI NCIt; C3720; Anaplastic large cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DL-221
AC CVCL_DQ91
RX PubMed=27270875;
CC Characteristics: Has lost chromosome Y.
CC Doubling time: 30 hours (PubMed=27270875).
CC Omics: Deep exome analysis.
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C27781; Myxoid liposarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DL-3
AC CVCL_J397
RX PubMed=10437788;
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID DL-4
AC CVCL_IU45
RX PubMed=9454894;
RX PubMed=9747876;
CC Characteristics: EBV-negative.
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DL-40
AC CVCL_2889
SY DL40
DR JCRB; JCRB1337
DR JCRB; NIHS0542
RX PubMed=1979248;
RX PubMed=10639591;
RX PubMed=15356658;
CC Doubling time: 72 hours (PubMed=1979248).
CC Discontinued: JCRB; NIHS0542; true.
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 9,13
ST D16S539: 10,11
ST D5S818: 9,12
ST D7S820: 10,11
ST TH01: 8
ST TPOX: 8,9
ST vWA: 14,19
DI NCIt; C3720; Anaplastic large cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID DL-5
AC CVCL_J398
RX PubMed=10437788;
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID DL-8
AC CVCL_J399
RX PubMed=2159524;
CC Breed/subspecies: DBA/2.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID dl-884-3Y1-KO1
AC CVCL_K110
DR RCB; RCB0347
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4563 ! 3Y1-B clone 1
SX Female
CA Transformed cell line
//
ID DL-95
AC CVCL_IR15
SY DL95
RX PubMed=9499341;
RX PubMed=10639591;
CC Characteristics: IL6 dependent.
DI NCIt; C3720; Anaplastic large cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DL3580 clone 1
AC CVCL_W825
RX PubMed=8320182;
CC Doubling time: 25.5 hours (PubMed=8320182).
CC Breed/subspecies: Boston Terrier.
DI NCIt; C129297; Canine glioma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_W826 ! DL3580 clone 2
OI CVCL_W827 ! DL3580 clone 3
SX Male
CA Cancer cell line
//
ID DL3580 clone 2
AC CVCL_W826
SY DL3580c2
RX PubMed=8320182;
CC Doubling time: 49.0 hours (PubMed=8320182).
CC Breed/subspecies: Boston Terrier.
DI NCIt; C129297; Canine glioma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_W825 ! DL3580 clone 1
OI CVCL_W827 ! DL3580 clone 3
SX Male
CA Cancer cell line
//
ID DL3580 clone 3
AC CVCL_W827
RX PubMed=8320182;
CC Doubling time: 50.1 hours (PubMed=8320182).
CC Breed/subspecies: Boston Terrier.
DI NCIt; C129297; Canine glioma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_W825 ! DL3580 clone 1
OI CVCL_W826 ! DL3580 clone 2
SX Male
CA Cancer cell line
//
ID DLB-1
AC CVCL_HG31
SY Dicentrarchus Labrax Brain-1
RX PubMed=27746373;
CC Group: Fish cell line.
CC Doubling time: 22.41 +- 4.5 hours (PubMed=27746373).
CC Transformant: NCBI_TaxID; 40270; Snakehead retrovirus.
OX NCBI_TaxID=13489; ! Dicentrarchus labrax
SX Sex undetermined
CA Transformed cell line
//
ID DLC 01
AC CVCL_FA12
SY DLC-01
RX Patent=WO2000070024A2;
RX PubMed=10450758;
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2200.
CC Characteristics: Infected by a retrovirus called DLCV-1.
CC Doubling time: 24 hours (PubMed=10450758).
CC Misspelling: Occasionally 'DCL-01'.
CC Breed/subspecies: Mixed breed.
DI NCIt; C128121; Canine lymphoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID DLC 02
AC CVCL_FA13
SY DLC-02
RX PubMed=10896392;
CC Breed/subspecies: Siberian Husky.
DI NCIt; C128120; Canine leukemia
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Female
CA Cancer cell line
//
ID DLD-1
AC CVCL_0248
SY DLD1
DR BTO; BTO:0000391
DR CLO; CLO_0002785
DR EFO; EFO_0006389
DR MCCL; MCC:0000138
DR CLDB; cl1065
DR CLDB; cl1066
DR ATCC; CCL-221
DR BCRC; 60132
DR BioSample; SAMN01821551
DR BioSample; SAMN01821680
DR BioSample; SAMN03472323
DR CCLE; DLD1_LARGE_INTESTINE
DR CCRID; 3131C0001000700134
DR ChEMBL-Cells; CHEMBL3307580
DR ChEMBL-Targets; CHEMBL614285
DR Cosmic; 687519
DR Cosmic; 755307
DR Cosmic; 870451
DR Cosmic; 873699
DR Cosmic; 876713
DR Cosmic; 905005
DR Cosmic; 913890
DR Cosmic; 934560
DR Cosmic; 948123
DR Cosmic; 983737
DR Cosmic; 985994
DR Cosmic; 1043810
DR Cosmic; 1066204
DR Cosmic; 1122323
DR Cosmic; 1154643
DR Cosmic; 1175839
DR Cosmic; 1184331
DR Cosmic; 1184082
DR Cosmic; 1187305
DR Cosmic; 1223137
DR Cosmic; 1310949
DR Cosmic; 1466813
DR Cosmic; 1479591
DR Cosmic; 1481418
DR Cosmic; 1519360
DR Cosmic; 1524004
DR Cosmic; 1552176
DR Cosmic; 1571767
DR Cosmic; 1609511
DR Cosmic; 1676737
DR Cosmic; 1805251
DR Cosmic; 2301544
DR Cosmic; 2301972
DR Cosmic; 2464668
DR Cosmic; 2550352
DR DSMZ; ACC-278
DR ECACC; 90102540
DR GEO; GSM206467
DR GEO; GSM513817
DR GEO; GSM514291
DR GEO; GSM741247
DR GEO; GSM886979
DR GEO; GSM888048
DR GEO; GSM1346869
DR GEO; GSM1374463
DR GEO; GSM1448161
DR ICLC; HTL95011
DR JCRB; JCRB9094
DR KCB; KCB 201196YJ
DR KCLB; 10221
DR Lonza; 806
DR PRIDE; PXD000218
DR SKY/M-FISH/CGH; 1992
DR SKY/M-FISH/CGH; 2763
DR TKG; TKG 0379
DR TOKU-E; 1078
RX PubMed=6652615;
RX PubMed=8422623;
RX PubMed=9290701;
RX PubMed=9515795;
RX PubMed=9809040;
RX PubMed=10612807;
RX PubMed=10674020;
RX PubMed=11226274;
RX PubMed=11414198;
RX PubMed=19927377;
RX PubMed=20606684;
RX PubMed=22460905;
RX PubMed=24042735;
RX PubMed=24755471;
RX PubMed=25485619;
RX PubMed=25926053;
RX PubMed=25984343;
RX PubMed=26537799;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW http://www.pawefish.path.cam.ac.uk/ColonCellLineDescriptions/DLD-1.html
WW http://www.addexbio.com/productdetail?pid=36
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 33 hours (PubMed=25984343); ~48 hours (DSMZ).
CC Microsatellite instability: Instable (MSI) (PubMed=10674020; PubMed=24042735; PubMed=25926053).
CC Omics: Deep glycome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'DLD' in Cosmic 1571767 and Cosmic 1676737.
ST Source(s): ATCC; DSMZ; ECACC; JCRB; KCLB; PubMed=11416159; PubMed=25877200; TKG
ST Amelogenin: X,Y
ST CSF1PO: 11,12 (ATCC; DSMZ; ECACC; JCRB; KCLB; PubMed=25877200)
ST CSF1PO: 12 (TKG)
ST D13S317: 8,11
ST D16S539: 12,13
ST D18S51: 11,17
ST D21S11: 29,32.2
ST D3S1358: 17
ST D5S818: 13
ST D7S820: 10,12
ST D8S1179: 15
ST FGA: 22
ST Penta D: 9,14
ST Penta E: 7,14
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_3449 ! __Parent_cell_line_of_DLD-1/HCT 8/HCT 15/HRT-18
SX Male
CA Cancer cell line
//
ID DLD-1 AKT1(-/-)
AC CVCL_HD52
SY AKT1 (-/-) DLD-1
RX PubMed=20133737;
WW https://www.horizondiscovery.com/human-akt1-dld-1-cell-line-hd-r00-001
CC Knockout cell: Method=Homologous recombination; HGNC; 391; AKT1.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLD-1 AKT2(-/-)
AC CVCL_HD53
SY AKT2 (-/-) DLD-1
RX PubMed=20133737;
WW https://www.horizondiscovery.com/human-akt2-dld-1-cell-line-hd-r00-002
CC Knockout cell: Method=Homologous recombination; HGNC; 392; AKT2.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLD-1 ATG7(+/-)
AC CVCL_HD54
SY ATG7 (+/-) DLD-1
WW https://www.horizondiscovery.com/human-atg7-dld-1-cell-line-hd-105-016
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 16935; ATG7.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLD-1 BBC3(-/-)
AC CVCL_HD55
SY BBC3 (-/-) DLD-1; DLD-1 PUMA-/-
RX PubMed=12574499;
WW https://www.horizondiscovery.com/human-bbc3-dld-1-cell-line-hd-r00-029
CC Knockout cell: Method=Homologous recombination; HGNC; 17868; BBC3.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLD-1 BRCA2(+/-)
AC CVCL_HD56
SY BRCA2 (+/-) DLD-1
RX PubMed=18593900;
WW https://www.horizondiscovery.com/human-brca2-dld-1-cell-line-hd-105-027
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 1101; BRCA2.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLD-1 BRCA2(-/-)
AC CVCL_HD57
SY BRCA2 (-/-) DLD-1
RX PubMed=18593900;
WW https://www.horizondiscovery.com/brca2-dld-1-cell-line-hd-105-007
CC Knockout cell: Method=Homologous recombination; HGNC; 1101; BRCA2.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLD-1 CDKN1A(-/-)
AC CVCL_HD58
SY CDKN1A (-/-) DLD-1; DLD1 p21-/-
RX PubMed=8756351;
WW https://www.horizondiscovery.com/human-cdkn1a-dld-1-cell-line-hd-r00-020
CC Knockout cell: Method=Homologous recombination; HGNC; 1784; CDKN1A.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLD-1 clone A
AC CVCL_V011
SY Clone A; CLONE A; CloneA
DR Cosmic; 1374647
DR Cosmic; 1481425
RX PubMed=427742;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLD-1 clone D
AC CVCL_V012
SY Clone D; CLONE D
DR Cosmic; 1374643
RX PubMed=427742;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLD-1 clone#1-Luc
AC CVCL_J250
DR JCRB; JCRB1382
DR JCRB; NIHS0650
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0650; true.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,11
ST D16S539: 12,13
ST D5S818: 13
ST D7S820: 10,12
ST TH01: 7,9.3
ST TPOX: 8,11
ST vWA: 18,19
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLD-1 DICER1(-/-)
AC CVCL_HD59
SY DICER1 (-/-) DLD-1
RX PubMed=16505370;
WW https://www.horizondiscovery.com/human-dicer1-dld-1-cell-line-hd-r00-009
CC Knockout cell: Method=Homologous recombination; HGNC; 17098; DICER1.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLD-1 FBXW7(+/-)
AC CVCL_HD60
SY FBXW7 (+/-) DLD-1
RX PubMed=14999283;
WW https://www.horizondiscovery.com/human-fbxw7-dld-1-cell-line-hd-r00-006
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 16712; FBXW7.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLD-1 FBXW7(-/-)
AC CVCL_HD61
SY FBXW7 (-/-) DLD-1; DLD-1 hCDC4 -/-
RX PubMed=14999283;
WW https://www.horizondiscovery.com/human-fbxw7-dld-1-cell-line-hd-r00-005
CC Knockout cell: Method=Homologous recombination; HGNC; 16712; FBXW7.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLD-1 KRAS(+/-) 1
AC CVCL_HD62
SY KRAS (+/-) DLD-1
RX PubMed=19661383;
WW https://www.horizondiscovery.com/human-kras-dld-1cell-line-hd-105-002-hd-105-002
CC Characteristics: In DLD-1 one of the two KRAS alleles has a p.Gly13Asp mutation. This cell line is KO for the mutant allele.
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 6407; KRAS.
CC Miscellaneous: Horizon distributes two DLD-1 KRAS(+/-) cell lines, one developed internally (CVCL_HE28) and one originating from the group of Volgenstein (CVCL_HD62).
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLD-1 KRAS(+/-) 2
AC CVCL_HE28
SY KRAS (+/-) DLD-1
WW https://www.horizondiscovery.com/kras-dld-1-cell-line-hd-105-040
CC Characteristics: In DLD-1 one of the two KRAS alleles has a p.Gly13Asp mutation. This cell line is KO for the mutant allele.
CC Knockout cell: Method=Homologous recombination (1 of 2 alleles); HGNC; 6407; KRAS.
CC Miscellaneous: Horizon distributes two DLD-1 KRAS(+/-) cell lines, one developed internally (CVCL_HE28) and one originating from the group of Volgenstein (CVCL_HD62).
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLD-1 SLC2A1(-/-)
AC CVCL_HD63
SY GLUT1 (-/-) DLD-1
RX PubMed=19661383;
WW https://www.horizondiscovery.com/human-glut1-dld-1-cell-line-hd-r00-024
CC Knockout cell: Method=Homologous recombination; HGNC; 11005; SLC2A1.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLD-1 USP7(-/-)
AC CVCL_HD64
SY USP7 (-/-) DLD-1
WW https://www.horizondiscovery.com/human-usp7-dld-1-cell-line-hd-115-028
CC Knockout cell: Method=Homologous recombination; HGNC; 12630; USP7.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLD-1/alpha-cat cell
AC CVCL_1Y05
DR BTO; BTO:0005484
RX PubMed=9792660;
CC Transfected with: HGNC; 2509; CTNNA1.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1Y04 ! DLD-1/delta-alpha
SX Male
CA Cancer cell line
//
ID DLD-1/delta-alpha
AC CVCL_1Y04
SY DLD-1/delta alpha
RX PubMed=9792660;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLD-2
AC CVCL_Y034
SY DLD2
RX PubMed=7139607;
RX PubMed=8422623;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DLDSNR6
AC CVCL_4V49
RX PubMed=16546964;
CC Selected for resistance to: ChEBI; CHEBI:8988; SN-38 (7-ethyl-10-hydroxy-camptothecin).
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0248 ! DLD-1
SX Male
CA Cancer cell line
//
ID DLEC
AC CVCL_6F79
SY Dicentrarchus Labrax Embryonic Cells
RX PubMed=16249966;
CC Group: Fish cell line.
OX NCBI_TaxID=13489; ! Dicentrarchus labrax
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID DLKP
AC CVCL_H737
DR ChEMBL-Cells; CHEMBL3308451
DR ChEMBL-Targets; CHEMBL614482
RX PubMed=1581877;
RX PubMed=17593620;
CC Omics: Proteome analysis by 2D-DE/MS.
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DLKP-A
AC CVCL_H741
RX PubMed=1369413;
RX PubMed=19242932;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H737 ! DLKP
SX Male
CA Cancer cell line
//
ID DLKP-A10
AC CVCL_H742
RX PubMed=9260877;
RX PubMed=19242932;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H741 ! DLKP-A
SX Male
CA Cancer cell line
//
ID DLKP-A2B
AC CVCL_H744
RX PubMed=9180164;
RX PubMed=19242932;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H741 ! DLKP-A
SX Male
CA Cancer cell line
//
ID DLKP-A5F
AC CVCL_H743
RX PubMed=9180164;
RX PubMed=19242932;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H741 ! DLKP-A
SX Male
CA Cancer cell line
//
ID DLKP-I
AC CVCL_H738
RX PubMed=9486560;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H737 ! DLKP
SX Male
CA Cancer cell line
//
ID DLKP-M
AC CVCL_H739
RX PubMed=9486560;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H737 ! DLKP
SX Male
CA Cancer cell line
//
ID DLKP-Mitox
AC CVCL_4U31
SY DLKP-MITOX
RX PubMed=15239124;
RX PubMed=17593620;
CC Selected for resistance to: ChEBI; CHEBI:50729; Mitoxantrone.
CC Omics: Proteome analysis by 2D-DE/MS.
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H737 ! DLKP
SX Male
CA Cancer cell line
//
ID DLKP-SQ
AC CVCL_H740
RX PubMed=9486560;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_H737 ! DLKP
SX Male
CA Cancer cell line
//
ID DLRP
AC CVCL_J019
RX PubMed=1581877;
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DM
AC CVCL_F549
SY 30458; TER190; TER275
DR IMGT/HLA; 11815
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID DM-15
AC CVCL_L864
DR CLO; CLO_0002790
DR CLDB; cl1071
RX PubMed=4006597;
RX PubMed=6941912;
OX NCBI_TaxID=10044; ! Phodopus sungorus
SX Female
CA Transformed cell line
//
ID DM-3
AC CVCL_2019
SY DM3
DR BioSample; SAMN03473059
DR CCLE; DM3_PLEURA
DR DSMZ; ACC-595
RX PubMed=15372243;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~50-60 hours (DSMZ).
ST Source(s): DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 9,13
ST D18S51: 12,15
ST D21S11: 29,30
ST D3S1358: 15,16
ST D5S818: 12,13
ST D7S820: 8,10
ST D8S1179: 11,15
ST FGA: 19,20
ST Penta D: 11,12
ST Penta E: 7,12
ST TH01: 6
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C45655; Sarcomatoid mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DM-4
AC CVCL_5644
DR BTO; BTO:0004415
DR Cosmic; 932704
DR Cosmic; 1238115
DR Cosmic; 1303037
RX PubMed=1826230;
CC Derived from metastatic site: Lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM(6-MP)
AC CVCL_L866
RX PubMed=196977;
CC Selected for resistance to: ChEBI; CHEBI:50667; Mercaptopurine (6-MP).
OX NCBI_TaxID=10044; ! Phodopus sungorus
HI CVCL_L864 ! DM-15
SX Female
CA Transformed cell line
//
ID DM(act12)
AC CVCL_4V32
SY DMact12
RX PubMed=6941912;
CC Selected for resistance to: ChEBI; CHEBI:27666; Actinomycin D (ActD).
OX NCBI_TaxID=10044; ! Phodopus sungorus
HI CVCL_L864 ! DM-15
SX Female
CA Transformed cell line
//
ID DM(adb-0.8)
AC CVCL_4V33
SY DMadb-0.8
RX PubMed=2988876;
RX PubMed=4006597;
CC Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
OX NCBI_TaxID=10044; ! Phodopus sungorus
HI CVCL_L864 ! DM-15
SX Female
CA Transformed cell line
//
ID DM(cap)
AC CVCL_L865
SY DMcap; DMCAP
RX PubMed=4006597;
RX PubMed=6957361;
CC Selected for resistance to: ChEBI; CHEBI:17698; Chloramphenicol.
OX NCBI_TaxID=10044; ! Phodopus sungorus
HI CVCL_L864 ! DM-15
SX Female
CA Transformed cell line
//
ID DM(ch-2/1)
AC CVCL_4W09
SY DMch-2/1; DM-15CH-R1/2; DM15/2
RX PubMed=6957361;
RX PubMed=7261678;
CC Selected for resistance to: ChEBI; CHEBI:23359; Colchicine.
OX NCBI_TaxID=10044; ! Phodopus sungorus
HI CVCL_L864 ! DM-15
SX Female
CA Transformed cell line
//
ID DM105
AC CVCL_F867
SY Duke Melanoma 105
RX PubMed=2404572;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM12
AC CVCL_1Q83
DR BioSample; SAMN03151988
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative (PubMed=21868764).
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10,11,12,14
ST D13S317: 8,11,13
ST D16S539: 9,12,13
ST D5S818: 9,11,13
ST D7S820: 8,9,12
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 15,18,20
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4912 ! Tu 167
SX Male
CA Cancer cell line
//
ID DM122
AC CVCL_6623
SY Duke Melanoma 122
RX PubMed=2404572;
RX PubMed=21654344;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM128
AC CVCL_F868
SY Duke Melanoma 128
RX PubMed=2404572;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM13
AC CVCL_6621
SY Duke Melanoma 13
DR GEO; GSM1572817
DR GEO; GSM1572818
DR GEO; GSM1572819
DR GEO; GSM1572820
DR GEO; GSM1572821
DR GEO; GSM1572822
RX PubMed=2404572;
RX PubMed=10752474;
RX PubMed=21654344;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM14 [Human melanoma]
AC CVCL_6622
SY Duke Melanoma 14
RX PubMed=2404572;
RX PubMed=10752474;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM14 [Human OCSCC]
AC CVCL_1Q84
DR BioSample; SAMN03151989
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Parent cell line (Tu 167) has been shown to be a UM-SCC-1 derivative (PubMed=21868764).
ST Source(s): PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 10,11,12,14
ST D13S317: 8,11,13
ST D16S539: 9,12,13
ST D5S818: 9,11,13
ST D7S820: 8,9,12
ST TH01: 6,7
ST TPOX: 8,11
ST vWA: 15,17,18,20
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4912 ! Tu 167
SX Male
CA Cancer cell line
//
ID DM150
AC CVCL_F869
SY DM-150; Duke Melanoma 150
WW http://www.gemcris.od.nih.gov/Contents/GC_EXV_CELL_TERM_RPT_VIEW.asp?WIN_TYPE=P&EXVCELLTERMID=72
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM154
AC CVCL_F870
SY Duke Melanoma 154
RX PubMed=2404572;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM161
AC CVCL_F871
SY Duke Melanoma 161
RX PubMed=2404572;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM166
AC CVCL_F872
SY Duke Melanoma 166
RX PubMed=2404572;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM169
AC CVCL_F873
SY Duke Melanoma 169
RX PubMed=2404572;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM175
AC CVCL_F874
SY Duke Melanoma 175
DR Cosmic; 1477320
DR GEO; GSM276724
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM179
AC CVCL_F875
SY Duke Melanoma 179
RX PubMed=2404572;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM196
AC CVCL_F876
SY Duke Melanoma 196
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Dm2008Wb1
AC CVCL_Z816
RX PubMed=20198874;
CC Group: Insect cell line.
CC Characteristics: Infected by the intracellular symbiont Wolbachia pipientis.
CC Breed/subspecies: Chernomorka x F12.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Male
CA Spontaneously immortalized cell line
//
ID DM208
AC CVCL_F877
SY Duke Melanoma 208
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM268
AC CVCL_F878
SY Duke Melanoma 268
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM281
AC CVCL_6624
SY Duke Melanoma 281
RX PubMed=10752474;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM319
AC CVCL_6625
SY Duke Melanoma 319
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM331
AC CVCL_6626
SY Duke Melanoma 331
RX PubMed=10752474;
RX PubMed=21654344;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Derived from metastatic site: Right axillary lymph node.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM336
AC CVCL_F879
SY Duke Melanoma 336
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM366
AC CVCL_F880
SY Duke Melanoma 366
DR Cosmic; 1477311
DR GEO; GSM276735
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM368
AC CVCL_F881
SY Duke Melanoma 368
DR GEO; GSM276728
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM377
AC CVCL_F882
SY Duke Melanoma 377
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM382
AC CVCL_IS49
SY Duke Melanoma 382
DR GEO; GSM276751
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM391
AC CVCL_F883
SY Duke Melanoma 391
DR GEO; GSM276731
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM401
AC CVCL_IS50
SY DM401p; Duke Melanoma 401
DR GEO; GSM276769
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM414
AC CVCL_F884
SY Duke Melanoma 414
DR Cosmic; 1477312
DR GEO; GSM276744
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM422
AC CVCL_F885
SY Duke Melanoma 422
DR GEO; GSM276758
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM424
AC CVCL_F886
SY Duke Melanoma 424
DR GEO; GSM276745
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM425
AC CVCL_F887
SY Duke Melanoma 425
DR GEO; GSM276756
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM440
AC CVCL_F888
SY Duke Melanoma 440
DR Cosmic; 1477316
DR GEO; GSM276729
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM443
AC CVCL_F889
SY Duke Melanoma 443
DR Cosmic; 1477317
DR GEO; GSM276742
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM451
AC CVCL_F890
SY Duke Melanoma 451
DR GEO; GSM276727
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM459
AC CVCL_IS51
SY Duke Melanoma 459
DR GEO; GSM276768
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM467
AC CVCL_IS52
SY Duke Melanoma 467
DR GEO; GSM276766
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM472
AC CVCL_6627
SY Duke Melanoma 472
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM497
AC CVCL_IS53
SY Duke Melanoma 497
DR GEO; GSM276746
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM515
AC CVCL_F891
SY Duke Melanoma 515
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM555
AC CVCL_IS54
SY Duke Melanoma 555
DR GEO; GSM276772
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM578
AC CVCL_F892
SY Duke Melanoma 578
DR GEO; GSM276752
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM589
AC CVCL_IS55
SY Duke Melanoma 589
DR GEO; GSM276753
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM595
AC CVCL_IS56
SY Duke Melanoma 595
DR GEO; GSM276765
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM598
AC CVCL_F893
SY Duke Melanoma 598
DR Cosmic; 1477313
DR GEO; GSM276759
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM6
AC CVCL_6628
SY DM006; Duke Melanoma 6
DR BTO; BTO:0002957
DR Cosmic; 1477315
DR GEO; GSM276737
RX PubMed=2404572;
RX PubMed=10752474;
RX PubMed=19147755;
RX PubMed=21654344;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM602
AC CVCL_IS57
SY Duke Melanoma 602
DR GEO; GSM276770
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM608
AC CVCL_F895
SY Duke Melanoma 608
DR GEO; GSM276743
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM636
AC CVCL_F896
SY Duke Melanoma 636
DR GEO; GSM276726
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM643
AC CVCL_IS58
SY Duke Melanoma 643
DR GEO; GSM276734
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM646
AC CVCL_F897
SY Duke Melanoma 646
DR Cosmic; 1477321
DR GEO; GSM276738
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM7
AC CVCL_F898
SY Duke Melanoma 7
RX PubMed=2404572;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM711
AC CVCL_F899
SY Duke Melanoma 711
DR GEO; GSM276754
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM733
AC CVCL_F900
SY Duke Melanoma 733
DR GEO; GSM276747
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM738
AC CVCL_F901
SY Duke Melanoma 738
DR Cosmic; 1477318
DR GEO; GSM276732
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM745
AC CVCL_IS59
SY Duke Melanoma 745
DR GEO; GSM276755
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM751
AC CVCL_F902
SY Duke Melanoma 751
DR GEO; GSM276723
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM779
AC CVCL_IS60
SY Duke Melanoma 779
DR GEO; GSM276764
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM787
AC CVCL_IS61
SY Duke Melanoma 787
DR GEO; GSM276767
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM792
AC CVCL_F903
SY Duke Melanoma 792
DR Cosmic; 1477314
DR GEO; GSM276748
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM798
AC CVCL_IS62
SY Duke Melanoma 798
DR GEO; GSM276763
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM806
AC CVCL_IS63
SY Duke Melanoma 806
DR GEO; GSM276757
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM833
AC CVCL_F904
SY Duke Melanoma 833
DR Cosmic; 1477322
DR GEO; GSM276725
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Microsatellite instability: Stable (MSS) (PubMed=19147755).
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM868
AC CVCL_F905
SY Duke Melanoma 868
DR GEO; GSM276740
RX PubMed=19147755;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM87
AC CVCL_9126
SY Indian Muntjac; M cell; Muntjac 157 cell; M; Indian Muntjac (M)
DR CLO; CLO_0006952
DR ATCC; CCL-157
DR BCRC; 60278
DR ECACC; 90112813
DR JCRB; JCRB9100
RX PubMed=5444269;
RX PubMed=25509114;
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/muntjac/muntjaccells.html
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/aindian_muntjac.htm
OX NCBI_TaxID=9888; ! Muntiacus muntjak
SX Male
CA Spontaneously immortalized cell line
//
ID DM92
AC CVCL_F906
SY Duke Melanoma 92
RX PubMed=2404572;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DM93
AC CVCL_6629
SY DM-93; Duke Melanoma 93
DR BTO; BTO:0002958
DR GEO; GSM1572811
DR GEO; GSM1572812
DR GEO; GSM1572813
DR GEO; GSM1572814
DR GEO; GSM1572815
DR GEO; GSM1572816
RX PubMed=2404572;
RX PubMed=10752474;
RX PubMed=21654344;
CC From: Duke University Medical Center; Durham; North Carolina; USA.
CC Omics: Transcriptome analysis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DMBA-8
AC CVCL_F716
SY DMBA#8; DMBA 8; DMBA8
RX PubMed=3679743;
RX PubMed=4547337;
CC Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC Breed/subspecies: Fischer 344.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID DMBA-8 clone 4
AC CVCL_F717
RX PubMed=3679743;
CC Transformant: ChEBI; CHEBI:59032; 7,12-dimethyltetraphene (DMBA; dimethylbenzanthracene).
CC Breed/subspecies: Fischer 344.
DI NCIt; C64011; Adenocarcinoma of the rat mammary gland
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_F716 ! DMBA-8
SX Female
CA Cancer cell line
//
ID DMBM-1
AC CVCL_D561
RX PubMed=9103234;
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID DMBM-2
AC CVCL_2020
DR CLO; CLO_0002793
DR CLDB; cl1075
DR DSMZ; ACC-269
RX PubMed=9103234;
WW http://www.infarktforschung.de/macrophages_cell_lines.html
CC Doubling time: ~50 hours (DSMZ).
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID DMBM-3
AC CVCL_D562
RX PubMed=9103234;
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID DMBM-4
AC CVCL_D563
RX PubMed=9103234;
CC Breed/subspecies: C3H/HeJ.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID DMBM-5
AC CVCL_D564
RX PubMed=9103234;
CC Breed/subspecies: CBA/J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID DMBM-6
AC CVCL_D565
RX PubMed=9103234;
CC Breed/subspecies: CBA/J.
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Spontaneously immortalized cell line
//
ID DMD-iPS (DYS-HAC)1
AC CVCL_C981
DR ISCR; 1814
RX PubMed=19997091;
CC From: Tottori University; Tottori; Japan.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L752 ! GM05169
SX Male
CA Induced pluripotent stem cell
//
ID DMD-iPS (DYS-HAC)2
AC CVCL_C982
DR ISCR; 1815
RX PubMed=19997091;
CC From: Tottori University; Tottori; Japan.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L752 ! GM05169
SX Male
CA Induced pluripotent stem cell
//
ID DMD-iPS (DYS-HAC)3
AC CVCL_C983
DR ISCR; 1816
RX PubMed=19997091;
CC From: Tottori University; Tottori; Japan.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L752 ! GM05169
SX Male
CA Induced pluripotent stem cell
//
ID DMD-iPS (DYS-HAC)4
AC CVCL_C984
DR ISCR; 1817
RX PubMed=19997091;
CC From: Tottori University; Tottori; Japan.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L752 ! GM05169
SX Male
CA Induced pluripotent stem cell
//
ID DMD-iPS (DYS-HAC)5
AC CVCL_C985
DR ISCR; 1818
RX PubMed=19997091;
CC From: Tottori University; Tottori; Japan.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L752 ! GM05169
SX Male
CA Induced pluripotent stem cell
//
ID DMD-iPS (DYS-HAC)6
AC CVCL_C986
DR ISCR; 1819
RX PubMed=19997091;
CC From: Tottori University; Tottori; Japan.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L752 ! GM05169
SX Male
CA Induced pluripotent stem cell
//
ID DMD-iPS (DYS-HAC)7
AC CVCL_C987
DR ISCR; 1820
RX PubMed=19997091;
CC From: Tottori University; Tottori; Japan.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L752 ! GM05169
SX Male
CA Induced pluripotent stem cell
//
ID DMD-iPS (DYS-HAC)8
AC CVCL_C988
DR ISCR; 1821
RX PubMed=19997091;
CC From: Tottori University; Tottori; Japan.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L752 ! GM05169
SX Male
CA Induced pluripotent stem cell
//
ID DMD-iPS (DYS-HAC)9
AC CVCL_C989
DR ISCR; 1822
RX PubMed=19997091;
CC From: Tottori University; Tottori; Japan.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L752 ! GM05169
SX Male
CA Induced pluripotent stem cell
//
ID DMD-iPS1 [Human iPSC Boston]
AC CVCL_C990
SY DMD-IPS1
DR ISCR; 19
RX Patent=US20110151447;
RX PubMed=18691744;
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C84587; Becker's muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8521 ! GM04981
SX Male
CA Induced pluripotent stem cell
//
ID DMD-iPS1 [Human iPSC Tottori]
AC CVCL_C991
DR ISCR; 1823
RX PubMed=19997091;
CC From: Tottori University; Tottori; Japan.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L752 ! GM05169
SX Male
CA Induced pluripotent stem cell
//
ID DMD-iPS2 [Human iPSC Boston]
AC CVCL_C992
SY DMD-IPS2
DR ISCR; 20
RX Patent=US20110151447;
RX PubMed=18691744;
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C84587; Becker's muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_8521 ! GM04981
SX Male
CA Induced pluripotent stem cell
//
ID DMD-iPS2 [Human iPSC Tottori]
AC CVCL_C993
DR ISCR; 1824
RX PubMed=19997091;
CC From: Tottori University; Tottori; Japan.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L752 ! GM05169
SX Male
CA Induced pluripotent stem cell
//
ID DMDCl2
AC CVCL_6B26
RX PubMed=22040608;
CC Transfected with: HGNC; 1773; CDK4.
CC Transfected with: HGNC; 11730; TERT.
DI NCIt; C75482; Duchenne muscular dystrophy
OX NCBI_TaxID=9606; ! Homo sapiens
CA Telomerase immortalized cell line
//
ID DMS 106
AC CVCL_Z037
RX PubMed=6266631;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DMS 114
AC CVCL_1174
SY DMS-114; DMS114
DR BTO; BTO:0004813
DR CLO; CLO_0002795
DR EFO; EFO_0002162
DR ATCC; CRL-2066
DR BioSample; SAMN03471429
DR CCLE; DMS114_LUNG
DR ChEMBL-Cells; CHEMBL3307670
DR ChEMBL-Targets; CHEMBL614642
DR Cosmic; 687983
DR Cosmic; 1436016
DR Cosmic; 2125177
DR Cosmic-CLP; 687983
DR GDSC; 687983
DR GEO; GSM784211
DR GEO; GSM886980
DR GEO; GSM888049
DR GEO; GSM1374464
DR GEO; GSM1374465
DR GEO; GSM1374466
DR GEO; GSM1669735
DR IGRhCellID; DMS114
RX PubMed=6266631;
RX PubMed=9212023;
RX PubMed=9744504;
RX PubMed=12712436;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=27397505;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: FGFR genetic alteration cell panel (ATCC TCP-1034).
CC Part of: JFCR39 cancer cell line panel.
CC Part of: KuDOS 95 cell line panel.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 13
ST D16S539: 12
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 8,9.3
ST TPOX: 8,11
ST vWA: 16,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DMS 139
AC CVCL_Z038
RX PubMed=6266631;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Z039 ! DMS 148
OI CVCL_Z040 ! DMS 149
CA Cancer cell line
//
ID DMS 148
AC CVCL_Z039
RX PubMed=6266631;
CC Derived from metastatic site: Liver.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Z038 ! DMS 139
OI CVCL_Z040 ! DMS 149
CA Cancer cell line
//
ID DMS 149
AC CVCL_Z040
RX PubMed=6266631;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Z038 ! DMS 139
OI CVCL_Z039 ! DMS 148
CA Cancer cell line
//
ID DMS 153
AC CVCL_1175
SY DMS-153; DMS153
DR CLO; CLO_0002796
DR EFO; EFO_0002163
DR CLDB; cl1078
DR ATCC; CRL-2064
DR BioSample; SAMN03471428
DR BioSample; SAMN03472954
DR CCLE; DMS153_LUNG
DR CCRID; 3142C0001000000139
DR ChEMBL-Cells; CHEMBL3308260
DR ChEMBL-Targets; CHEMBL2366167
DR Cosmic; 687984
DR Cosmic; 2125220
DR ECACC; 95062827
DR GDSC; 687984
DR GEO; GSM827561
DR GEO; GSM886981
DR GEO; GSM888050
DR IGRhCellID; DMS153
RX PubMed=6266631;
RX PubMed=9744504;
RX PubMed=12712436;
RX PubMed=22460905;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Liver.
ST Source(s): ATCC; ECACC; PubMed=25877200
ST Amelogenin: X (ATCC)
ST Amelogenin: X,Y (ECACC; PubMed=25877200)
ST CSF1PO: 10
ST D13S317: 13 (ATCC; ECACC)
ST D13S317: 12,13 (PubMed=25877200)
ST D16S539: 12,13
ST D18S51: 16,17
ST D21S11: 26.2,30
ST D3S1358: 14,17
ST D5S818: 12
ST D7S820: 8,10
ST D8S1179: 12,14
ST FGA: 21
ST Penta D: 9,12
ST Penta E: 12,13
ST TH01: 7,9.3
ST TPOX: 11
ST vWA: 14,15
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_Z033 ! DMS 154
SX Male
CA Cancer cell line
//
ID DMS 154
AC CVCL_Z033
RX PubMed=6266631;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1175 ! DMS 153
SX Male
CA Cancer cell line
//
ID DMS 187
AC CVCL_Z041
RX PubMed=6266631;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DMS 217
AC CVCL_Z042
RX PubMed=6266631;
CC Derived from metastatic site: Pericardial mass.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DMS 235
AC CVCL_Z043
RX PubMed=6266631;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DMS 273
AC CVCL_1176
SY DMS-273; DMS273
DR BTO; BTO:0005903
DR CLO; CLO_0002797
DR EFO; EFO_0002164
DR CLDB; cl1079
DR BioSample; SAMN03472955
DR CCLE; DMS273_LUNG
DR ChEMBL-Cells; CHEMBL3308487
DR ChEMBL-Targets; CHEMBL614034
DR Cosmic; 687985
DR Cosmic; 1436015
DR Cosmic; 1609521
DR Cosmic; 2125191
DR Cosmic-CLP; 687985
DR ECACC; 95062830
DR GDSC; 687985
DR GEO; GSM827419
DR GEO; GSM886982
DR GEO; GSM888051
DR GEO; GSM1669736
DR IGRhCellID; DMS273
RX PubMed=9212023;
RX PubMed=9744504;
RX PubMed=12712436;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12,13
ST D16S539: 11
ST D18S51: 12,16
ST D21S11: 28,31
ST D3S1358: 16
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 12,13
ST FGA: 20
ST Penta D: 9,11
ST Penta E: 13
ST TH01: 9.3
ST TPOX: 10
ST vWA: 15
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID DMS 406
AC CVCL_0B91
SY DMS406
RX PubMed=9212023;
RX PubMed=9744504;
RX PubMed=12712436;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DMS 44
AC CVCL_Z034
RX PubMed=190410;
RX PubMed=222962;
RX PubMed=6266631;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DMS 454
AC CVCL_2438
SY DMS-454; DMS454
DR CLO; CLO_0002798
DR EFO; EFO_0006390
DR CLDB; cl1080
DR BioSample; SAMN03472956
DR CCLE; DMS454_LUNG
DR ECACC; 95062832
DR GEO; GSM886983
DR GEO; GSM888052
RX PubMed=22460905;
RX PubMed=25485619;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ECACC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11,12
ST D16S539: 11,13
ST D18S51: 12
ST D21S11: 29
ST D3S1358: 16
ST D5S818: 12
ST D7S820: 8
ST D8S1179: 12,13
ST FGA: 21,22
ST Penta D: 9
ST Penta E: 10,14
ST TH01: 6,9
ST TPOX: 8
ST vWA: 18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DMS 456
AC CVCL_0B92
SY DMS456
RX PubMed=9212023;
RX PubMed=9744504;
RX PubMed=12712436;
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DMS 47
AC CVCL_Z035
RX PubMed=6266631;
CC Derived from metastatic site: Liver.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DMS 53
AC CVCL_1177
SY DMS-53; DMS53
DR BTO; BTO:0005668
DR CLO; CLO_0002799
DR EFO; EFO_0002165
DR CLDB; cl1081
DR ATCC; CRL-2062
DR BioSample; SAMN03472957
DR CCLE; DMS53_LUNG
DR ChEMBL-Cells; CHEMBL3308726
DR ChEMBL-Targets; CHEMBL1075434
DR Cosmic; 907295
DR Cosmic; 2125221
DR Cosmic-CLP; 907295
DR ECACC; 95062823
DR GDSC; 907295
DR GEO; GSM17307
DR GEO; GSM169436
DR GEO; GSM886984
DR GEO; GSM888053
DR GEO; GSM1669737
DR IGRhCellID; DMS53
RX PubMed=6266631;
RX PubMed=9744504;
RX PubMed=12712436;
RX PubMed=15016488;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=DMS%2053
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 10
ST D16S539: 12,13
ST D18S51: 15,16
ST D21S11: 33.2
ST D3S1358: 15
ST D5S818: 10,11
ST D7S820: 8,11
ST D8S1179: 12
ST FGA: 20
ST Penta D: 10
ST Penta E: 13
ST TH01: 8,9.3
ST TPOX: 12
ST vWA: 15,17
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DMS 55
AC CVCL_Z036
RX PubMed=6266631;
CC Derived from metastatic site: Bone marrow.
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DMS 79
AC CVCL_1178
SY DMS-79; DMS79
DR CLO; CLO_0002800
DR CLO; CLO_0002802
DR EFO; EFO_0002166
DR CLDB; cl1082
DR CLDB; cl4907
DR ATCC; CRL-2049
DR BioSample; SAMN03473247
DR CCLE; DMS79_LUNG
DR ChEMBL-Cells; CHEMBL3307581
DR ChEMBL-Targets; CHEMBL614286
DR CLS; 300164/p548_DMS-79
DR Cosmic; 753551
DR Cosmic; 1609526
DR Cosmic-CLP; 753551
DR ECACC; 95062824
DR GDSC; 753551
DR GEO; GSM17308
DR GEO; GSM169445
DR GEO; GSM886985
DR GEO; GSM888054
DR GEO; GSM1669738
DR ICLC; HTL98009
DR IGRhCellID; DMS79
RX PubMed=6266631;
RX PubMed=9744504;
RX PubMed=12712436;
RX PubMed=15016488;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=DMS%2079
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'DMS76' in PubMed=20439192.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): ATCC; CLS; Cosmic-CLP; DSMZ; ECACC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 10
ST D13S317: 11
ST D16S539: 12
ST D18S51: 14,17
ST D21S11: 30
ST D3S1358: 18
ST D5S818: 10
ST D7S820: 9,11
ST D8S1179: 12,14
ST FGA: 21
ST Penta D: 11,13
ST Penta E: 7
ST TH01: 8
ST TPOX: 8
ST vWA: 18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DMS 92
AC CVCL_2439
SY DMS-92; DMS92
DR CLO; CLO_0002801
DR CLDB; cl1083
DR BioSample; SAMN03472958
DR Cosmic; 929980
DR ECACC; 95062825
DR GEO; GSM827447
RX PubMed=6266631;
RX PubMed=9212023;
RX PubMed=9744504;
CC Derived from metastatic site: Bone marrow.
ST Source(s): ECACC; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,13
ST D13S317: 12
ST D16S539: 12,13
ST D18S51: 13,14
ST D21S11: 28,31
ST D3S1358: 15
ST D5S818: 11,13
ST D7S820: 10,11
ST D8S1179: 10,12
ST FGA: 22,24
ST Penta D: 11,12
ST Penta E: 10,12
ST TH01: 9.3
ST TPOX: 8,12
ST vWA: 16,18
DI NCIt; C4917; Small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DMyc3-45
AC CVCL_U810
DR CLO; CLO_0050241
DR RCB; RCB1606
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID DMyc9-36
AC CVCL_U811
DR CLO; CLO_0050244
DR RCB; RCB1610
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybridoma
//
ID DN-30
AC CVCL_IQ99
SY DN30
RX Patent=EP2127683A1;
RX PubMed=9405310;
CC Registration: International Depositary Authority, Advanced Biotechnology Center (ABC), Interlab Cell Line Collection (ICLC), Italy; PD 05006.
CC Monoclonal antibody target: UniProtKB; P08581; Human MET.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID DN435.5
AC CVCL_V372
DR IMGT/HLA; 14468
RX PubMed=16948657;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID DND-10B
AC CVCL_E994
SY DND
DR Cosmic; 733813
RX CelloPub=CLPUB00035;
RX PubMed=3334988;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DND-39
AC CVCL_2021
SY DND39
DR BioSample; SAMN03473461
DR CGH-DB; 9197-4
DR Cosmic; 919151
DR DSMZ; ACC-648
CC Characteristics: EBV-negative.
CC Doubling time: ~30-50 hours (DSMZ).
CC Misspelling: 'OND39' in Cosmic 919151.
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 11
ST D16S539: 9,13
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 15,19
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DND-41
AC CVCL_2022
SY DND 41; DND41; Dnd41
DR EFO; EFO_0007074
DR BioSample; SAMN03473521
DR CCLE; DND41_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 721705
DR Cosmic; 801725
DR Cosmic; 913405
DR Cosmic; 933551
DR Cosmic; 944546
DR Cosmic; 998728
DR Cosmic; 1037686
DR Cosmic; 1115582
DR Cosmic; 1118466
DR Cosmic; 1151777
DR Cosmic; 1175127
DR Cosmic; 1224375
DR Cosmic; 1281366
DR Cosmic; 1330488
DR Cosmic; 1375579
DR Cosmic; 1524795
DR Cosmic; 1664514
DR Cosmic; 1641377
DR Cosmic; 1760521
DR Cosmic; 2165710
DR Cosmic-CLP; 1297446
DR DSMZ; ACC-525
DR ENCODE; ENCBS282AAA
DR ENCODE; ENCBS688JZQ
DR GDSC; 1297446
DR GEO; GSM886986
DR GEO; GSM888055
DR GEO; GSM1669739
DR NCBI_Iran; C183
RX PubMed=9933131;
RX PubMed=10071127;
RX PubMed=22460905;
RX PubMed=22675565;
RX PubMed=27397505;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/Dnd41_Bernstein_protocol.pdf
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ENCODE project common cell types; tier 3.
CC Doubling time: ~35 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: H3K4me3 ChIP-seq epigenome analysis.
CC Omics: H3K79me2 ChIP-seq epigenome analysis.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: H4K20me1 ChIP-seq epigenome analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 10,11
ST D16S539: 10,14
ST D5S818: 12,13
ST D7S820: 8,12
ST TH01: 8,10
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DNI.Bl
AC CVCL_R958
DR ATCC; CRL-6002
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6002; true.
OX NCBI_TaxID=9361; ! Dasypus novemcinctus
OI CVCL_R959 ! DNI.F
OI CVCL_R960 ! DNI.Ht
OI CVCL_R961 ! DNI.K
OI CVCL_R962 ! DNI.Lu
OI CVCL_R963 ! DNI.Sk
OI CVCL_R964 ! DNI.Sp
OI CVCL_3676 ! DNI.Tr
SX Male
CA Finite cell line
//
ID DNI.F
AC CVCL_R959
DR ATCC; CRL-6003
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6003; true.
OX NCBI_TaxID=9361; ! Dasypus novemcinctus
OI CVCL_R958 ! DNI.Bl
OI CVCL_R960 ! DNI.Ht
OI CVCL_R961 ! DNI.K
OI CVCL_R962 ! DNI.Lu
OI CVCL_R963 ! DNI.Sk
OI CVCL_R964 ! DNI.Sp
OI CVCL_3676 ! DNI.Tr
SX Male
CA Finite cell line
//
ID DNI.Ht
AC CVCL_R960
DR ATCC; CRL-6004
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6004; true.
OX NCBI_TaxID=9361; ! Dasypus novemcinctus
OI CVCL_R958 ! DNI.Bl
OI CVCL_R959 ! DNI.F
OI CVCL_R961 ! DNI.K
OI CVCL_R962 ! DNI.Lu
OI CVCL_R963 ! DNI.Sk
OI CVCL_R964 ! DNI.Sp
OI CVCL_3676 ! DNI.Tr
SX Male
CA Finite cell line
//
ID DNI.K
AC CVCL_R961
DR ATCC; CRL-6005
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6005; true.
OX NCBI_TaxID=9361; ! Dasypus novemcinctus
OI CVCL_R958 ! DNI.Bl
OI CVCL_R959 ! DNI.F
OI CVCL_R960 ! DNI.Ht
OI CVCL_R962 ! DNI.Lu
OI CVCL_R963 ! DNI.Sk
OI CVCL_R964 ! DNI.Sp
OI CVCL_3676 ! DNI.Tr
SX Male
CA Finite cell line
//
ID DNI.Lu
AC CVCL_R962
DR ATCC; CRL-6006
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6006; true.
OX NCBI_TaxID=9361; ! Dasypus novemcinctus
OI CVCL_R958 ! DNI.Bl
OI CVCL_R959 ! DNI.F
OI CVCL_R960 ! DNI.Ht
OI CVCL_R961 ! DNI.K
OI CVCL_R963 ! DNI.Sk
OI CVCL_R964 ! DNI.Sp
OI CVCL_3676 ! DNI.Tr
SX Male
CA Finite cell line
//
ID DNI.Sk
AC CVCL_R963
DR ATCC; CRL-6007
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6007; true.
OX NCBI_TaxID=9361; ! Dasypus novemcinctus
OI CVCL_R958 ! DNI.Bl
OI CVCL_R959 ! DNI.F
OI CVCL_R960 ! DNI.Ht
OI CVCL_R961 ! DNI.K
OI CVCL_R962 ! DNI.Lu
OI CVCL_R964 ! DNI.Sp
OI CVCL_3676 ! DNI.Tr
SX Male
CA Finite cell line
//
ID DNI.Sp
AC CVCL_R964
DR ATCC; CRL-6008
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6008; true.
OX NCBI_TaxID=9361; ! Dasypus novemcinctus
OI CVCL_R958 ! DNI.Bl
OI CVCL_R959 ! DNI.F
OI CVCL_R960 ! DNI.Ht
OI CVCL_R961 ! DNI.K
OI CVCL_R962 ! DNI.Lu
OI CVCL_R963 ! DNI.Sk
OI CVCL_3676 ! DNI.Tr
SX Male
CA Finite cell line
//
ID DNI.Tr
AC CVCL_3676
DR CLO; CLO_0002803
DR ATCC; CRL-6009
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
OX NCBI_TaxID=9361; ! Dasypus novemcinctus
OI CVCL_R958 ! DNI.Bl
OI CVCL_R959 ! DNI.F
OI CVCL_R960 ! DNI.Ht
OI CVCL_R961 ! DNI.K
OI CVCL_R962 ! DNI.Lu
OI CVCL_R963 ! DNI.Sk
OI CVCL_R964 ! DNI.Sp
SX Male
CA Finite cell line
//
ID Dnmt1-/-Dnmt3a-/-Dnmt3b-/- ES (clone19)
AC CVCL_1T48
DR RCB; AES0146
RX PubMed=16824199;
CC Knockout cell: Method=Homologous recombination; MGI; MGI:94912; Dnmt1.
CC Knockout cell: Method=Homologous recombination; MGI; MGI:1261827; Dnmt3a.
CC Knockout cell: Method=Homologous recombination; MGI; MGI:1261819; Dnmt3b.
CC Discontinued: RCB; AES0146; probable.
CC Breed/subspecies: 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6412 ! J1
SX Male
CA Embryonic stem cell
//
ID Dnmt3a-/- ES (clone 6aa)
AC CVCL_0J16
SY Line 6aa
DR RCB; AES0164
RX PubMed=10555141;
CC Knockout cell: Method=Homologous recombination; MGI; MGI:1261827; Dnmt3a.
CC Breed/subspecies: 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6412 ! J1
SX Male
CA Embryonic stem cell
//
ID Dnmt3b-/- ES (clone 8bb)
AC CVCL_0J17
SY Line 8bb
DR RCB; AES0165
RX PubMed=10555141;
CC Knockout cell: Method=Homologous recombination; MGI; MGI:1261819; Dnmt3b.
CC Breed/subspecies: 129S4/SvJae.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6412 ! J1
SX Male
CA Embryonic stem cell
//
ID DNRR1
AC CVCL_M723
RX PubMed=6135505;
CC Selected for resistance to: ChEBI; CHEBI:41977; Daunorubicin (Daunomycin).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_M722 ! CHO-AUXE29
SX Female
CA Spontaneously immortalized cell line
//
ID DNRR15
AC CVCL_M724
RX PubMed=6135505;
CC Selected for resistance to: ChEBI; CHEBI:41977; Daunorubicin (Daunomycin).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_M722 ! CHO-AUXE29
SX Female
CA Spontaneously immortalized cell line
//
ID DNRR159
AC CVCL_M725
RX PubMed=2412130;
RX PubMed=6135505;
CC Selected for resistance to: ChEBI; CHEBI:41977; Daunorubicin (Daunomycin).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_M722 ! CHO-AUXE29
SX Female
CA Spontaneously immortalized cell line
//
ID DNRR5
AC CVCL_M726
RX PubMed=6135505;
CC Selected for resistance to: ChEBI; CHEBI:41977; Daunorubicin (Daunomycin).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_D264 ! CHO-AUXB1
SX Female
CA Spontaneously immortalized cell line
//
ID DNRR51
AC CVCL_M727
RX PubMed=2412130;
RX PubMed=6135505;
CC Selected for resistance to: ChEBI; CHEBI:41977; Daunorubicin (Daunomycin).
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_D264 ! CHO-AUXB1
SX Female
CA Spontaneously immortalized cell line
//
ID Do-11-10
AC CVCL_4163
SY Do11.10; DO11.10
DR BTO; BTO:0004333
DR ECACC; 85082301
DR Lonza; 881
DR TOKU-E; 4126
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/d/cell-lines-detail-77.html
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3896 ! BW5147
CA Hybridoma
//
ID DO-24
AC CVCL_IR00
RX PubMed=9405310;
CC Monoclonal antibody target: UniProtKB; P08581; Human MET.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID DO-s
AC CVCL_5478
RX PubMed=2548714;
DI NCIt; C4026; Ovarian mucinous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID DOBIL-6
AC CVCL_M490
RX PubMed=9674742;
RX PubMed=10936422;
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID DoCl1 (S+L-)
AC CVCL_4164
SY S+L- DoCl1
DR CLO; CLO_0002804
DR CLDB; cl1085
DR ATCC; CCL-34.1
DR ECACC; 90102523
RX PubMed=52940;
CC Transformant: NCBI_TaxID; 11801; Moloney murine leukemia virus (MoMuLV).
CC Breed/subspecies: Cocker Spaniel.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_0422 ! MDCK
SX Female
CA Transformed cell line
//
ID DoGKiT
AC CVCL_2023
SY DOGKIT
DR BioSample; SAMN03473509
DR DSMZ; ACC-629
RX PubMed=17562080;
RX PubMed=17622530;
CC Characteristics: EBV-negative.
CC Doubling time: ~40-50 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 10,12
ST D13S317: 9,12
ST D16S539: 11,13
ST D5S818: 11
ST D7S820: 9,11
ST TH01: 6,9
ST TPOX: 8
ST vWA: 14,16
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DogL1
AC CVCL_BS94
DR CCRID; 3153C0001000000102
DR KCB; KCB 90014
OX NCBI_TaxID=9615; ! Canis lupus familiaris
CA Finite cell line
//
ID DOGUM
AC CVCL_2024
SY DoGum
DR BioSample; SAMN03473458
DR DSMZ; ACC-644
RX PubMed=17562080;
CC Characteristics: EBV-negative.
CC Doubling time: ~50 hours, but up to 100 hours after recovery from liquid nitrogen freezing (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8
ST D16S539: 11,12
ST D5S818: 12
ST D7S820: 11,12
ST TH01: 9,9.3
ST TPOX: 11
ST vWA: 16,17
DI NCIt; C7954; Adult Burkitt leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID DoHH2
AC CVCL_1179
SY DOHH2; DoHH-2; DOHH-2
DR CLO; CLO_0002805
DR EFO; EFO_0002167
DR CLDB; cl1086
DR CLDB; cl4974
DR BioSample; SAMN03472093
DR CCLE; DOHH2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308537
DR ChEMBL-Targets; CHEMBL2366181
DR Cosmic; 906842
DR Cosmic; 1086332
DR Cosmic; 1629929
DR Cosmic; 1995387
DR Cosmic; 2297004
DR Cosmic; 2437317
DR Cosmic-CLP; 906842
DR DSMZ; ACC-47
DR ENCODE; ENCBS100ZVH
DR ENCODE; ENCBS652PBR
DR ENCODE; ENCBS662OGM
DR ENCODE; ENCBS898JGF
DR GDSC; 906842
DR GEO; GSM115817
DR GEO; GSM179646
DR GEO; GSM201345
DR GEO; GSM886987
DR GEO; GSM888056
DR GEO; GSM1374467
DR GEO; GSM1669740
DR ICLC; HTL99022
DR IGRhCellID; DOHH2
DR IZSLER; BS TCL 228
DR Lonza; 666
RX PubMed=7849311;
RX PubMed=16960149;
RX PubMed=22460905;
RX PubMed=23699601;
RX PubMed=25355872;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Genome sequenced.
CC Omics: H3K9ac ChIP-seq epigenome analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using RNAseq.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 11,12
ST D13S317: 12,13
ST D16S539: 11,14
ST D18S51: 11,14
ST D21S11: 30
ST D3S1358: 15,17
ST D5S818: 11,12
ST D7S820: 11
ST D8S1179: 13,16
ST FGA: 21,27
ST Penta D: 9,12
ST Penta E: 12,16
ST TH01: 9
ST TPOX: 8,11
ST vWA: 14,19
DI NCIt; C8851; Diffuse large B-cell lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DOK
AC CVCL_1180
SY Dysplastic Oral Keratinocyte
DR CLO; CLO_0002806
DR EFO; EFO_0006564
DR CLDB; cl1087
DR BioSample; SAMN03473147
DR ChEMBL-Cells; CHEMBL3308727
DR ChEMBL-Targets; CHEMBL1075435
DR Cosmic; 910936
DR Cosmic; 1339915
DR Cosmic-CLP; 910936
DR ECACC; 94122104
DR GDSC; 910936
DR GEO; GSM827453
DR GEO; GSM1374468
DR GEO; GSM1431134
DR GEO; GSM1669741
DR Ximbio; 153251
RX PubMed=1459732;
RX PubMed=25169794;
RX PubMed=25485619;
RX PubMed=26234610;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Proteome analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 11,13
ST D16S539: 9,12
ST D18S51: 12,15
ST D21S11: 29,31
ST D3S1358: 17
ST D5S818: 12
ST D7S820: 11,13
ST D8S1179: 9,15
ST FGA: 20,23
ST Penta D: 9,14
ST Penta E: 10,12
ST TH01: 6,8
ST TPOX: 10
ST vWA: 14,18
DI NCIt; C129863; Oral dysplasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Don
AC CVCL_3472
SY DON; CCL16; CHD; Chinese Hamster Don; CHL-Don
DR BTO; BTO:0000354
DR CLO; CLO_0002807
DR CLDB; cl1088
DR CLDB; cl1089
DR ATCC; CCL-16
DR ChEMBL-Cells; CHEMBL3307359
DR ChEMBL-Targets; CHEMBL614288
DR ECACC; 87091501
DR IZSLER; BS CL 37
DR KCB; KCB 82010YJ
RX PubMed=483122;
RX PubMed=1027147;
RX PubMed=4038934;
RX PubMed=7065527;
RX PubMed=14171598;
RX PubMed=14328610;
RX PubMed=19291904;
OX NCBI_TaxID=10029; ! Cricetulus griseus
SX Male
CA Spontaneously immortalized cell line
//
ID Don D-6
AC CVCL_5634
SY Don(D-6)
DR CLO; CLO_0051574
DR RCB; RCB0096
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_3472 ! Don
SX Male
CA Spontaneously immortalized cell line
//
ID Don Q
AC CVCL_J503
SY CdtR-Q
RX PubMed=1816487;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_3472 ! Don
SX Male
CA Spontaneously immortalized cell line
//
ID Don/a23
AC CVCL_K265
SY a23; A23; A-23
RX CelloPub=CLPUB00259;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_3472 ! Don
SX Male
CA Spontaneously immortalized cell line
//
ID Don/a3
AC CVCL_1Q37
SY DON-a3; a3; A3
RX CelloPub=CLPUB00259;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_3472 ! Don
SX Male
CA Spontaneously immortalized cell line
//
ID DOP-ND
AC CVCL_E569
DR dbMHC; 48763
DR ECACC; 94022527
DR IHW; IHW9225
DR IMGT/HLA; 10517
WW http://bioinformatics.hsanmartino.it/ecbr/cl225.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID Dopa.4U
AC CVCL_1E61
WW http://axiogenesis.com/products/neuronal-cells/dopa-4u-hipsc-dopaminergic-neurons.html
WW http://axiogenesis.com/images/phocadownload/flyers/Dopa.4U_Flyer.pdf
CC From: Axiogenesis AG; Germany.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Induced pluripotent stem cell
//
ID Dor Bel
AC CVCL_U678
DR ATCC; CRL-1188
RX PubMed=3860870;
CC Discontinued: ATCC; CRL-1188; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Dor Son
AC CVCL_U687
DR ATCC; CRL-1126
CC Discontinued: ATCC; CRL-1126; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID DoSmi
AC CVCL_CZ87
RX PubMed=2720636;
RX PubMed=4038916;
RX PubMed=7153601;
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID DoTc2 4510
AC CVCL_1181
SY DoTc2-4510; DOTC2-4510; DoTc2
DR CLO; CLO_0002808
DR EFO; EFO_0002171
DR ATCC; CRL-7920
DR BioSample; SAMN03471123
DR ChEMBL-Cells; CHEMBL3308728
DR ChEMBL-Targets; CHEMBL1075436
DR Cosmic; 687508
DR Cosmic; 906843
DR Cosmic; 1995388
DR Cosmic-CLP; 906843
DR GDSC; 906843
DR GEO; GSM113862
DR GEO; GSM675734
DR GEO; GSM685440
DR GEO; GSM1669742
DR IGRhCellID; DoTc2
RX PubMed=27397505;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 12,13
ST D5S818: 14
ST D7S820: 11,13
ST TH01: 7
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C9039; Cervical carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID DOV13
AC CVCL_6774
SY DOV-13; DOV 13
DR BTO; BTO:0003638
DR BioSample; SAMN03470841
DR ChEMBL-Cells; CHEMBL3307753
DR ChEMBL-Targets; CHEMBL615004
DR Cosmic; 924143
DR Cosmic; 927565
DR Cosmic-CLP; 1479987
DR GDSC; 1479987
DR GEO; GSM659373
DR GEO; GSM851916
DR GEO; GSM1669743
DR Lonza; 269
RX PubMed=1536252;
RX PubMed=7836420;
RX PubMed=10972993;
RX PubMed=22710073;
RX PubMed=23415752;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27561551;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'DOR 13' in PubMed=25485619 and PubMed=25877200.
ST Source(s): Cosmic-CLP; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 8,10
ST D13S317: 11
ST D16S539: 10,13
ST D18S51: 12,16
ST D21S11: 32.2,33.2
ST D3S1358: 14,16
ST D5S818: 11
ST D7S820: 10
ST D8S1179: 14
ST FGA: 21,24
ST Penta D: 3.2,8
ST Penta E: 8
ST TH01: 6,9.3
ST TPOX: 6,8
ST vWA: 19
DI NCIt; C7700; Ovarian adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID DP-6
AC CVCL_9542
RX PubMed=8656685;
RX PubMed=10936422;
CC Characteristics: IL6 dependent.
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID DP0002
AC CVCL_8W09
DR ECACC; 95100605
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C2989; DiGeorge syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID DP31
AC CVCL_DP75
SY Dental Pulp cells 31
RX PubMed=20554890;
ST Source(s): PubMed=20554890
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 8,10
ST D16S539: 10
ST D18S51: 15
ST D21S11: 30
ST D3S1358: 16,17
ST D5S818: 11,12
ST D7S820: 10,12
ST D8S1179: 12,15
ST FGA: 21,23
ST Penta D: 12,14
ST Penta E: 16,19
ST TH01: 7
ST TPOX: 8,11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID DP74
AC CVCL_DP68
SY Dental Pulp cells 74
DR GEO; GSM1040300
DR GEO; GSM1040370
DR GEO; GSM1493717
RX PubMed=20554890;
RX PubMed=21460823;
RX PubMed=24259714;
CC Omics: DNA methylation analysis.
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=21460823
ST Amelogenin: X
ST CSF1PO: 12,14
ST D13S317: 10,14
ST D16S539: 9,10
ST D18S51: 13,19
ST D21S11: 29,30
ST D3S1358: 17
ST D5S818: 12,13
ST D7S820: 11
ST D8S1179: 11,12
ST FGA: 21,24
ST Penta D: 10,13
ST Penta E: 5,15
ST TH01: 7
ST TPOX: 8
ST vWA: 17,21
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID DP75
AC CVCL_DP76
SY Dental Pulp cells 75
RX PubMed=20554890;
ST Source(s): PubMed=20554890
ST Amelogenin: X,Y
ST CSF1PO: 9,11
ST D13S317: 9,11
ST D16S539: 8,11
ST D18S51: 13,16
ST D21S11: 28,29
ST D3S1358: 14
ST D5S818: 10,11
ST D7S820: 7,10
ST D8S1179: 13,14
ST FGA: 22,24
ST Penta D: 8,11
ST Penta E: 12,16
ST TH01: 5,8
ST TPOX: 8,11
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID DP94
AC CVCL_DQ50
SY Dental Pulp cells 94
RX PubMed=20554890;
RX PubMed=21460823;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID DPC-1
AC CVCL_DN59
SY DPC1; Dog Prostate Carcinoma-1
RX Patent=US20030013191;
RX PubMed=11170126;
RX PubMed=21882212;
RX PubMed=26714499;
CC Registration: International Depositary Authority, Pasteur Institute Collection Nationale de Cultures de Micro-organismes (CNCM); I-2279.
CC Breed/subspecies: Doberman Pinscher.
DI NCIt; C128122; Canine prostate carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
SX Male
CA Cancer cell line
//
ID DPK
AC CVCL_7188
DR Lonza; 1306
RX PubMed=1423605;
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID DPK-SKDF-H
AC CVCL_U979
DR BTO; BTO:0003254
CC From: Dominion Pharmakine (Bizkaia, Spain) which ceased operation.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID DPM
AC CVCL_0P21
SY Dental Papilla Mesenchyme
RX PubMed=16927272;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID DpN1
AC CVCL_Z404
RX PubMed=12573024;
RX PubMed=20574041;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
OX NCBI_TaxID=13037; ! Danaus plexippus
SX Female
CA Spontaneously immortalized cell line
//
ID DPSC
AC CVCL_AV90
SY Dental Pulp Stem Cells
DR CLS; 300702/p4504_DPSC
OX NCBI_TaxID=9606; ! Homo sapiens
CA Adult stem cell
//
ID DPSO 114/74
AC CVCL_6386
DR CLO; CLO_0002811
DR ATCC; CCL-194
RX PubMed=7065527;
RX PubMed=11528123;
WW http://www.mdanderson.org/education-and-research/departments-programs-and-labs/programs-centers-institutes/michale-e-keeling-center-for-comparative-medicine-and-research/animal-resources/squirel-monkey-cell-lines.html
CC Group: Non-human primate cell line.
OX NCBI_TaxID=495297; ! Saimiri boliviensis peruviensis
SX Male
CA Finite cell line
//
ID DPW 5
AC CVCL_V076
DR CLO; CLO_0002812
DR CLDB; cl1093
DR IHW; IHW8307
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID DQSHS1
AC CVCL_BS95
DR KCB; KCB 94026
CC Breed/subspecies: Diqing.
OX NCBI_TaxID=9940; ! Ovis aries
CA Finite cell line
//
ID DR 9
AC CVCL_V077
DR CLO; CLO_0002813
DR CLDB; cl1094
DR IHW; IHW8139
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID DR-EcoScreen
AC CVCL_EG66
DR JCRB; JCRB1630
RX PubMed=18835618;
RX PubMed=26087926;
CC Biotechnology: Used in a bioassay for the determination of polychlorinated dibenzo-p-dioxins (PCDDs), polychlorinated dibenzofurans (PCDFs), and dioxin-like polychlorinated biphenyls (DL-PCBs) in environmental and food samples.
CC Characteristics: Acts through the activation of a luciferase gene under the control of dioxin-response elements (DREs).
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Breed/subspecies: C57L.
DI NCIt; C38756; Hepatocellular carcinoma of the mouse
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0328 ! Hepa-1c1c7
SX Female
CA Cancer cell line
//
ID DR-Wildtype
AC CVCL_J238
DR ATCC; CRL-2977
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID DR4 MEF
AC CVCL_5277
SY DR-4 MEF; MEF (DR4)
DR CLO; CLO_0002814
DR ATCC; SCRC-1045
RX PubMed=9278500;
OX NCBI_TaxID=10090; ! Mus musculus
SX Mixed sex
CA Finite cell line
//
ID DR4 MEF MITC
AC CVCL_Y468
SY MEF (DR4) MITC
DR ATCC; SCRC-1045.2
CC Discontinued: ATCC; SCRC-1045.2; true.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5277 ! DR4 MEF
SX Mixed sex
CA Finite cell line
//
ID DREG200
AC CVCL_G117
SY DREG-200
DR CLO; CLO_0002817
DR ATCC; HB-302
RX PubMed=2179952;
CC Monoclonal antibody target: UniProtKB; P14151; Human SELL/CD62L.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID DREG56
AC CVCL_G133
SY DREG-56
DR CLO; CLO_0002818
DR ATCC; HB-300
RX PubMed=2179952;
CC Monoclonal antibody target: UniProtKB; P14151; Human SELL/CD62L.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID DRHEp2
AC CVCL_W888
SY DrHep-2
DR Cosmic; 1530735
RX PubMed=17637738;
CC Problematic cell line: Contaminated. Parent cell line (HEp-2) has been shown to be a HeLa derivative (PubMed=1246601, PubMed=20143388).
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1906 ! HEp-2
SX Female
CA Cancer cell line
//
ID DRI,SM
AC CVCL_E570
SY DRI, SM
DR dbMHC; 48764
DR ECACC; 94082227
DR IHW; IHW9128
DR IMGT/HLA; 11671
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl128.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID Drill A
AC CVCL_R789
SY Drill iPSC line A
RX PubMed=21892153;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9568; ! Mandrillus leucophaeus
OI CVCL_R790 ! Drill C
OI CVCL_R791 ! Drill H
OI CVCL_R792 ! Drill J
SX Male
CA Induced pluripotent stem cell
//
ID Drill C
AC CVCL_R790
SY Drill iPSC line C
RX PubMed=21892153;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9568; ! Mandrillus leucophaeus
OI CVCL_R789 ! Drill A
OI CVCL_R791 ! Drill H
OI CVCL_R792 ! Drill J
SX Male
CA Induced pluripotent stem cell
//
ID Drill H
AC CVCL_R791
SY Drill iPSC line H
RX PubMed=21892153;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9568; ! Mandrillus leucophaeus
OI CVCL_R789 ! Drill A
OI CVCL_R790 ! Drill C
OI CVCL_R792 ! Drill J
SX Male
CA Induced pluripotent stem cell
//
ID Drill J
AC CVCL_R792
SY Drill iPSC line J
RX PubMed=21892153;
CC Group: Non-human primate cell line.
OX NCBI_TaxID=9568; ! Mandrillus leucophaeus
OI CVCL_R789 ! Drill A
OI CVCL_R790 ! Drill C
OI CVCL_R791 ! Drill H
SX Male
CA Induced pluripotent stem cell
//
ID DriPS16
AC CVCL_0H62
DR SKIP; SKIP000586
RX PubMed=25479750;
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Induced pluripotent stem cell
//
ID dRLa-74
AC CVCL_L636
RX PubMed=4258665;
CC Transformant: ChEBI; CHEBI:90994; 3,3'-diaminobenzidine (DAB).
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID dRLa-74 Clone 2
AC CVCL_6535
SY dRLa-74 cl-2; JTC-36; Japanese Tissue Culture-36
DR JCRB; JCRB0409
CC Transformant: ChEBI; CHEBI:90994; 3,3'-diaminobenzidine (DAB).
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_L636 ! dRLa-74
CA Transformed cell line
//
ID dRLh-84
AC CVCL_6536
SY dRLh84
DR JCRB; JCRB0410
RX PubMed=4258665;
CC Transformant: ChEBI; CHEBI:90994; 3,3'-diaminobenzidine (DAB).
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID dRLN-4
AC CVCL_6537
DR JCRB; JCRB0418
RX CelloPub=CLPUB00010;
CC Transformant: ChEBI; CHEBI:76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID dRLN-53
AC CVCL_E900
RX PubMed=4258665;
CC Transformant: ChEBI; CHEBI:90994; 3,3'-diaminobenzidine (DAB).
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID dRLN-6
AC CVCL_6538
DR JCRB; JCRB0420
RX CelloPub=CLPUB00010;
CC Transformant: ChEBI; CHEBI:76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID dRLN-60
AC CVCL_L637
RX PubMed=4258665;
CC Transformant: ChEBI; CHEBI:90994; 3,3'-diaminobenzidine (DAB).
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID dRLN-61
AC CVCL_L638
RX PubMed=4258665;
CC Transformant: ChEBI; CHEBI:90994; 3,3'-diaminobenzidine (DAB).
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID dRLN-9
AC CVCL_6539
DR JCRB; JCRB0419
RX CelloPub=CLPUB00010;
CC Transformant: ChEBI; CHEBI:76329; 3'-methyl-4-dimethylaminoazobenzene (3'-Me-DAB).
CC Breed/subspecies: Donryu.
OX NCBI_TaxID=10116; ! Rattus norvegicus
CA Transformed cell line
//
ID DRM
AC CVCL_1G81
SY Danio Rerio Muscle
RX PubMed=26985868;
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=50
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC050.
OX NCBI_TaxID=7955; ! Danio rerio
SX Male
CA Spontaneously immortalized cell line
//
ID DRO
AC CVCL_6286
SY DRO-90-1; DRO 90-1; DRO90-1; DRO-90; RO 90-D-1; UCLA RO 90-D-1
DR BioSample; SAMN03151608
DR BioSample; SAMN03151609
DR Cosmic; 886551
DR Cosmic; 888278
DR Cosmic; 913249
DR Cosmic; 1155330
RX PubMed=8871538;
RX PubMed=18713817;
RX PubMed=20143388;
RX PubMed=21868764;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a A-375 derivative (PubMed=18713817, PubMed=20143388, PubMed=21868764). Originally thought to originate from a thyroid gland anaplastic carcinoma.
CC From: Juillard G.J.F.; University of California, Los Angeles; Los Angeles; USA.
ST Source(s): PubMed=18713817; PubMed=21868764
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 11,14
ST D16S539: 9
ST D18S51: 12,17
ST D21S11: 29,30
ST D3S1358: 15,17
ST D5S818: 12
ST D7S820: 9
ST D8S1179: 11,14
ST FGA: 20,23
ST TH01: 8
ST TPOX: 8,10
ST vWA: 16,17
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0132 ! A-375
SX Female
CA Cancer cell line
//
ID DRP 153
AC CVCL_T701
RX PubMed=2569015;
RX PubMed=2910704;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8404; ! Lithobates pipiens
HI CVCL_4345 ! ICR-2A
CA Spontaneously immortalized cell line
//
ID DRP 36
AC CVCL_T700
SY DRP36
RX PubMed=2569015;
RX PubMed=2910704;
RX PubMed=3500873;
RX PubMed=3860965;
RX PubMed=4033674;
CC Group: Amphibian cell line.
OX NCBI_TaxID=8404; ! Lithobates pipiens
HI CVCL_4345 ! ICR-2A
CA Spontaneously immortalized cell line
//
ID DRS
AC CVCL_3677
DR CLO; CLO_0002819
DR ATCC; CRL-6497
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
SX Female
CA Finite cell line
//
ID Drsub-H
AC CVCL_DF36
RX PubMed=16948501;
CC Group: Insect cell line.
OX NCBI_TaxID=7241; ! Drosophila subobscura
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Drsub-WT
AC CVCL_DF37
RX PubMed=16948501;
CC Group: Insect cell line.
OX NCBI_TaxID=7241; ! Drosophila subobscura
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID DS-1 [Human]
AC CVCL_5278
DR CLO; CLO_0002821
DR ATCC; CRL-11102
DR BioSample; SAMN03471329
RX PubMed=8142604;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=DS-1
CC Characteristics: IL6 dependent.
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 9,12
ST D16S539: 9,10
ST D5S818: 11,14
ST D7S820: 8,14
ST TH01: 6,9.3
ST TPOX: 9,11
ST vWA: 18,19
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
DI NCIt; C97087; Lymphangiectasia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID DS-1 [Mouse hybridoma]
AC CVCL_5279
DR CLO; CLO_0002822
DR ATCC; HB-8906
RX Patent=US4656253;
RX PubMed=3277500;
CC Monoclonal antibody target: UniProtKB; P06908; Dog SFTPA1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID DS-3
AC CVCL_C450
DR CLO; CLO_0002825
DR ATCC; HB-8651
RX Patent=US4656253;
RX PubMed=3277500;
CC Monoclonal antibody target: UniProtKB; P06908; Dog SFTPA1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID DS-5
AC CVCL_C449
DR CLO; CLO_0002826
DR ATCC; HB-8653
RX Patent=US4656253;
RX PubMed=3277500;
CC Monoclonal antibody target: UniProtKB; P06908; Dog SFTPA1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID DS-6
AC CVCL_C448
DR CLO; CLO_0002827
DR ATCC; HB-8652
RX Patent=US4656253;
RX PubMed=3277500;
CC Monoclonal antibody target: UniProtKB; P06908; Dog SFTPA1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID DS-T3
AC CVCL_R775
RX PubMed=16281302;
CC Group: Cetacean cell line.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pZIP SV 776-1].
OX NCBI_TaxID=9739; ! Tursiops truncatus
SX Female
CA Transformed cell line
//
ID DS-T4
AC CVCL_R776
RX PubMed=16281302;
CC Group: Cetacean cell line.
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [pZIP SV 776-1].
OX NCBI_TaxID=9739; ! Tursiops truncatus
SX Female
CA Transformed cell line
//
ID DS1 [Mouse hybridoma]
AC CVCL_G559
DR ATCC; CRL-2484
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID DS1 [Tursiops]
AC CVCL_7893
RX PubMed=16281302;
CC Group: Cetacean cell line.
OX NCBI_TaxID=9739; ! Tursiops truncatus
SX Female
CA Finite cell line
//
ID DS1-iPS4
AC CVCL_D012
SY DS1-IPS4
DR ISCR; 21
RX Patent=US20110151447;
RX PubMed=18691744;
RX PubMed=22344463;
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L780 ! AG05397
SX Male
CA Induced pluripotent stem cell
//
ID DS179
AC CVCL_W747
SY DS 179
RX PubMed=1325212;
RX PubMed=6286763;
RX PubMed=8344493;
DI NCIt; C3457; B-cell non-Hodgkin lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DS2
AC CVCL_7894
RX PubMed=16281302;
CC Group: Cetacean cell line.
OX NCBI_TaxID=9739; ! Tursiops truncatus
SX Female
CA Finite cell line
//
ID DS2-iPS1
AC CVCL_D013
SY DS2-IPS1
DR ISCR; 22
RX Patent=US20110151447;
RX PubMed=18691744;
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D014 ! DS2-iPS10
SX Male
CA Induced pluripotent stem cell
//
ID DS2-iPS10
AC CVCL_D014
SY DS2-IPS10
DR ISCR; 23
RX Patent=US20110151447;
RX PubMed=18691744;
CC From: Children's Hospital Boston; Boston; USA.
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_D013 ! DS2-iPS1
SX Male
CA Induced pluripotent stem cell
//
ID DS3
AC CVCL_7895
RX PubMed=16281302;
CC Group: Cetacean cell line.
OX NCBI_TaxID=9739; ! Tursiops truncatus
SX Female
CA Finite cell line
//
ID DS4
AC CVCL_7896
RX PubMed=16281302;
CC Group: Cetacean cell line.
OX NCBI_TaxID=9739; ! Tursiops truncatus
SX Female
CA Finite cell line
//
ID DS5
AC CVCL_7897
RX PubMed=16281302;
CC Group: Cetacean cell line.
OX NCBI_TaxID=9739; ! Tursiops truncatus
SX Female
CA Finite cell line
//
ID DS6
AC CVCL_7898
RX PubMed=16281302;
CC Group: Cetacean cell line.
OX NCBI_TaxID=9739; ! Tursiops truncatus
SX Female
CA Finite cell line
//
ID DSDh
AC CVCL_1918
DR CLO; CLO_0002828
DR ATCC; CRL-2131
CC Group: Retrovirus packaging cell line.
CC Derived from metastatic site: Lung.
CC Breed/subspecies: Poodle.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_1916 ! D-17
SX Female
CA Cancer cell line
//
ID DSH1
AC CVCL_1182
DR ChEMBL-Cells; CHEMBL3308520
DR ChEMBL-Targets; CHEMBL2366079
DR Cosmic; 753552
DR Cosmic; 1046688
DR Cosmic; 1175826
DR Cosmic; 1285116
DR Cosmic; 1285991
DR Cosmic; 2050441
DR Cosmic; 2057445
DR Cosmic; 2444226
DR Cosmic-CLP; 753552
DR GDSC; 753552
DR GEO; GSM1669744
RX PubMed=11921286;
RX PubMed=24367658;
RX PubMed=27397505;
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP
ST Amelogenin: X,Y
ST CSF1PO: 12
ST D13S317: 8,10
ST D16S539: 10,12
ST D5S818: 11
ST D7S820: 9,11
ST TH01: 9
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DSH1PV
AC CVCL_L867
DR CLO; CLO_0002830
DR CLDB; cl1102
DI NCIt; C118435; Dyschromatosis symmetrica hereditaria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID DSH2PV
AC CVCL_L868
DR CLO; CLO_0002831
DR CLDB; cl1103
DI NCIt; C118435; Dyschromatosis symmetrica hereditaria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID DSH3PV
AC CVCL_L869
DR CLO; CLO_0002832
DR CLDB; cl1104
DI NCIt; C118435; Dyschromatosis symmetrica hereditaria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID DSH4PV
AC CVCL_L870
DR CLO; CLO_0002833
DR CLDB; cl1105
DI NCIt; C118435; Dyschromatosis symmetrica hereditaria
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID DSIR-HA-1179
AC CVCL_Z330
RX DOI=10.1007/BF02796321;
RX DOI=10.1080/03014223.1983.10423936;
RX PubMed=8799737;
RX PubMed=23979321;
CC Group: Insect cell line.
OX NCBI_TaxID=295550; ! Heteronychus arator
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID DSL-6A/C1
AC CVCL_4166
SY DSL-6A-C1; DSL6A/C1
DR CLO; CLO_0002834
DR ATCC; CRL-2132
DR CLS; 500166/p566_DSL-6A-C1
DR ECACC; 94022431
RX PubMed=8391218;
WW http://www.addexbio.com/productdetail?pid=4883
CC Transformant: ChEBI; CHEBI:74846; Azaserine.
CC Breed/subspecies: Lewis.
DI NCIt; C60682; Rat digestive system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_W197 ! DSL-6B/C1
SX Male
CA Cancer cell line
//
ID DSL-6B/C1
AC CVCL_W197
SY DSL-6B-C1; DSL6B/C1
RX PubMed=8391218;
CC Transformant: ChEBI; CHEBI:74846; Azaserine.
CC Breed/subspecies: Lewis.
DI NCIt; C60682; Rat digestive system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_4166 ! DSL-6A/C1
SX Male
CA Cancer cell line
//
ID DSL-6B/C2
AC CVCL_4167
SY DSL-6B-C2; DSL6B/C2
DR CLO; CLO_0002835
DR ATCC; CRL-2133
DR CLS; 500167/p544_DSL-6B-C2
RX PubMed=8391218;
CC Transformant: ChEBI; CHEBI:74846; Azaserine.
CC Breed/subspecies: Lewis.
DI NCIt; C60682; Rat digestive system neoplasms
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_W197 ! DSL-6B/C1
SX Male
CA Cancer cell line
//
ID DSN
AC CVCL_1919
DR CLO; CLO_0002836
DR ATCC; CRL-9939
RX Patent=US5124263;
RX PubMed=2524600;
CC Group: Retrovirus packaging cell line.
CC Derived from metastatic site: Lung.
CC Breed/subspecies: Poodle.
DI NCIt; C120045; Canine osteosarcoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
HI CVCL_1916 ! D-17
SX Female
CA Cancer cell line
//
ID DSPT200
AC CVCL_2890
DR JCRB; JCRB0217
CC Transformant: Unknown.
OX NCBI_TaxID=10036; ! Mesocricetus auratus
CA Transformed cell line
//
ID DSS3
AC CVCL_Y626
RX PubMed=23954875;
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X867 ! AG06872
SX Female
CA Induced pluripotent stem cell
//
ID DSV2
AC CVCL_Y627
RX PubMed=21861759;
DI NCIt; C2993; Down syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X867 ! AG06872
SX Female
CA Induced pluripotent stem cell
//
ID DT1CPEx
AC CVCL_1G82
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=24
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC024.
OX NCBI_TaxID=50790; ! Dascyllus trimaculatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID DT1CPTr
AC CVCL_1G83
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=26
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC026.
OX NCBI_TaxID=50790; ! Dascyllus trimaculatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID DT1F4Ex
AC CVCL_1G84
WW http://mail.nbfgr.res.in/nrfc/celldetail.php?id=25
CC Group: Fish cell line.
CC Registration: National Repository of Fish Cell Line (NRFC), National Bureau of Fish Genetic Resources, India; NRFC025.
OX NCBI_TaxID=50790; ! Dascyllus trimaculatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID DT40
AC CVCL_0249
SY DT-40; DT 40; DT40B; LSCC-DT40
DR BTO; BTO:0004814
DR CLO; CLO_0002837
DR CLO; CLO_0051524
DR EFO; EFO_0006274
DR MCCL; MCC:0000139
DR ATCC; CRL-2111
DR CCRID; 3131C0001000900002
DR DSMZ; ACC-636
DR JCRB; JCRB9130
DR Lonza; 267
DR NCBI_Iran; C618
DR RCB; RCB1464
DR TOKU-E; 1101
RX PubMed=2998040;
RX PubMed=11226459;
RX PubMed=17675859;
RX PubMed=18766641;
RX PubMed=25227228;
WW http://www2.mrc-lmb.cam.ac.uk/groups/jes/pages/dt40.html
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/d/cell-lines-detail-140.html
CC Group: Bird cell line.
CC Doubling time: ~48 hours (DSMZ).
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Omics: Genome sequenced.
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID DT40 CL18
AC CVCL_J437
SY DT40 cl18; CL18; CL-18; Clone 18
RX PubMed=2155784;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40 Cre1
AC CVCL_6D46
DR RCB; RCB1851
RX PubMed=17363341;
CC Group: Bird cell line.
CC Transfected with: UniProtKB; P01104; Avian myeloblastosis virus v-Myb.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-3KO
AC CVCL_4634
SY DT40 3KO; DT-40 3KO; Dt-40 3ko
DR BTO; BTO:0005034
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-ATM(-/-)
AC CVCL_1T23
SY ATM-/- DT40; Delta-Atm-DT40
DR CLO; CLO_0051493
DR RCB; RCB1649
RX PubMed=10597300;
RX PubMed=10654944;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; ATM.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-ATM(-/-)-XRCC6(-/-)
AC CVCL_1T24
SY ATM-/- Ku70-/- DT40; Delta-Atm-delta-Ku70-DT40
DR CLO; CLO_0051500
DR RCB; RCB1650
RX PubMed=10654944;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; ATM+XRCC6.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_1T23 ! DT40-ATM(-/-)
SX Female
CA Cancer cell line
//
ID DT40-BLM(-/-)
AC CVCL_1T25
SY BLM-/- DT40; Delta-BLM-DT40
DR CLO; CLO_0051518
DR RCB; RCB1811
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; BLM.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-BLM(-/-)-WRN(-/-)
AC CVCL_2H96
SY Delta-WRN-delta-BLM-DT40
DR CLO; CLO_0051521
DR RCB; RCB1813
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; BLM+WRN.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-BLNK(-/-)
AC CVCL_1T38
SY BLNK-/- DT40; BLNK^(-) DT40
DR CLO; CLO_0051487
DR RCB; RCB1510
RX PubMed=10023776;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; BLNK.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-BLNK(-/-)-GRB2(-/-)
AC CVCL_4E62
SY BLNK^(-)Grb2^(-)DT40
DR CLO; CLO_0051471
DR RCB; RCB1860
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; BLNK+GRB2.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-BLNK(-/-)-SYK(-/-)
AC CVCL_1T52
SY BLNK^(-)/Syk^(-) DT40; Syk-BLNK- DT40
DR CLO; CLO_0051475
DR RCB; RCB1704
RX PubMed=10993915;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; BLNK+SYK.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_1T38 ! DT40-BLNK(-/-)
SX Female
CA Cancer cell line
//
ID DT40-BTK(-/-)
AC CVCL_1T45
SY BTK-/- DT40; Btk^(-) DT40
DR CLO; CLO_0051476
DR RCB; RCB1468
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; BTK.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-CARD11(-/-)
AC CVCL_1T40
SY CARMA1-/- DT40; CARMA1^(-)DT40
DR CLO; CLO_0051525
DR RCB; RCB2296
RX PubMed=16301747;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; CARD11.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-CBL(-/-)
AC CVCL_1T46
SY CBL-/- DT40; Cbl^(-) DT40
DR CLO; CLO_0051488
DR RCB; RCB1675
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; CBL.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-GRAP(-/-)
AC CVCL_1U33
SY GRAP-/- DT40; Grap^(-) DT40
DR CLO; CLO_0051480
DR RCB; RCB1498
RX PubMed=9763608;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; GRAP.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-GRB2(-/-)
AC CVCL_1U32
SY GRB2-/- DT40; Grb2^(-) DT40
DR CLO; CLO_0051473
DR RCB; RCB1499
RX PubMed=9763608;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; GRB2.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-GRB2(-/-)-GRAP(-/-)
AC CVCL_4E68
SY Grb2^(-)/Grap^(-) DT40
DR CLO; CLO_0051483
DR RCB; RCB1836
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; GRAP+GRB2.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-INPP5D(-/-)
AC CVCL_2G93
SY SHIP^(-) DT40; SHIP-deficient DT40
DR CLO; CLO_0051472
DR RCB; RCB1465
RX PubMed=9244303;
RX PubMed=9547347;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; INPP5D.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-ITRP1(-/-)-ITPR2(-/-)
AC CVCL_8B31
SY IP3R type1^(-)/2^(-) DT40
DR CLO; CLO_0051501
DR RCB; RCB1717
RX PubMed=9214625;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; ITPR1+ITPR2.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-ITRP1(-/-)-ITPR2(-/-)-ITPR3(-/-)
AC CVCL_8B34
SY IP3R^(-) DT40; DT40-3KO
DR CLO; CLO_0051504
DR RCB; RCB1467
RX PubMed=9214625;
RX PubMed=27048566;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; ITPR1+ITPR2+ITPR3.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-ITRP1(-/-)-ITPR3(-/-)
AC CVCL_8B32
SY IP3R type1^(-)/3^(-) DT40
DR CLO; CLO_0051481
DR RCB; RCB1718
RX PubMed=10064596;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; ITPR1+ITPR3.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-ITRP2(-/-)-ITPR3(-/-)
AC CVCL_8B33
SY IP3R type2^(-)/3^(-) DT40
DR CLO; CLO_0051482
DR RCB; RCB1719
RX PubMed=10064596;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; ITPR2+ITPR3.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-LIG4(-/-)
AC CVCL_1T44
SY Delta-ligIV-DT40
DR CLO; CLO_0051528
DR RCB; RCB1766
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; LIG4.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-LYN(-/-)
AC CVCL_1T41
SY LYN-/- DT40; Lyn^(-) DT40
DR CLO; CLO_0051479
DR RCB; RCB1471
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; LYN.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-LYN(-/-)-SYK(-/-)
AC CVCL_2H33
SY Lyn^(-)/Syk^(-) DT40
DR CLO; CLO_0051497
DR RCB; RCB1500
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; LYN+SYK.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-MAP3K7(-/-)
AC CVCL_1T50
SY TAK1-/- DT40; TAK1^(-)DT40
DR CLO; CLO_0051527
DR RCB; RCB2298
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; MAP3K7.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-MRE11A(-/-)-XRCC6(-/-)
AC CVCL_4Z66
SY Delta-Mre11-delta-Ku70-DT40
DR CLO; CLO_0051530
DR RCB; RCB1633
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; MRE11A+XRCC6.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-NBN(-/-)
AC CVCL_1T33
SY Delta-NBS1-DT40
DR CLO; CLO_0051505
DR RCB; RCB1747
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; NBN.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-ORAI1(-/-)
AC CVCL_1T26
SY Orai1^(-/-)DT40
DR RCB; RCB4518
RX PubMed=20679432;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; ORAI1.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-ORAI2(-/-)
AC CVCL_1T27
SY Orai2^(-/-)DT40
DR RCB; RCB4519
RX PubMed=20679432;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; ORAI2.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-PIK3AP1(-/-)
AC CVCL_1T39
SY BCAP^(-) DT40
DR CLO; CLO_0051489
DR RCB; RCB1716
RX PubMed=11163197;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; PIK3AP1.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-PIK3CA(-/-)
AC CVCL_4E64
SY PI3Kp110alpha^(-) DT40
DR CLO; CLO_0051491
DR RCB; RCB1810
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; PIK3CA.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-PLCG2(-/-)
AC CVCL_1T47
SY PLC-gamma2^(-) DT40
DR CLO; CLO_0051477
DR RCB; RCB1469
RX PubMed=9763608;
RX PubMed=14676298;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; PLCG2.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-POLK(-/-)
AC CVCL_1T32
SY Delta-DinB-DT40
DR CLO; CLO_0051506
DR RCB; RCB1749
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; POLK.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-POLK(-/-)-XPA(-/-)
AC CVCL_4E66
SY Delta-DinB-delta-XPA-DT40
DR CLO; CLO_0051516
DR RCB; RCB1814
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; POLK+XPA.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-PRKCB(-/-)
AC CVCL_1T42
SY PKCbeta^(-)DT40
DR CLO; CLO_0051526
DR RCB; RCB2297
RX PubMed=16301747;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; PRKCB.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-PRKDC(-/-)
AC CVCL_1Y06
SY Delta-DNAPK-DT40
DR CLO; CLO_0051498
DR RCB; RCB1620
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; PRKDC.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-PRKDC(-/-)-XRCC6(-/-)
AC CVCL_9Q56
SY Delta-DNAPK-delta-Ku70-DT40
DR CLO; CLO_0051522
DR RCB; RCB1759
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; PRKDC+XRCC6.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-PTPN11(-/-)
AC CVCL_2G90
SY SHP2^(-) DT40; SHP-2-deficient DT40
DR CLO; CLO_0051485
DR RCB; RCB1502
RX PubMed=9547347;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; PTPN11.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-PTPN6(-/-)
AC CVCL_2G91
SY SHP1^(-) DT40; SHP-1-deficient DT40
DR CLO; CLO_0051460
DR RCB; RCB1466
RX PubMed=9244303;
RX PubMed=9547347;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; PTPN6.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-PTPN6(-/-)-PTPN11(-/-)
AC CVCL_2G92
SY SHP1^(-)/SHP2^(-) DT40; SHP-1/SHP-2-deficient DT40
DR CLO; CLO_0051474
DR RCB; RCB1501
RX PubMed=9547347;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; PTPN6+PTPN11.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_2G91 ! DT40-PTPN6(-/-)
SX Female
CA Cancer cell line
//
ID DT40-RAD18(-/-)
AC CVCL_1U31
SY RAD18-/- DT40; Delta-Rad18-DT40
DR CLO; CLO_0051507
DR RCB; RCB1750
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; RAD18.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-RAD18(-/-)-POLK(-/-)
AC CVCL_4E67
SY Delta-Rad18-delta-DinB-DT40
DR CLO; CLO_0051520
DR RCB; RCB1795
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; POLK+RAD18.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-RAD18(-/-)-XPA(-/-)
AC CVCL_4E65
SY Delta-Rad18-delta-XPA-DT40
DR CLO; CLO_0051519
DR RCB; RCB1794
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; RAD18+XPA.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-RAD51B(-/-)
AC CVCL_X637
SY RAD51B-/- DT40; Delta-Rad51B-DT40
DR CLO; CLO_0051462
DR RCB; RCB1622
RX PubMed=10938124;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; RAD51B.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-RAD51C(-/-)
AC CVCL_X638
SY RAD51C-/- DT40; Delta-Rad51C-DT40
DR CLO; CLO_0051463
DR RCB; RCB1623
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; RAD51C.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-RAD51D(-/-)
AC CVCL_X639
SY RAD51D-/- DT40; Delta-Rad51D-DT40
DR CLO; CLO_0051464
DR RCB; RCB1624
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; RAD51D.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-RAD52(-/-)
AC CVCL_X640
SY RAD52-/- DT40; Delta-Rad52-DT40
DR CLO; CLO_0051466
DR RCB; RCB1627
RX PubMed=9774659;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; RAD52.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-RAD52(-/-)-XRCC3(-/-)
AC CVCL_2H95
SY Delta-Rad52-delta-XRCC3-DT40
DR CLO; CLO_0051510
DR RCB; RCB1767
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; RAD52+XRCC3.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-RAD54B(-/-)-XRCC6(-/-)
AC CVCL_6D41
SY Delta-Ku70-delta-Rad54B-DT40
DR CLO; CLO_0051469
DR RCB; RCB1632
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; RAD54B, XRCC6.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-RAD54L(-/-)
AC CVCL_1T34
SY RAD54-/- DT40; Delta-Rad54-DT40
DR CLO; CLO_0051468
DR RCB; RCB1628
RX PubMed=9108474;
RX PubMed=10938124;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; RAD54L.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_J437 ! DT40 CL18
SX Female
CA Cancer cell line
//
ID DT40-RAD54L(-/-)-RAD54B(-/-)
AC CVCL_1Y07
SY Delta-Rad54-delta-Rad54B-DT40
DR CLO; CLO_0051467
DR RCB; RCB1634
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; RAD54L, RAD54B.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-RAD54L(-/-)-XRCC6(-/-)
AC CVCL_4W13
SY Delta-Rad54.delta-Ku70-DT40
DR CLO; CLO_0051508
DR RCB; RCB1687
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; RAD54L, XRCC6.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-RASGRP1(-/-)
AC CVCL_1U38
SY GRP1^(-)DT40
DR CLO; CLO_0051496
DR RCB; RCB1863
RX PubMed=14676298;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; RASGRP1.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-RASGRP1(-/-)-RASGRP3(-/-)
AC CVCL_1U39
SY GRP1^(-)/GRP3^(-)DT40
DR CLO; CLO_0051511
DR RCB; RCB1865
RX PubMed=14676298;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; RASGRP1+RASGRP3.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-RASGRP3(-/-)
AC CVCL_1U40
SY GRP3^(-)DT40
DR CLO; CLO_0051512
DR RCB; RCB1864
RX PubMed=14676298;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; RASGRP3.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-REV3L(-/-)
AC CVCL_1T51
SY Delta-Rev3-DT40
DR CLO; CLO_0051509
DR RCB; RCB1764
RX PubMed=15988022;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; REV3L.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_J437 ! DT40 CL18
SX Female
CA Cancer cell line
//
ID DT40-SHC1(-/-)
AC CVCL_1U34
SY Shc^(-) DT40
DR CLO; CLO_0051486
DR RCB; RCB1503
RX PubMed=9763608;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; SHC1.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-SOS1(-/-)
AC CVCL_1U35
SY SOS1-/- DT40; Sos1^(-)DT40
DR CLO; CLO_0051513
DR RCB; RCB1866
RX PubMed=14676298;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; SOS1.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-SOS1(-/-)-SOS2(-/-)
AC CVCL_1U37
SY SOS1-/ SOS2-/- DT40; Sos1^(-)/Sos2^(-)DT40
DR CLO; CLO_0051515
DR RCB; RCB1868
RX PubMed=14676298;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; SOS1+SOS2.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-SOS2(-/-)
AC CVCL_1U36
SY SOS2-/- DT40; Sos2^(-)DT40
DR CLO; CLO_0051514
DR RCB; RCB1867
RX PubMed=14676298;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; SOS2.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-STIM1(-/-)
AC CVCL_1T28
SY STIM1-/- DT40; STIM1^(-/-)DT40; STIM1^-DT40; S1-/-; DT40 STIM1 KO
DR CLO; CLO_0051529
DR RCB; RCB2402
RX PubMed=19376967;
RX PubMed=20679432;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; STIM1.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-STIM1(-/-)-STIM2(-/-)
AC CVCL_1T29
SY STIM1-/ STIM2-/- DT40; STIM1^(-/-)STIM2^(-/-)DT40; S1/S2-/-
DR RCB; RCB4517
RX PubMed=19376967;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; STIM1+STIM2.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-STIM2(-/-)
AC CVCL_1T30
SY STIM2-/- DT40; STIM2^(-/-)DT40; S2-/-
DR RCB; RCB4516
RX PubMed=19376967;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; STIM2.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-SYK(-/-)
AC CVCL_1T43
SY Syk^(-) DT40
DR CLO; CLO_0051478
DR RCB; RCB1470
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; SYK.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-TRPC1(-/-)
AC CVCL_2I01
SY TRP1^(-) DT40
DR CLO; CLO_0051484
DR RCB; RCB1824
RX PubMed=11901194;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; TRPC1.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-VAV3(-/-)
AC CVCL_1T49
SY Vav3^(-) DT40
DR CLO; CLO_0051490
DR RCB; RCB1809
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; VAV3.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-WRN(-/-)
AC CVCL_1T35
SY Delta-WRN-DT40
DR CLO; CLO_0051523
DR RCB; RCB1812
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; WRN.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-XRCC2(-/-)
AC CVCL_1T36
SY Delta-XRCC2-DT40
DR CLO; CLO_0051465
DR RCB; RCB1625
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; XRCC2.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-XRCC3(+/-)
AC CVCL_2G89
SY XRCC3+/--DT40
DR CLO; CLO_0051517
DR RCB; RCB1770
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration (1 of 2 alleles); XRCC3.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-XRCC3(-/-)
AC CVCL_1T37
SY Delta-XRCC3-DT40
DR CLO; CLO_0051470
DR RCB; RCB1626
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; XRCC3.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40-XRCC6(-/-)
AC CVCL_1T31
SY Ku70-/- DT40; Delta-Ku70-DT40
DR CLO; CLO_0051461
DR RCB; RCB1621
RX PubMed=10654944;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; XRCC6.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40(v-myb)delta-pol-beta
AC CVCL_6D43
DR RCB; RCB1818
RX PubMed=17363341;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; POLB.
CC Transfected with: UniProtKB; P01104; Avian myeloblastosis virus v-Myb.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40(v-myb)delta-pol-beta-delta-pol-lambda
AC CVCL_6D45
DR RCB; RCB1820
RX PubMed=17363341;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; POLB, POLL.
CC Transfected with: UniProtKB; P01104; Avian myeloblastosis virus v-Myb.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40(v-myb)delta-pol-lambda
AC CVCL_6D44
DR RCB; RCB1819
RX PubMed=17363341;
CC Group: Bird cell line.
CC Knockout cell: Method=Targeted integration; POLL.
CC Transfected with: UniProtKB; P01104; Avian myeloblastosis virus v-Myb.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT40(v-myb)WT
AC CVCL_6D42
DR RCB; RCB1817
RX PubMed=17363341;
CC Group: Bird cell line.
CC Transfected with: UniProtKB; P01104; Avian myeloblastosis virus v-Myb.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_0249 ! DT40
SX Female
CA Cancer cell line
//
ID DT45
AC CVCL_T442
SY DT-45; LSCC-DT45
RX PubMed=2998040;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID Dt81Hepa1-6
AC CVCL_IU28
RX PubMed=28152020;
CC Doubling time: 32.12 +- 2.11 hours (PubMed=28152020).
DI NCIt; C38756; Hepatocellular carcinoma of the mouse
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0327 ! Hepa 1-6
SX Female
CA Cancer cell line
//
ID DT95
AC CVCL_3462
SY DT-95; LSCC-DT95
DR CLO; CLO_0002839
DR ATCC; CRL-2112
RX PubMed=2998040;
RX PubMed=18766641;
CC Group: Bird cell line.
CC Transformant: NCBI_TaxID; 11864; Avian leukosis virus (ALV).
CC Breed/subspecies: Hy-Line SC.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Female
CA Cancer cell line
//
ID DTC1
AC CVCL_0J31
SY DTC-1
RX PubMed=7753552;
RX PubMed=12966428;
RX PubMed=15150091;
RX PubMed=16766266;
DI NCIt; C3745; Clear cell sarcoma of soft tissue
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DTE 1-6-4
AC CVCL_U417
RX PubMed=6300143;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID DTF 1-5-1
AC CVCL_U418
RX PubMed=6300143;
RX PubMed=6480694;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID DTG 1-5-4
AC CVCL_U419
SY DTG 1-5-4-22
RX PubMed=6480694;
OX NCBI_TaxID=10029; ! Cricetulus griseus
HI CVCL_0214 ! CHO-K1
SX Female
CA Spontaneously immortalized cell line
//
ID DTK-E
AC CVCL_Y463
RX PubMed=25267010;
CC Breed/subspecies: Mixed breed.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_Y464 ! DTK-SME
SX Female
CA Cancer cell line
//
ID DTK-SME
AC CVCL_Y464
RX PubMed=25267010;
CC Breed/subspecies: Mixed breed.
DI NCIt; C124249; Canine mammary carcinoma
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_Y463 ! DTK-E
SX Female
CA Cancer cell line
//
ID DU #2
AC CVCL_5528
SY DU 2; DU-2
DR BTO; BTO:0002944
RX PubMed=994214;
RX PubMed=2624919;
CC Doubling time: 44 hours, at 61th passage (PubMed=994214).
CC Derived from metastatic site: Inguinal lymph node.
DI NCIt; C3802; Amelanotic melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DU-145-Luc
AC CVCL_J251
DR JCRB; JCRB1387
DR JCRB; NIHS0655
CC Transfected with: UniProtKB; P08659; Firefly luciferase.
CC Discontinued: JCRB; NIHS0655; true.
CC Derived from metastatic site: Brain.
ST Source(s): JCRB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12,13
ST D16S539: 11,12,13
ST D5S818: 10,13
ST D7S820: 7,10,10.3,11
ST TH01: 7
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0105 ! DU145
SX Male
CA Cancer cell line
//
ID DU-145 R
AC CVCL_4Y36
RX PubMed=21982118;
CC Selected for resistance to: ChEBI; CHEBI:4672; Docetaxel anhydrous (Taxotere).
CC Derived from metastatic site: Brain.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0105 ! DU145
SX Male
CA Cancer cell line
//
ID DU-528
AC CVCL_5617
SY Du-528; DU.528; DU528
DR Cosmic; 913423
DR Cosmic; 1115590
DR Cosmic; 1151778
DR Cosmic; 1281367
RX PubMed=4056659;
RX PubMed=17117183;
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DU0001
AC CVCL_8W10
DR ECACC; 94070810
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID DU1-29
AC CVCL_G118
SY Du 1-29
DR CLO; CLO_0002841
DR ATCC; HB-263
DR ECACC; 91060553
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID DU145
AC CVCL_0105
SY DU-145; Du-145; DU 145; DU_145
DR BTO; BTO:0001332
DR CLO; CLO_0002840
DR CLO; CLO_0051536
DR EFO; EFO_0005441
DR MCCL; MCC:0000140
DR CLDB; cl1108
DR CLDB; cl1109
DR CLDB; cl4961
DR CLDB; cl5184
DR ATCC; HTB-81
DR BCRC; 60348
DR BCRJ; 0078
DR BioSample; SAMN03472017
DR BioSample; SAMN03472041
DR BioSample; SAMN03472757
DR CCLE; DU145_PROSTATE
DR CCRID; 3111C0001CCC000006
DR CCRID; 3131C0001000700080
DR ChEMBL-Cells; CHEMBL3308034
DR ChEMBL-Targets; CHEMBL613508
DR CLS; 300168/p708_DU-145
DR Cosmic; 688116
DR Cosmic; 699306
DR Cosmic; 704850
DR Cosmic; 721367
DR Cosmic; 721558
DR Cosmic; 755299
DR Cosmic; 759893
DR Cosmic; 801349
DR Cosmic; 809223
DR Cosmic; 809224
DR Cosmic; 850415
DR Cosmic; 850824
DR Cosmic; 869156
DR Cosmic; 875891
DR Cosmic; 876395
DR Cosmic; 897454
DR Cosmic; 905935
DR Cosmic; 911998
DR Cosmic; 918501
DR Cosmic; 921050
DR Cosmic; 922550
DR Cosmic; 923401
DR Cosmic; 923956
DR Cosmic; 943177
DR Cosmic; 948075
DR Cosmic; 949247
DR Cosmic; 974300
DR Cosmic; 1028649
DR Cosmic; 1028700
DR Cosmic; 1057758
DR Cosmic; 1070887
DR Cosmic; 1071478
DR Cosmic; 1071905
DR Cosmic; 1075274
DR Cosmic; 1092597
DR Cosmic; 1172627
DR Cosmic; 1175887
DR Cosmic; 1176617
DR Cosmic; 1212490
DR Cosmic; 1218869
DR Cosmic; 1305381
DR Cosmic; 1312368
DR Cosmic; 1330912
DR Cosmic; 1436047
DR Cosmic; 1481419
DR Cosmic; 1542078
DR Cosmic; 1689715
DR Cosmic; 1712065
DR Cosmic; 1995389
DR Cosmic; 1998439
DR Cosmic; 2580127
DR Cosmic; 2585152
DR Cosmic; 2585229
DR Cosmic-CLP; 905935
DR DSMZ; ACC-261
DR GDSC; 905935
DR GEO; GSM50224
DR GEO; GSM50288
DR GEO; GSM91924
DR GEO; GSM142455
DR GEO; GSM142456
DR GEO; GSM482671
DR GEO; GSM525794
DR GEO; GSM648818
DR GEO; GSM648819
DR GEO; GSM750774
DR GEO; GSM750834
DR GEO; GSM784791
DR GEO; GSM799369
DR GEO; GSM799379
DR GEO; GSM799432
DR GEO; GSM799442
DR GEO; GSM843494
DR GEO; GSM886988
DR GEO; GSM888057
DR GEO; GSM1153440
DR GEO; GSM1153441
DR GEO; GSM1181273
DR GEO; GSM1181302
DR GEO; GSM1181306
DR GEO; GSM1181328
DR GEO; GSM1374469
DR GEO; GSM1374470
DR GEO; GSM1669745
DR ICLC; HTL99013
DR IZSLER; BS TCL 141
DR KCB; KCB 200701YJ
DR KCLB; 30081
DR Lonza; 761
DR NCBI_Iran; C428
DR PRIDE; PXD003105
DR RCB; RCB2143
DR SKY/M-FISH/CGH; 2792
DR TKG; TKG 0604
DR TOKU-E; 1103
DR Wikidata; Q5206280
RX PubMed=2041050;
RX PubMed=6244232;
RX PubMed=6935474;
RX PubMed=9018337;
RX PubMed=9214606;
RX PubMed=10702678;
RX PubMed=10972993;
RX PubMed=11135431;
RX PubMed=11172901;
RX PubMed=11414198;
RX PubMed=12615715;
RX PubMed=12725112;
RX PubMed=14518029;
RX PubMed=15486987;
RX PubMed=17088437;
RX PubMed=17254797;
RX PubMed=19372543;
RX PubMed=22336246;
RX PubMed=22460905;
RX PubMed=23671654;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=25485619;
RX PubMed=26972028;
RX PubMed=27141528;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://en.wikipedia.org/wiki/DU145
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=54
WW http://capcelllines.ca/details.asp?id=61
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/d/cell-lines-detail-135.html
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: JFCR39 cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Doubling time: 32.3 hours (DTP); ~29 hours (ATCC); ~30-40 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (PubMed=23671654; Sanger).
CC Omics: Array-based CGH.
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: GPI-anchored proteins analysis by proteomics.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'DU145T' in GEO GSM843494.
CC Derived from metastatic site: Brain.
ST Source(s): ATCC; CLS; Cosmic-CLP; COG; DSMZ; KCLB; PubMed=11416159; PubMed=17254797; PubMed=19372543; PubMed=25877200; RCB; TKG
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12,13,14 (ATCC; CLS; COG; DSMZ; PubMed=25877200)
ST D13S317: 12,14 (Cosmic-CLP; KCLB; PubMed=17254797; PubMed=19372543; RCB; TKG)
ST D16S539: 11,13
ST D18S51: 12,13 (CLS)
ST D18S51: 12 (PubMed=17254797; PubMed=19372543; PubMed=25877200)
ST D19S433: 13
ST D21S11: 30,33,34 (CLS)
ST D21S11: 29,30,33 (PubMed=11416159)
ST D21S11: 29,30 (PubMed=17254797)
ST D21S11: 30,33 (PubMed=19372543; PubMed=25877200)
ST D2S1338: 16
ST D3S1358: 16
ST D5S818: 10,13
ST D7S820: 7,10,11 (ATCC; COG; Cosmic-CLP; DSMZ; KCLB; PubMed=17254797; PubMed=25877200)
ST D7S820: 7,10,11,12 (CLS)
ST D8S1179: 13,14
ST FGA: 22,23 (CLS)
ST FGA: 22 (PubMed=17254797; PubMed=25877200)
ST Penta D: 9,13
ST Penta E: 12,14
ST TH01: 7
ST TPOX: 11
ST vWA: 17,18,19 (ATCC; CLS; Cosmic-CLP; PubMed=11416159; RCB)
ST vWA: 17,18 (COG; DSMZ; KCLB; PubMed=19372543; PubMed=25877200; TKG)
ST vWA: 16,17,18 (PubMed=17254797)
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DU145/RC0.1
AC CVCL_AS75
SY DU145 RC0.1; RC0.1; RCO.1; RC01
DR GEO; GSM750772
DR GEO; GSM799380
DR GEO; GSM799443
DR GEO; GSM1153443
DR GEO; GSM1181318
DR GEO; GSM1181329
RX PubMed=12615715;
RX PubMed=19372543;
CC Selected for resistance to: ChEBI; CHEBI:90225; Rubitecan (Orathecin; 9-nitrocamptothecin; 9NC).
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Brain.
ST Source(s): PubMed=19372543
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 12,14
ST D18S51: 12
ST D19S433: 13
ST D21S11: 30,33
ST D2S1338: 16,17
ST D3S1358: 16
ST D5S818: 10,13
ST D7S820: 7,11
ST D8S1179: 13,14
ST FGA: 22
ST TH01: 7
ST TPOX: 11
ST vWA: 17,18
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0105 ! DU145
SX Male
CA Cancer cell line
//
ID DU145/RC1
AC CVCL_D639
SY DU-145/RC1; DU-145/RC; RC1
RX PubMed=8993507;
CC Selected for resistance to: ChEBI; CHEBI:90225; Rubitecan (Orathecin; 9-nitrocamptothecin; 9NC).
CC Derived from metastatic site: Brain.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0105 ! DU145
SX Male
CA Cancer cell line
//
ID DU4475
AC CVCL_1183
SY DU-4475; Du-4475
DR CLO; CLO_0002842
DR EFO; EFO_0002168
DR ATCC; CRL-7921
DR ATCC; HTB-123
DR BioSample; SAMN03471772
DR BioSample; SAMN03473595
DR CCLE; DU4475_BREAST
DR CCRID; 3111C0001CCC000342
DR ChEMBL-Cells; CHEMBL3308261
DR ChEMBL-Targets; CHEMBL2366246
DR Cosmic; 685863
DR Cosmic; 871141
DR Cosmic; 904355
DR Cosmic; 906844
DR Cosmic; 921975
DR Cosmic; 934523
DR Cosmic; 997915
DR Cosmic; 1046952
DR Cosmic; 1047716
DR Cosmic; 1091340
DR Cosmic; 1152520
DR Cosmic; 1289387
DR Cosmic; 1287936
DR Cosmic; 1609476
DR Cosmic; 2164988
DR Cosmic-CLP; 906844
DR DSMZ; ACC-427
DR GDSC; 906844
DR GEO; GSM217568
DR GEO; GSM344345
DR GEO; GSM344395
DR GEO; GSM783961
DR GEO; GSM886989
DR GEO; GSM888058
DR GEO; GSM1669746
DR IGRhCellID; DU4475
DR LINCS; 50577
RX PubMed=10862037;
RX PubMed=11414198;
RX PubMed=15677628;
RX PubMed=22460905;
RX PubMed=23601657;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.pawefish.path.cam.ac.uk/BreastCellLineDescriptions/DU4475.html
WW http://lincs.hms.harvard.edu/resources/reagents/icbp43/
WW http://tcpaportal.org/mclp/
CC Part of: BRAF genetic alteration cell panel (ATCC TCP-1032).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: ICBP43 breast cancer cell line panel.
CC Part of: MD Anderson Cell Lines Project.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Doubling time: 90 hours (PubMed=25984343); ~80-100 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: miRNA expression profiling.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Misspelling: 'DU-475' in PubMed=12702766.
CC Misspelling: 'DU447' in Cosmic 1609476.
CC Discontinued: ATCC; CRL-7921; true.
CC Derived from metastatic site: Skin nodule.
ST Source(s): ATCC; Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,12
ST D13S317: 11,14
ST D16S539: 11,12
ST D18S51: 14,16
ST D21S11: 29,31.2
ST D3S1358: 14,16
ST D5S818: 11 (ATCC; Cosmic-CLP; PubMed=25877200)
ST D5S818: 6,11 (DSMZ)
ST D7S820: 9,10
ST D8S1179: 10,13
ST FGA: 22,25
ST Penta D: 13,14
ST Penta E: 7,13
ST TH01: 6,8
ST TPOX: 8
ST vWA: 17
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID DU5873
AC CVCL_6G37
SY DU 5873
RX PubMed=590019;
RX PubMed=6244232;
DI NCIt; C9385; Renal cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DU9479
AC CVCL_4828
SY 9479
RX DOI=10.1002/pros.2990070405;
WW http://capcelllines.ca/details.asp?id=106
CC Derived from metastatic site: Iliac crest.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Dubca
AC CVCL_3678
SY Dubai camel
DR CLO; CLO_0002843
DR ATCC; CRL-2276
RX PubMed=8556315;
RX PubMed=18837913;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9838; ! Camelus dromedarius
SX Female
CA Transformed cell line
//
ID DUCAF
AC CVCL_E571
DR dbMHC; 48765
DR ECACC; 88052019
DR IHW; IHW9019
DR IMGT/HLA; 10536
WW http://bioinformatics.hsanmartino.it/ecbr/cl19.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID DuCaP
AC CVCL_2025
SY DUCaP; Dura mater Cancer of the Prostate
DR Cosmic; 1028647
DR Cosmic; 1043329
DR Cosmic; 1995390
RX PubMed=11317521;
RX PubMed=14518029;
WW http://capcelllines.ca/details.asp?id=73
CC Derived from metastatic site: Brain dura mater.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2235 ! VCaP
SX Male
CA Cancer cell line
//
ID Duck embryo
AC CVCL_T281
SY Duck Embryo; SPDC-CCL141
DR CLDB; cl1111
DR CLDB; cl1112
DR ATCC; CCL-141
DR ECACC; 89051503
DR IZSLER; BS CL 38
RX PubMed=4368600;
RX PubMed=18766641;
CC Group: Bird cell line.
OX NCBI_TaxID=8839; ! Anas platyrhynchos
CA Spontaneously immortalized cell line
//
ID DUG150
AC CVCL_E572
DR dbMHC; 48766
DR IHW; IHW9397
DR IMGT/HLA; 26001
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID DuK50
AC CVCL_4742
RX PubMed=8826087;
WW http://capcelllines.ca/details.asp?id=72
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID Dunn osteosarcoma
AC CVCL_W629
SY Dunn's osteosarcoma
RX PubMed=14173606;
CC Breed/subspecies: C3H/HeJ.
DI NCIt; C24021; Mouse osteosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID DuPro-1
AC CVCL_4738
SY DuPro; DUPRO
DR BTO; BTO:0004186
DR BioSample; SAMN03151892
DR ChEMBL-Cells; CHEMBL3307488
DR ChEMBL-Targets; CHEMBL614289
DR Wikidata; Q27972077
RX PubMed=1875519;
RX PubMed=14518029;
RX PubMed=20143388;
WW http://capcelllines.ca/details.asp?id=153
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a PC-3 derivative (PubMed=14518029, PubMed=20143388).
CC Derived from metastatic site: Bone.
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0035 ! PC-3
SX Male
CA Cancer cell line
//
ID DUTKO-1
AC CVCL_6217
SY DUTKO1
RX PubMed=6278188;
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0004 ! K-562
HI CVCL_6220 ! Daudi-TG
CA Hybrid cell line
//
ID DV-1
AC CVCL_AQ54
RX PubMed=3033590;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID DV-90
AC CVCL_1184
SY DV90
DR CLO; CLO_0002847
DR EFO; EFO_0006565
DR BioSample; SAMN03473076
DR CCLE; DV90_LUNG
DR ChEMBL-Cells; CHEMBL3308729
DR ChEMBL-Targets; CHEMBL1075437
DR Cosmic; 753553
DR Cosmic; 1146951
DR DSMZ; ACC-307
DR GDSC; 753553
DR GEO; GSM434301
DR GEO; GSM784284
DR GEO; GSM886990
DR GEO; GSM888059
DR IGRhCellID; DV-90_02GEO
DR PRIDE; PXD002556
RX PubMed=10908148;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=26361996;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~95 hours (DSMZ).
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10,12
ST D16S539: 11,12
ST D18S51: 13,14
ST D21S11: 31,31.2
ST D3S1358: 13,16
ST D5S818: 11,13
ST D7S820: 11,14
ST D8S1179: 14,16
ST FGA: 22,24
ST Penta D: 9,10
ST Penta E: 10,13
ST TH01: 7,8
ST TPOX: 8
ST vWA: 14,15
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID DV68F
AC CVCL_7953
DR CLO; CLO_0002846
DR ATCC; CRL-6345
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6345; true.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybrid cell line
//
ID DVE1
AC CVCL_Z190
DR TCB; 3101
RX PubMed=17662657;
RX PubMed=22743047;
WW https://www.dsmz.de/fileadmin/Bereiche/Microbiology/Dateien/Kultivierungshinweise/TickCellCultureMethods-4.pdf
CC Group: Tick cell line.
OX NCBI_TaxID=34621; ! Dermacentor variabilis
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID DW0001
AC CVCL_8W11
DR ECACC; 94081259
CC Part of: ECACC chromosomal abnormality collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybrid cell line
//
ID DW0002
AC CVCL_8W12
DR ECACC; 94081260
CC Part of: ECACC chromosomal abnormality collection.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
CA Hybrid cell line
//
ID DW34
AC CVCL_5280
RX PubMed=2787384;
RX PubMed=3264531;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=DW34
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2205 ! ST-2
CA Stromal cell line
//
ID DW6
AC CVCL_N702
RX PubMed=6243721;
RX PubMed=6243722;
RX PubMed=6265077;
RX PubMed=8515068;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID DWFb1-rho0
AC CVCL_4U14
SY Rho0-DWFb1
RX PubMed=15913645;
CC Characteristics: Cell line devoid of mitochondrial DNA (rho0).
OX NCBI_TaxID=9606; ! Homo sapiens
CA Transformed cell line
//
ID DX
AC CVCL_Z822
DR DGRC; 176
WW http://flybase.org/reports/FBrf0205934.html
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
HI CVCL_Z425 ! 67j25D
SX Female
CA Spontaneously immortalized cell line
//
ID DX3-puro/beta6
AC CVCL_1D33
SY DX3purobeta6
DR Ximbio; 151625
RX PubMed=17699789;
CC Transfected with: HGNC; 6161; ITGB6.
CC Derived from metastatic site: Hypodermis.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_5650 ! SK-MEL-93 DX-3
SX Female
CA Cancer cell line
//
ID DY36T2
AC CVCL_EQ21
SY Dy36T2
DR GEO; GSM1401663
CC Omics: Deep RNAseq analysis.
CC Derived from metastatic site: Brain.
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0620 ! MDA-MB-361
SX Female
CA Cancer cell line
//
ID DZ0001
AC CVCL_8W13
DR ECACC; 94083008
CC Part of: ECACC chromosomal abnormality collection.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID DZNU-Bm-1
AC CVCL_Z082
SY Bm-1
RX CelloPub=CLPUB00164;
RX PubMed=16713602;
CC Group: Insect cell line.
CC Breed/subspecies: Swarnandhra.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Female
CA Spontaneously immortalized cell line
//
ID DZNU-Bm-12
AC CVCL_Z115
SY DZNU-BM-12; Bm-12
RX CelloPub=CLPUB00164;
RX PubMed=19357932;
CC Group: Insect cell line.
CC Breed/subspecies: Kolar Gold.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Female
CA Spontaneously immortalized cell line
//
ID DZNU-Bm-16
AC CVCL_Z304
SY Bm-16
RX CelloPub=CLPUB00164;
CC Group: Insect cell line.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID DZNU-Bm-17
AC CVCL_Z116
SY Bm-17
RX CelloPub=CLPUB00164;
RX DOI=10.1016/j.aspen.2012.09.004;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Breed/subspecies: Kolar Gold.
OX NCBI_TaxID=7091; ! Bombyx mori
SX Female
CA Spontaneously immortalized cell line
//
ID E 20
AC CVCL_J751
SY E20; M-13
DR CLO; CLO_0002850
DR ATCC; HB-8443
RX Patent=US4806628;
RX Patent=US4808704;
CC Discontinued: ATCC; HB-8443; probable.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID E-8
AC CVCL_J885
DR CLO; CLO_0002865
DR ATCC; HB-10179
RX Patent=WO1991002250A1;
CC Monoclonal antibody target: Ictalurus punctatus immunoglobulin heavy chain.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID E-Adh-n1
AC CVCL_Z901
SY E adn(n1)
DR DGRC; 12
RX CelloPub=CLPUB00207;
RX DOI=10.1016/B978-012229460-0/50004-X;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID E-CS
AC CVCL_Z893
SY ECS
DR DGRC; 22
RX CelloPub=CLPUB00207;
RX DOI=10.1016/B978-012229460-0/50004-X;
CC Group: Insect cell line.
CC Breed/subspecies: Canton-S.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID E-E12[ts] mal[1]
AC CVCL_Z902
SY EE12(ts)mal(1)
DR DGRC; 14
RX CelloPub=CLPUB00207;
RX DOI=10.1016/B978-012229460-0/50004-X;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID E-FM1
AC CVCL_Z903
SY EFM1
DR DGRC; 20
RX CelloPub=CLPUB00207;
RX DOI=10.1016/B978-012229460-0/50004-X;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID E-mal[1]
AC CVCL_Z904
SY E-mal(1); Emal1
DR DGRC; 24
RX CelloPub=CLPUB00207;
RX DOI=10.1016/B978-012229460-0/50004-X;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID E-mal[F3]
AC CVCL_Z905
SY E-mal(F3); EmalF3
DR DGRC; 17
RX CelloPub=CLPUB00207;
RX DOI=10.1016/B978-012229460-0/50004-X;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID E-OR
AC CVCL_Z894
SY EOR
DR DGRC; 21
RX CelloPub=CLPUB00207;
RX DOI=10.1016/B978-012229460-0/50004-X;
CC Group: Insect cell line.
CC Breed/subspecies: Oregon-R.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID E-r[1]
AC CVCL_Z906
SY Er1; Er(1); r1
DR DGRC; 15
RX CelloPub=CLPUB00207;
RX DOI=10.1007/BF00848269;
RX DOI=10.1016/B978-012229460-0/50004-X;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID E-r[36]
AC CVCL_Z907
SY Er36; Er(36); r26
DR DGRC; 18
RX CelloPub=CLPUB00207;
RX DOI=10.1007/BF00848269;
RX DOI=10.1016/B978-012229460-0/50004-X;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID E. Derm
AC CVCL_3368
SY E.Derm; E. Derm (NBL-6); NBL-6; Eq.Derm; EC1D
DR CLO; CLO_0002852
DR CLO; CLO_0002853
DR CLDB; cl1117
DR CLDB; cl1118
DR CLDB; cl1119
DR ATCC; CCL-57
DR ATCC; CRL-6288
DR ECACC; 88032803
DR ICLC; AL97004
DR IZSLER; BS CL 40
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/nbl6/nbl6cells.html
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Characteristics: Senesces at ~40 PDL.
CC Discontinued: ATCC; CRL-6288; true.
OX NCBI_TaxID=9796; ! Equus caballus
SX Female
CA Finite cell line
//
ID E.G7-OVA
AC CVCL_3505
SY E.G7-Ova
DR CLO; CLO_0002854
DR ATCC; CRL-2113
DR BCRC; 60418
DR CCRID; 3111C0001CCC000370
RX PubMed=3261634;
CC Transfected with: UniProtKB; P01012; Chicken ovalbumin (SERPINB14).
CC Breed/subspecies: C57BL/6N.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0255 ! EL4
CA Cancer cell line
//
ID E.H.IV
AC CVCL_2440
SY E.H. IV; EHIV; Elaine IV
DR CLO; CLO_0002855
DR CLO; CLO_0002856
DR CLDB; cl1120
DR ATCC; CCL-104
DR BioSample; SAMN03472691
DR ECACC; 90121307
DR KCLB; 10104
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Misspelling: 'Elanine IV' in KCLB 10104.
ST Source(s): ATCC; KCLB
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 9,10
ST D16S539: 10,13
ST D3S1358: 14
ST D5S818: 10,11
ST D7S820: 10
ST FGA: 20,25
ST TH01: 9,9.3
ST TPOX: 8
ST vWA: 16,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID E006AA
AC CVCL_4834
SY E006AA-Par
DR Millipore; SCC102
RX PubMed=15162380;
RX PubMed=25076860;
WW http://capcelllines.ca/details.asp?id=69
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_4766 ! S006AA
SX Male
CA Cancer cell line
//
ID E006AA-hT
AC CVCL_X480
DR ATCC; CRL-3277
RX PubMed=25076860;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 12
ST D5S818: 9
ST D7S820: 11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 15,17
DI NCIt; C4863; Prostate carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_4834 ! E006AA
SX Male
CA Cancer cell line
//
ID E0771
AC CVCL_GR23
RX PubMed=16312045;
WW https://ch3biosystems.com/product/e0771/
CC Breed/subspecies: C57BL/6.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID E10.3
AC CVCL_0E81
DR ATCC; CRL-2145
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: ATCC; CRL-2145; true.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID E10V
AC CVCL_AZ86
RX PubMed=8041783;
CC Transformant: Polyoma middle T antigen.
CC Breed/subspecies: C57BL/6.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID E11 [Channa]
AC CVCL_4168
DR ECACC; 01110916
CC Group: Fish cell line.
OX NCBI_TaxID=64152; ! Channa striata
HI CVCL_4306 ! SSN-1
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID E11 [Mouse]
AC CVCL_5737
DR CLS; 400494/p13025_E11
RX PubMed=15200416;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40) [tsA58].
CC Breed/subspecies: (CBA/Ca x C57BL/10)Tg(H2Kb-tsA58) Immortomouse.
OX NCBI_TaxID=10090; ! Mus musculus
CA Conditionally immortalized cell line
//
ID E111
AC CVCL_2441
SY EIII
DR CLO; CLO_0002904
DR CLDB; cl1151
DR ECACC; 86072804
RX PubMed=3763403;
CC Group: Human/rodent somatic cell hybrid.
OX NCBI_TaxID=9606; ! Homo sapiens
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0439 ! MNNG/HOS Cl #5
HI CVCL_0594 ! NIH 3T3
CA Hybrid cell line
//
ID E13 161-7
AC CVCL_9172
DR CLO; CLO_0002858
DR ATCC; HB-215
CC Monoclonal antibody target: UniProtKB; P05533; Mouse Ly6a.
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID E14-nlsrtTA-7
AC CVCL_X727
RX PubMed=11780141;
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_C320 ! ES-E14
SX Male
CA Embryonic stem cell
//
ID E15.3
AC CVCL_0E82
DR ATCC; CRL-2152
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: ATCC; CRL-2152; true.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID E195
AC CVCL_EP95
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4872; Breast carcinoma
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID E1a
AC CVCL_V078
DR CLO; CLO_0002859
DR CLDB; cl1122
DR IHW; IHW8025
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID E1A-3Y1-1
AC CVCL_H226
DR JCRB; JCRB0738
DR RCB; RCB0332
RX PubMed=2961438;
CC Transformant: NCBI_TaxID; 28282; Adenovirus 12 [E1A].
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID E1A-3Y1-2
AC CVCL_H231
DR RCB; RCB0333
RX PubMed=2961438;
CC Transformant: NCBI_TaxID; 28282; Adenovirus 12 [E1A].
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID E1A-3Y1-3
AC CVCL_H232
DR RCB; RCB0334
RX PubMed=2961438;
CC Transformant: NCBI_TaxID; 28282; Adenovirus 12 [E1A].
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_E147 ! 3Y1-B clone 1-6
SX Female
CA Transformed cell line
//
ID E1A-NR.3
AC CVCL_5I34
SY E1A-NR3; E1A.NR3
RX PubMed=8907116;
RX PubMed=24644404;
WW https://www.kerafast.com/product/1026/retinal-cell-line-e1a-nr3
WW https://www.kerafast.com/product/1291/retinal-cell-line-e1a-nr3-cytospin
WW http://news.kerafast.com/2012/10/31/on-the-road-to-retinal-cells/
CC Doubling time: ~24 hours (Kerafast).
CC Transformant: Psi2 defective retrovirus adenovirus E1A.
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Transformed cell line
//
ID E1C1
AC CVCL_6967
SY POWHe001-A-1
DR CCRID; 3142C0001000000597
DR hPSCreg; POWHe001-A-1
RX Patent=US20070160974;
RX PubMed=18271699;
CC From: Prince of Wales Hospital; Australia.
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C200626.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6966 ! Endeavour-1
SX Female
CA Embryonic stem cell
//
ID E1C2
AC CVCL_6968
SY POWHe001-A-2
DR CCRID; 3142C0001000000598
DR hPSCreg; POWHe001-A-2
RX Patent=US20070160974;
RX PubMed=18271699;
CC From: Prince of Wales Hospital; Australia.
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C200627.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6966 ! Endeavour-1
SX Female
CA Embryonic stem cell
//
ID E1C3
AC CVCL_6969
SY POWHe001-A-3
DR hPSCreg; POWHe001-A-3
RX PubMed=18271699;
CC From: Prince of Wales Hospital; Australia.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6966 ! Endeavour-1
SX Female
CA Embryonic stem cell
//
ID E1C4
AC CVCL_6970
SY POWHe001-A-4
DR CCRID; 3142C0001000000599
DR hPSCreg; POWHe001-A-4
RX Patent=US20070160974;
RX PubMed=18271699;
CC From: University of New South Wales; Australia.
CC Registration: International Depositary Authority, China Center for Type Culture Collection (CCTCC); C200628.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6966 ! Endeavour-1
SX Female
CA Embryonic stem cell
//
ID E2
AC CVCL_S003
SY AD-Ca E2
RX PubMed=20631921;
CC Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
DI NCIt; C21732; Carcinoma of the mouse prostate gland
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S004 ! E4
SX Male
CA Cancer cell line
//
ID E22758
AC CVCL_E573
DR dbMHC; 48768
DR IHW; IHW9399
DR IMGT/HLA; 26003
CC Part of: 13th International Histocompatibility Workshop (13IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID E242
AC CVCL_EP96
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4833; Oral cavity squamous cell carcinoma
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E245
AC CVCL_EP82
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E246
AC CVCL_EP83
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E247
AC CVCL_EP84
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E248
AC CVCL_EP85
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E249
AC CVCL_EP86
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E250
AC CVCL_EP87
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E252
AC CVCL_EP97
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E253
AC CVCL_EP98
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID E254
AC CVCL_EP99
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4024; Esophageal squamous cell carcinoma
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID E264
AC CVCL_EQ00
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E265
AC CVCL_EQ01
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4044; Laryngeal squamous cell carcinoma
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E270
AC CVCL_EQ02
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4833; Oral cavity squamous cell carcinoma
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E3
AC CVCL_W345
DR Ximbio; 152597
RX PubMed=10457219;
CC Transfected with: HGNC; 7508; MUC1.
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_W343 ! 410.4
SX Female
CA Cancer cell line
//
ID E301
AC CVCL_EP88
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E302
AC CVCL_EP89
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E303
AC CVCL_EP90
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E305
AC CVCL_EQ03
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID E306
AC CVCL_EQ04
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4044; Laryngeal squamous cell carcinoma
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E307
AC CVCL_EQ05
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4044; Laryngeal squamous cell carcinoma
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E308
AC CVCL_EQ06
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E311
AC CVCL_EQ07
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4833; Oral cavity squamous cell carcinoma
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID E313
AC CVCL_EP91
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E314
AC CVCL_EP92
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E319
AC CVCL_EQ08
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4024; Esophageal squamous cell carcinoma
DI NCIt; C4044; Laryngeal squamous cell carcinoma
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E320
AC CVCL_EQ09
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID E321
AC CVCL_EQ10
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4833; Oral cavity squamous cell carcinoma
DI NCIt; C4648; Tongue squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID E322
AC CVCL_EQ11
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E325
AC CVCL_EQ12
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID E326
AC CVCL_EQ13
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4024; Esophageal squamous cell carcinoma
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E329
AC CVCL_EQ14
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E330
AC CVCL_EQ15
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4872; Breast carcinoma
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID E331
AC CVCL_EQ16
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C9154; Adult acute myeloid leukemia
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E332
AC CVCL_EQ17
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4833; Oral cavity squamous cell carcinoma
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E333
AC CVCL_EQ18
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C35427; Malignant neoplasm of multiple primary sites
DI NCIt; C4833; Oral cavity squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID E334
AC CVCL_EP93
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID E335
AC CVCL_EP94
RX PubMed=22825601;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID E3C/O
AC CVCL_Y441
DR ATCC; CRL-6179
CC Group: Bird cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6179; true.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Sex undetermined
CA Undefined cell line type
//
ID E3GS2.4
AC CVCL_DH86
DR GEO; GSM784711
DI NCIt; C8294; Pancreatic adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID E3STn
AC CVCL_W346
SY E3-STn; E3 STn
DR Ximbio; 151847
RX PubMed=19436292;
CC Transfected with: HGNC; 7508; MUC1.
CC Transfected with: MGI; MGI:1341826; St6galnac1.
CC Breed/subspecies: BALB/cfC3H.
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_W345 ! E3
SX Female
CA Cancer cell line
//
ID E4
AC CVCL_S004
SY AD-Ca E4
RX PubMed=20631921;
CC Knockout cell: Method=KO mouse; MGI; MGI:109583; Pten.
DI NCIt; C21732; Carcinoma of the mouse prostate gland
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_S003 ! E2
SX Male
CA Cancer cell line
//
ID E4181324
AC CVCL_E574
SY E481324
DR dbMHC; 48769
DR ECACC; 88052011
DR IHW; IHW9011
DR IMGT/HLA; 10546
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl11.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID E487
AC CVCL_6G66
DR IMGT/HLA; 12602
RX PubMed=11782282;
CC Part of: International Histocompatibility Workshop cell lines.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID E4D
AC CVCL_0E83
DR ATCC; CRL-2144
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Discontinued: ATCC; CRL-2144; true.
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID E522L
AC CVCL_U104
RX PubMed=12114371;
DI NCIt; C3512; Lung adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID E5ab2
AC CVCL_V079
DR CLO; CLO_0002862
DR CLDB; cl1125
DR IHW; IHW8029
CC Part of: 11th International Histocompatibility Workshop (11IHW) cell line panel.
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C3H/An.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4536 ! L-M(TK-)
SX Male
CA Spontaneously immortalized cell line
//
ID E5BB3IIA2
AC CVCL_J894
DR CLO; CLO_0002863
DR ATCC; HB-121
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID E6(2)2
AC CVCL_J895
SY E6 (2) 2
DR CLO; CLO_0002864
DR ATCC; HB-8172
DR IZSLER; BS Hy 63
RX Patent=US4465776;
CC Monoclonal antibody target: ChEBI; CHEBI:27306; Vitamin B6.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID E63
AC CVCL_0252
DR MCCL; MCC:0000143
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4236 ! L8
CA Spontaneously immortalized cell line
//
ID E6SM
AC CVCL_W081
SY E(6)SM
DR ChEMBL-Cells; CHEMBL3307548
DR ChEMBL-Cells; CHEMBL3308633
DR ChEMBL-Targets; CHEMBL614149
DR ChEMBL-Targets; CHEMBL614726
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID EA
AC CVCL_E575
DR dbMHC; 48770
DR ECACC; 88052080
DR IHW; IHW9081
DR IMGT/HLA; 11629
WW http://bioinformatics.hsanmartino.it/ecbr/cl81.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID EA-1
AC CVCL_IR16
DR Cosmic; 713490
RX PubMed=1696575;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID Ea.4
AC CVCL_Z256
SY Ea-4; Ea4
DR CLO; CLO_0002866
DR ECACC; 96073116
RX DOI=10.1038/nbt0296-197;
CC Group: Insect cell line.
CC Group: Recombinant protein production insect cell line.
CC Doubling time: 36 hours (ECACC).
OX NCBI_TaxID=56594; ! Estigmene acrea
HI CVCL_Z253 ! BTI-EAA
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID EA.hy 926
AC CVCL_3901
SY EA. hy 926; EA hy 926; EAhy 926; EA.Hy926; EA.hy926; EAhy926
DR BTO; BTO:0000396
DR EFO; EFO_0003039
DR ATCC; CRL-2922
DR BCRJ; 0345
DR BioSample; SAMN03471700
DR KCB; KCB 2014048YJ
DR Lonza; 685
DR NCBI_Iran; C641
RX PubMed=6407019;
RX PubMed=12453433;
CC Doubling time: 12 hours (PubMed=6407019).
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,11,12
ST D13S317: 11
ST D16S539: 11,12
ST D5S818: 11
ST D7S820: 8,9,10
ST TH01: 6,8,9.3
ST TPOX: 8,9
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0023 ! A-549
SX Male
CA Hybrid cell line
//
ID EA1.Lu
AC CVCL_R941
DR ATCC; CRL-6015
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6015; true.
OX NCBI_TaxID=9643; ! Ursus americanus
SX Female
CA Finite cell line
//
ID EA13.5
AC CVCL_DD02
DR ATCC; CRL-10934
RX Patent=US5198428;
RX PubMed=8445326;
CC Discontinued: ATCC; CRL-10934; probable.
CC Breed/subspecies: BALB/c.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0493 ! RAW 264.7
SX Male
CA Cancer cell line
//
ID Ea3
AC CVCL_HE66
RX PubMed=6201749;
RX PubMed=6422470;
CC Characteristics: IL3 dependent.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
CA Factor-dependent cell line
//
ID Ea3.123
AC CVCL_HE67
SY 123
RX PubMed=3089920;
RX PubMed=3491256;
CC Characteristics: IL3 dependent.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_HE66 ! Ea3
CA Factor-dependent cell line
//
ID Ea3.17
AC CVCL_5281
SY Ea3-17; Ea 3-17; Ea3 clone 17
RX PubMed=2497280;
RX PubMed=6201749;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=Ea3.17
CC Characteristics: IL3 dependent.
CC Breed/subspecies: BALB/c.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_HE66 ! Ea3
CA Factor-dependent cell line
//
ID EAGB
AC CVCL_R892
SY Epinephelus Akaara Grouper Brain
RX DOI=10.1016/j.aquaculture.2010.11.037;
CC Group: Fish cell line.
OX NCBI_TaxID=215347; ! Epinephelus akaara
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID EAGK
AC CVCL_R893
SY Epinephelus Akaara Grouper Kidney
RX PubMed=21838711;
CC Group: Fish cell line.
OX NCBI_TaxID=215347; ! Epinephelus akaara
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID EAGL
AC CVCL_R894
SY Epinephelus Akaara Grouper Liver
RX PubMed=21039492;
CC Group: Fish cell line.
OX NCBI_TaxID=215347; ! Epinephelus akaara
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID EAGS
AC CVCL_R895
SY Epinephelus Akaara Grouper Spleen
RX DOI=10.1016/j.aquaculture.2009.04.019;
CC Group: Fish cell line.
OX NCBI_TaxID=215347; ! Epinephelus akaara
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID EAGSB
AC CVCL_R896
SY Epinephelus Akaara Grouper Swim Bladder
RX DOI=10.1016/j.aquaculture.2009.04.019;
CC Group: Fish cell line.
OX NCBI_TaxID=215347; ! Epinephelus akaara
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID EAM306
AC CVCL_AV62
SY THJ-306T
RX CelloPub=CLPUB00321;
ST Source(s): CelloPub=CLPUB00321
ST Amelogenin: X
ST CSF1PO: 10,13
ST D13S317: 8,12
ST D16S539: 12
ST D18S51: 12,15
ST D21S11: 28,31.2
ST D3S1358: 15,18
ST D5S818: 11
ST D7S820: 11,12
ST D8S1179: 14,15
ST FGA: 21
ST TPOX: 9,11
ST vWA: 16,17
DI NCIt; C8054; Thyroid gland follicular carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EAP1
AC CVCL_J956
WW https://www.komp.org/pdf.php?cloneID=112973
WW https://www.komp.org/pdf/EAP1_Culture_Protocol.pdf
CC Breed/subspecies: C57BL/6NCrl.
OX NCBI_TaxID=10090; ! Mus musculus
CA Embryonic stem cell
//
ID EAV,AC
AC CVCL_E576
SY EAV, AC
DR dbMHC; 48771
DR ECACC; 94082251
DR IHW; IHW9151
DR IMGT/HLA; 11694
RX PubMed=8307784;
WW http://bioinformatics.hsanmartino.it/ecbr/cl151.html
CC Part of: 4th Asia-Oceania Histocompatibility Workshop (4AOHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID EB [Human colon carcinoma]
AC CVCL_F287
SY HCT-EB
DR Cosmic; 711274
DR Cosmic; 887228
DR Cosmic; 889530
DR Cosmic; 948124
DR Cosmic; 1057762
RX PubMed=3349466;
RX PubMed=7329817;
RX PubMed=9000147;
RX PubMed=9000572;
RX PubMed=11526487;
RX PubMed=24042735;
CC Microsatellite instability: Stable (MSS) (PubMed=9000147; PubMed=24042735).
CC Miscellaneous: STR profile mentioned but not shown in PubMed=24042735; obtained by personal communication of Lind G.E.
ST Source(s): PubMed=24042735
ST Amelogenin: X
ST CSF1PO: 12,15
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 14,16
ST D19S433: 13
ST D21S11: 28,32.2
ST D2S1338: 19
ST D3S1358: 14,15
ST D5S818: 10,11
ST D7S820: 8,9
ST D8S1179: 11,13
ST FGA: 21,22.2
ST TH01: 9,9.3
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID EB [Human skin fibroblast]
AC CVCL_5282
DR CLO; CLO_0002867
DR ATCC; CRL-1365
DI NCIt; C34568; Ehlers-Danlos syndrome
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID EB (JC)
AC CVCL_4169
DR CLO; CLO_0002868
DR CLDB; cl1126
DR ECACC; 89072703
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9595; ! Gorilla gorilla gorilla
SX Female
CA Transformed cell line
//
ID EB-PE
AC CVCL_F014
RX PubMed=9558375;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=EB-PE
CC Breed/subspecies: 129S/SvEv-Gpi1<c>.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_C313 ! CCE
CA Transformed cell line
//
ID EB.Sk
AC CVCL_S388
DR ATCC; CRL-6524
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6524; true.
OX NCBI_TaxID=39304; ! Erignathus barbatus
SX Female
CA Finite cell line
//
ID EB1
AC CVCL_2027
AS CVCL_2026
SY EB-1; Epstein-Barr-1
DR BTO; BTO:0003000
DR CLO; CLO_0002869
DR CLO; CLO_0002870
DR EFO; EFO_0002172
DR CLDB; cl1127
DR ATCC; HTB-60
DR BioSample; SAMN03472402
DR BioSample; SAMN03473402
DR CCLE; EB1_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR CLS; 300403/p863_EB1
DR Cosmic; 1086328
DR Cosmic; 1818341
DR DSMZ; ACC-80
DR GEO; GSM827341
DR GEO; GSM886991
DR GEO; GSM888060
DR IGRhCellID; EB1
RX PubMed=6018567;
RX PubMed=7316467;
RX PubMed=8515068;
RX PubMed=14090852;
RX PubMed=14293790;
RX PubMed=14293791;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~30-40 hours (DSMZ).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; CLS; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,13
ST D16S539: 8,10
ST D18S51: 15,16
ST D21S11: 30,32.2
ST D3S1358: 16,17
ST D5S818: 8,12
ST D7S820: 10,12
ST D8S1179: 14,15
ST FGA: 24,30
ST Penta D: 6.4,13 (CLS)
ST Penta D: 6.3,13 (PubMed=25877200)
ST Penta E: 13,17
ST TH01: 9,9.3 (ATCC; CLS; PubMed=25877200)
ST TH01: 9,10 (DSMZ)
ST TPOX: 8,9
ST vWA: 14,16
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EB14
AC CVCL_4Z57
RX DOI=10.1007/978-1-4020-5476-1_101;
RX Patent=US7432101;
RX Patent=US9382513;
CC Group: Bird cell line.
CC Breed/subspecies: S86N.
OX NCBI_TaxID=9031; ! Gallus gallus
HI CVCL_4Z58 ! EB45
SX Sex undetermined
CA Embryonic stem cell
//
ID EB176 (JC)
AC CVCL_3816
SY EB176
DR CLO; CLO_0002871
DR CLDB; cl1129
DR ECACC; 89072704
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9598; ! Pan troglodytes
SX Male
CA Transformed cell line
//
ID EB185 (JC)
AC CVCL_4170
SY EB185
DR CLO; CLO_0002872
DR CLDB; cl1130
DR ECACC; 89072705
CC Group: Non-human primate cell line.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9600; ! Pongo pygmaeus
SX Male
CA Transformed cell line
//
ID EB2
AC CVCL_1186
SY EB-2; Epstein-Barr-2
DR CLO; CLO_0002873
DR EFO; EFO_0002173
DR ATCC; HTB-61
DR CCLE; EB2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308867
DR ChEMBL-Targets; CHEMBL2366338
DR Cosmic; 906846
DR Cosmic; 1818342
DR Cosmic-CLP; 906846
DR GDSC; 906846
DR GEO; GSM886992
DR GEO; GSM888061
DR GEO; GSM1669747
DR IGRhCellID; EB2
RX PubMed=4736620;
RX PubMed=6018567;
RX PubMed=7316467;
RX PubMed=8515068;
RX PubMed=14284371;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Instable (MSI-low) (Sanger).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; Cosmic-CLP
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 11,13
ST D16S539: 8,10
ST D5S818: 8,12
ST D7S820: 10,12
ST TH01: 9,9.3
ST TPOX: 8,9
ST vWA: 14,16
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EB3 [Human Burkitt lymphoma]
AC CVCL_1185
SY EB-3; Epstein-Barr-3; GM04679
DR CLO; CLO_0002874
DR CLO; CLO_0019013
DR EFO; EFO_0002174
DR ATCC; CCL-85
DR BioSample; SAMN03473119
DR CCRID; 3111C0001CCC000343
DR CGH-DB; 9198-4
DR ChEMBL-Cells; CHEMBL3308824
DR ChEMBL-Targets; CHEMBL2366369
DR Coriell; GM04679
DR Cosmic; 687840
DR Cosmic; 906847
DR Cosmic; 1818343
DR Cosmic-CLP; 906847
DR ECACC; 90121003
DR GDSC; 906847
DR GEO; GSM1669748
DR IFO; IFO50028
DR IGRhCellID; EB3
RX PubMed=2052620;
RX PubMed=4736620;
RX PubMed=5884338;
RX PubMed=6018567;
RX PubMed=6286763;
RX PubMed=7316467;
RX PubMed=8515068;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
WW http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
CC Problematic cell line: Partially contaminated. Some stocks (such as IFO50028) were contaminated by Daudi.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Discontinued: IFO; IFO50028; true.
ST Source(s): ATCC; Cosmic-CLP; ECACC; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 12,15
ST D13S317: 12,14
ST D16S539: 10,12
ST D18S51: 15,17
ST D21S11: 29
ST D3S1358: 15,16
ST D5S818: 9,10
ST D7S820: 11
ST D8S1179: 14
ST FGA: 22
ST Penta D: 10,11
ST Penta E: 14,16
ST TH01: 7
ST TPOX: 6,9
ST vWA: 17,19 (ATCC; ECACC; PubMed=25877200)
ST vWA: 16,17,19 (Cosmic-CLP)
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID EB3 [Mouse ESC]
AC CVCL_J647
DR RCB; AES0139
DR RCB; RCB2717
RX PubMed=11839818;
CC Discontinued: RCB; RCB2717; true.
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9108 ! ES-E14TG2a
SX Male
CA Embryonic stem cell
//
ID EB33
AC CVCL_8344
SY EB 33; EB-33
DR BioSample; SAMN03151687
RX CelloPub=CLPUB00262;
RX PubMed=87387;
RX PubMed=93571;
RX PubMed=372824;
RX PubMed=535908;
RX PubMed=1246601;
RX PubMed=4374785;
RX PubMed=6451928;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=93571, PubMed=6451928, PubMed=1246601, PubMed=20143388). Originally thought to originate from a prostate carcinoma.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID EB4
AC CVCL_W738
SY EB-4; Epstein-Barr-4
RX PubMed=5922251;
RX PubMed=6074691;
RX PubMed=7316467;
CC Doubling time: 24 hours (PubMed=5922251).
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EB45
AC CVCL_4Z58
SY S86N45
RX Patent=US7432101;
CC Group: Bird cell line.
CC Breed/subspecies: S86N.
OX NCBI_TaxID=9031; ! Gallus gallus
SX Sex undetermined
CA Embryonic stem cell
//
ID EB5 [Human Burkitt lymphoma]
AC CVCL_W739
SY EB-5; Epstein-Barr-5
RX PubMed=5922251;
CC Doubling time: 36 hours (PubMed=5922251).
DI NCIt; C2912; Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID EB5 [Mouse ESC]
AC CVCL_J648
DR RCB; AES0151
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_9108 ! ES-E14TG2a
SX Male
CA Embryonic stem cell
//
ID EB66
AC CVCL_G703
RX Patent=US9260694;
RX PubMed=20562528;
RX PubMed=21502045;
RX PubMed=25903999;
WW http://www.valneva.com/?page=35
CC Group: Bird cell line.
CC Group: Vaccine production cell line.
CC Breed/subspecies: GL30.
OX NCBI_TaxID=8839; ! Anas platyrhynchos
SX Male
CA Embryonic stem cell
//
ID EBC-1
AC CVCL_2891
SY EBC-1/original; EBC1
DR BTO; BTO:0003001
DR CLO; CLO_0050039
DR EFO; EFO_0003115
DR BioSample; SAMN03472045
DR BioSample; SAMN03472311
DR CCLE; EBC1_LUNG
DR CGH-DB; 185-1
DR CGH-DB; 9172-4
DR Cosmic; 753554
DR Cosmic; 801583
DR Cosmic; 844845
DR Cosmic; 876170
DR Cosmic; 889089
DR Cosmic; 917995
DR Cosmic; 932929
DR Cosmic; 946069
DR Cosmic; 1048220
DR Cosmic; 1219069
DR Cosmic; 1239905
DR Cosmic; 1571731
DR Cosmic; 1656904
DR Cosmic; 1694670
DR Cosmic; 1802303
DR Cosmic; 2060527
DR Cosmic; 2125222
DR Cosmic; 2546867
DR Cosmic-CLP; 753554
DR GDSC; 753554
DR GEO; GSM827595
DR GEO; GSM886993
DR GEO; GSM888062
DR GEO; GSM1374471
DR GEO; GSM1669749
DR JCRB; JCRB0820
DR RCB; RCB1965
DR TKG; TKG 0481
RX CelloPub=CLPUB00014;
RX CelloPub=CLPUB00257;
RX DOI=10.2482/haigan.22.53;
RX PubMed=9290701;
RX PubMed=11005564;
RX PubMed=12569360;
RX PubMed=14581340;
RX PubMed=15185009;
RX PubMed=15746151;
RX PubMed=17325662;
RX PubMed=19472407;
RX PubMed=22313637;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-570.html
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 42 hours (CelloPub=CLPUB00014).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Skin.
ST Source(s): Cosmic-CLP; JCRB; PubMed=25877200; RCB
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 12
ST D16S539: 9 (Cosmic-CLP; JCRB; PubMed=25877200; TKG)
ST D16S539: 8,9 (RCB)
ST D18S51: 12,17
ST D21S11: 29,30
ST D3S1358: 15
ST D5S818: 11
ST D7S820: 10,11
ST D8S1179: 14
ST FGA: 22
ST Penta D: 13
ST Penta E: 16
ST TH01: 7
ST TPOX: 8
ST vWA: 16,17
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID EBC-1/bone
AC CVCL_U892
RX PubMed=14965364;
CC Derived from metastatic site: Skin.
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2891 ! EBC-1
SX Male
CA Cancer cell line
//
ID EBC-1/brain
AC CVCL_U893
RX PubMed=14965364;
CC Derived from metastatic site: Skin.
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2891 ! EBC-1
SX Male
CA Cancer cell line
//
ID EBC-2
AC CVCL_DH99
SY EBC2
RX PubMed=10213231;
RX PubMed=11844606;
CC Derived from metastatic site: Pericardial effusion.
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DI00 ! EBC-2/R
SX Male
CA Cancer cell line
//
ID EBC-2/R
AC CVCL_DI00
RX PubMed=11844606;
CC Derived from metastatic site: Pericardial effusion.
DI NCIt; C3493; Squamous cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_DH99 ! EBC-2
SX Male
CA Cancer cell line
//
ID EBL
AC CVCL_2028
SY Embryonic Bovine Lung
DR CLO; CLO_0002875
DR CLDB; cl1131
DR DSMZ; ACC-192
CC Doubling time: ~70 hours (DSMZ).
OX NCBI_TaxID=9913; ! Bos taurus
CA Spontaneously immortalized cell line
//
ID EBLC-1
AC CVCL_DF73
SY Enzootic Bovine Leukosis Cell line-1
RX PubMed=3012214;
CC Breed/subspecies: Japanese black.
DI NCIt; C131469; Bovine leukemia
OX NCBI_TaxID=9913; ! Bos taurus
SX Female
CA Cancer cell line
//
ID EBNA1+H9
AC CVCL_C100
SY CSUe002-A
DR hPSCreg; CSUe002-A
RX PubMed=15645084;
CC From: Central South University; China.
CC Transfected with: UniProtKB; P03211; EBV EBNA1.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_9773 ! WA09
SX Female
CA Embryonic stem cell
//
ID EBRTcH3
AC CVCL_J649
DR RCB; AES0054
DR RCB; RCB2325
CC Discontinued: RCB; RCB2325; true.
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID EBRTcH3(serum)
AC CVCL_U953
DR RCB; AES0119
DR RCB; RCB2659
CC Discontinued: RCB; RCB2659; true.
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_J649 ! EBRTcH3
SX Male
CA Embryonic stem cell
//
ID EBT-8
AC CVCL_8445
RX PubMed=8057683;
CC Characteristics: IL2 dependent.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
DI NCIt; C4664; T-cell large granular lymphocyte leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID EBTr
AC CVCL_2442
SY EBTr (NBL-4); NBL-4
DR BTO; BTO:0001199
DR CLO; CLO_0002876
DR CLO; CLO_0002877
DR CLDB; cl1132
DR CLDB; cl1133
DR ATCC; CCL-44
DR ATCC; CRL-6565
DR CCRID; 3131C0001000400005
DR ECACC; 87090202
DR IZSLER; BS CL 39
DR JCRB; JCRB9038
DR KCLB; 10044
RX PubMed=5587551;
RX PubMed=7065527;
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6565; true.
OX NCBI_TaxID=9913; ! Bos taurus
SX Male
CA Finite cell line
//
ID EC [Human B-cell]
AC CVCL_E577
DR dbMHC; 48772
DR ECACC; 94050330
DR IHW; IHW9312
DR IMGT/HLA; 10550
WW http://bioinformatics.hsanmartino.it/ecbr/cl312.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID EC [Human ovarian carcinoma]
AC CVCL_W130
RX DOI=10.1063/1.1291135;
RX PubMed=8718548;
RX PubMed=15677628;
DI NCIt; C4908; Ovarian carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EC-50
AC CVCL_IR37
SY EC50
RX PubMed=629296;
CC Derived from metastatic site: Ascites.
DI NCIt; C9039; Cervical carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EC-82
AC CVCL_IR38
RX PubMed=629296;
DI NCIt; C7736; Vaginal squamous cell carcinoma, not otherwise specified
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EC-GI-10
AC CVCL_1187
SY ECGI10; EC-GI
DR CLO; CLO_0051378
DR BioSample; SAMN03472227
DR CCLE; ECGI10_OESOPHAGUS
DR ChEMBL-Cells; CHEMBL3308289
DR ChEMBL-Targets; CHEMBL2366240
DR Cosmic; 753555
DR Cosmic-CLP; 753555
DR GDSC; 753555
DR GEO; GSM886996
DR GEO; GSM888065
DR GEO; GSM1669753
DR RCB; RCB0774
RX PubMed=2824416;
RX PubMed=3261732;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; PubMed=11416159; RCB
ST Amelogenin: X,Y
ST CSF1PO: 10,11
ST D13S317: 11
ST D16S539: 11,12
ST D18S51: 19
ST D21S11: 31
ST D5S818: 11
ST D7S820: 8,11
ST D8S1179: 9,13
ST FGA: 21,24
ST TH01: 7,9
ST TPOX: 11
ST vWA: 16,18
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID EC-MZ-1
AC CVCL_L445
RX PubMed=7681807;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EC-MZ-11
AC CVCL_L446
RX PubMed=7681807;
DI NCIt; C7558; Endometrial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EC-MZ-2
AC CVCL_L447
RX PubMed=7681807;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EC-MZ-3
AC CVCL_L448
RX PubMed=7681807;
DI NCIt; C7558; Endometrial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EC-MZ-5
AC CVCL_L449
RX PubMed=7681807;
DI NCIt; C8719; Endometrial squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EC-MZ-9
AC CVCL_L450
RX PubMed=7681807;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID ec-r.0
AC CVCL_0A37
RX PubMed=9542648;
CC Group: Insect cell line.
OX NCBI_TaxID=7153; ! Chironomus tentans
HI CVCL_0A36 ! Chironomus tentans epithelial cell line
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ec-r.1
AC CVCL_0A38
RX PubMed=9542648;
CC Group: Insect cell line.
OX NCBI_TaxID=7153; ! Chironomus tentans
HI CVCL_0A36 ! Chironomus tentans epithelial cell line
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID ec-r.2
AC CVCL_0A39
RX PubMed=9542648;
CC Group: Insect cell line.
OX NCBI_TaxID=7153; ! Chironomus tentans
HI CVCL_0A36 ! Chironomus tentans epithelial cell line
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID EC-RF24
AC CVCL_AX74
SY ECRF24; ECRF 24; ECRF; EC-RF
DR BTO; BTO:0004188
RX PubMed=7813621;
WW https://www.abmgood.com/Immortalized-Vascular-Endothelial-Cells-%5BEC-RF24%5D-T0003.html
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN16)].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AX75 ! EC-RF7
CA Transformed cell line
//
ID EC-RF7
AC CVCL_AX75
RX PubMed=7813621;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN16)].
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_AX74 ! EC-RF24
CA Transformed cell line
//
ID ec-rh.3
AC CVCL_0A40
RX PubMed=9542648;
CC Group: Insect cell line.
OX NCBI_TaxID=7153; ! Chironomus tentans
HI CVCL_0A36 ! Chironomus tentans epithelial cell line
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID EC1
AC CVCL_DC74
RX PubMed=8069445;
OX NCBI_TaxID=9925; ! Capra hircus
SX Female
CA Spontaneously immortalized cell line
//
ID EC109/CDDP
AC CVCL_6897
RX PubMed=19513506;
CC Selected for resistance to: ChEBI; CHEBI:27899; Cisplatin (CDDP).
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6898 ! Eca-109
SX Female
CA Cancer cell line
//
ID EC109/Taxol
AC CVCL_T047
RX PubMed=24002547;
CC Doubling time: 31.3 +- 0.39 hours (PubMed=24002547).
CC Selected for resistance to: ChEBI; CHEBI:45863; Paclitaxel (Taxol).
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_6898 ! Eca-109
SX Female
CA Cancer cell line
//
ID EC8501
AC CVCL_4N02
RX PubMed=9531643;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID EC8712
AC CVCL_E314
RX PubMed=9531643;
RX PubMed=10921044;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID EC8733
AC CVCL_E315
RX PubMed=9531643;
RX PubMed=10921044;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID EC9706
AC CVCL_E307
SY EC-9706
DR BTO; BTO:0005757
DR TOKU-E; 3567
RX PubMed=12476413;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID EC9706 clone EC1
AC CVCL_5V05
SY EC1
RX PubMed=17989041;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E307 ! EC9706
SX Male
CA Cancer cell line
//
ID EC9706 clone EC2
AC CVCL_5V06
SY EC2
RX PubMed=17989041;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E307 ! EC9706
SX Male
CA Cancer cell line
//
ID EC9706 clone EC3
AC CVCL_5V07
SY EC3
RX PubMed=17989041;
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_E307 ! EC9706
SX Male
CA Cancer cell line
//
ID Eca-109
AC CVCL_6898
SY Eca109; Eca 109; EC-109; EC109
DR BTO; BTO:0005758
DR CCRID; 3111C0001CCC000246
DR CCRID; 3131C0001000700069
DR ChEMBL-Cells; CHEMBL3308477
DR ChEMBL-Targets; CHEMBL614668
DR Cosmic; 932976
DR Cosmic; 2267320
DR Cosmic; 2395000
RX PubMed=6525939;
RX PubMed=9531643;
RX PubMed=24002547;
WW http://www.addexbio.com/productdetail?pid=37
CC Doubling time: 28.57 +- 0.12 hours (PubMed=24002547).
DI NCIt; C4024; Esophageal squamous cell carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID eCAS
AC CVCL_7189
SY e-CAS
DR Lonza; 265
RX PubMed=14700538;
CC Transfected with: HGNC; 11730; TERT.
OX NCBI_TaxID=9796; ! Equus caballus
CA Telomerase immortalized cell line
//
ID ECC-1
AC CVCL_7260
SY ECC1; EnCa1
DR BTO; BTO:0005365
DR EFO; EFO_0005231
DR ATCC; CRL-2923
DR BioSample; SAMN03151801
DR BioSample; SAMN03472871
DR Cosmic; 1102375
DR Cosmic; 1576451
DR Cosmic; 1622895
DR Cosmic; 2030461
DR ENCODE; ENCBS034DOC
DR ENCODE; ENCBS159ITB
DR ENCODE; ENCBS222DWG
DR ENCODE; ENCBS312UTV
DR ENCODE; ENCBS336PJO
DR ENCODE; ENCBS347ANJ
DR ENCODE; ENCBS624SHM
DR ENCODE; ENCBS670ZEX
DR ENCODE; ENCBS731RSG
DR ENCODE; ENCBS743VIZ
DR ENCODE; ENCBS758FSP
DR ENCODE; ENCBS767JJY
DR ENCODE; ENCBS862NRL
DR ENCODE; ENCBS896YZO
DR GEO; GSM843495
DR GEO; GSM843496
DR GEO; GSM923422
DR GEO; GSM923423
DR GEO; GSM923426
DR GEO; GSM923427
DR GEO; GSM1008597
DR GEO; GSM1008574
DR Lonza; 1319
RX PubMed=10478797;
RX PubMed=16707768;
RX PubMed=22710073;
RX PubMed=23325432;
WW http://genome.ucsc.edu/ENCODE/protocols/cell/human/ECC1_Myers_protocol.pdf
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a Ishikawa 3-H-12 derivative (PubMed=22710073).
CC Part of: ENCODE project common cell types; tier 3.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): ATCC; PubMed=22710073; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9,12
ST D16S539: 9
ST D18S51: 12,19
ST D19S433: 12.2,14
ST D21S11: 28
ST D2S1338: 20
ST D3S1358: 16,17
ST D5S818: 10,11
ST D7S820: 9,10
ST D8S1179: 13,16
ST FGA: 21
ST Penta D: 10,11
ST Penta E: 11,19.1
ST TH01: 9,10
ST TPOX: 8
ST vWA: 14,17
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_D199 ! Ishikawa 3-H-12
SX Female
CA Cancer cell line
//
ID ECC10
AC CVCL_1188
SY ECC-10
DR CLO; CLO_0050796
DR BioSample; SAMN03472196
DR CCLE; ECC10_STOMACH
DR ChEMBL-Cells; CHEMBL3308191
DR ChEMBL-Targets; CHEMBL2366117
DR Cosmic; 848376
DR Cosmic; 906848
DR Cosmic; 1187269
DR Cosmic-CLP; 906848
DR GDSC; 906848
DR GEO; GSM886994
DR GEO; GSM888063
DR GEO; GSM1669750
DR RCB; RCB0983
RX PubMed=8392984;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 11
ST D16S539: 11
ST D5S818: 12
ST D7S820: 10,12
ST TH01: 7
ST TPOX: 11
ST vWA: 19
DI NCIt; C6764; Gastric small cell neuroendocrine carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ECC12
AC CVCL_1189
SY ECC-12
DR CLO; CLO_0050807
DR BioSample; SAMN03472198
DR CCLE; ECC12_STOMACH
DR ChEMBL-Cells; CHEMBL3308192
DR ChEMBL-Targets; CHEMBL2366180
DR Cosmic; 848377
DR Cosmic; 906849
DR Cosmic; 1187270
DR Cosmic-CLP; 906849
DR GDSC; 906849
DR GEO; GSM886995
DR GEO; GSM888064
DR GEO; GSM1669751
DR RCB; RCB1009
RX PubMed=8392984;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; RCB
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 12
ST D16S539: 9,11
ST D5S818: 13
ST D7S820: 10,11
ST TH01: 9
ST TPOX: 11
ST vWA: 16,19
DI NCIt; C6764; Gastric small cell neuroendocrine carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ECC18
AC CVCL_L207
RX PubMed=8392984;
DI NCIt; C6762; Esophageal small cell neuroendocrine carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ECC4
AC CVCL_1190
DR CLO; CLO_0051398
DR BioSample; SAMN03472195
DR ChEMBL-Cells; CHEMBL3308162
DR ChEMBL-Targets; CHEMBL2366367
DR Cosmic; 906850
DR GDSC; 906850
DR GEO; GSM1669752
DR RCB; RCB0982
RX PubMed=8392984;
CC Omics: DNA methylation analysis.
ST Source(s): RCB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 11
ST D16S539: 10
ST D5S818: 11
ST D7S820: 10,12
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C9383; Rectal adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ECF-R
AC CVCL_5738
DR CLS; 601469/p2050_ECF-R
CC Group: Bird cell line.
OX NCBI_TaxID=9031; ! Gallus gallus
CA Finite cell line
//
ID ECF50.Ht
AC CVCL_S054
DR ATCC; CRL-6252
CC Discontinued: ATCC; CRL-6252; true.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S378 ! ECF50.Lu
SX Sex undetermined
CA Finite cell line
//
ID ECF50.Lu
AC CVCL_S378
DR ATCC; CRL-6346
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6346; true.
OX NCBI_TaxID=9615; ! Canis lupus familiaris
OI CVCL_S054 ! ECF50.Ht
SX Sex undetermined
CA Finite cell line
//
ID eCG 100.6
AC CVCL_9W10
SY 100.6
RX PubMed=11572789;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9796; ! Equus caballus
SX Female
CA Transformed cell line
//
ID eCG 50.5
AC CVCL_9W11
SY 50.5
RX PubMed=11572789;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9796; ! Equus caballus
SX Female
CA Transformed cell line
//
ID eCG 500.1
AC CVCL_9W12
SY 500.1
RX PubMed=11572789;
CC Transfected with: UniProtKB; P00552; Transposon Tn5 neo.
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=9796; ! Equus caballus
SX Female
CA Transformed cell line
//
ID ECL-2
AC CVCL_J412
RX PubMed=11437454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_J413 ! ECL-32
OI CVCL_J414 ! ECL-38
OI CVCL_J415 ! ECL-41
CA Transformed cell line
//
ID ECL-32
AC CVCL_J413
RX PubMed=11437454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_J412 ! ECL-2
OI CVCL_J414 ! ECL-38
OI CVCL_J415 ! ECL-41
CA Transformed cell line
//
ID ECL-38
AC CVCL_J414
RX PubMed=11437454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_J412 ! ECL-2
OI CVCL_J413 ! ECL-32
OI CVCL_J415 ! ECL-41
CA Transformed cell line
//
ID ECL-41
AC CVCL_J415
RX PubMed=11437454;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_J412 ! ECL-2
OI CVCL_J413 ! ECL-32
OI CVCL_J414 ! ECL-38
CA Transformed cell line
//
ID ECPC-3
AC CVCL_4835
DR CLO; CLO_0050206
DR RCB; RCB1286
RX PubMed=8878450;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6 IgH-T-Ag transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_4836 ! ECPC-4
SX Sex undetermined
CA Transformed cell line
//
ID ECPC-4
AC CVCL_4836
DR CLO; CLO_0050205
DR RCB; RCB1287
RX PubMed=8878450;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
CC Breed/subspecies: C57BL/6 IgH-T-Ag transgenic.
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_4835 ! ECPC-3
SX Sex undetermined
CA Transformed cell line
//
ID EcR-RKO/KLF4
AC CVCL_9807
DR EFO; EFO_0002052
RX PubMed=17017123;
CC Transfected with: MGI; MGI:1342287; Klf4.
DI NCIt; C4910; Colon carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0504 ! RKO
CA Cancer cell line
//
ID EcR293
AC CVCL_7261
SY EcR-293
DR Lonza; 695
DR TOKU-E; 3682
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-144.html
CC Transformant: NCBI_TaxID; 28285; Adenovirus 5.
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0045 ! HEK293
SX Female
CA Transformed cell line
//
ID Ect1/E6E7
AC CVCL_3679
SY ECT1/E6E7; Ect1
DR CLO; CLO_0002879
DR EFO; EFO_0005264
DR ATCC; CRL-2614
DR BioSample; SAMN03471693
RX PubMed=9314589;
CC Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16) [E6/E7 (pLXSN)].
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 12
ST D16S539: 10,13
ST D5S818: 11,12
ST D7S820: 10
ST TH01: 6,10
ST TPOX: 8,11
ST vWA: 16,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID ECTC
AC CVCL_4518
SY Embryonic Calf Thyroid Cell
DR CLO; CLO_0002880
DR CLDB; cl1135
DR BioSample; SAMN03152037
DR IZSLER; BS CL 96
RX PubMed=14505435;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Group: Non-human primate cell line.
CC Problematic cell line: Misidentified/contaminated. Originally thought to be of bovine origin but found to be a monkey Vero derivative (PubMed=14505435, PubMed=20143388).
OX NCBI_TaxID=60711; ! Chlorocebus sabaeus
HI CVCL_0059 ! Vero
SX Female
CA Spontaneously immortalized cell line
//
ID ECV-304
AC CVCL_2029
SY ECV 304; ECV304; ECV; E304; T24(ECV304)
DR BTO; BTO:0002043
DR CLO; CLO_0002881
DR CLO; CLO_0002882
DR CLDB; cl1136
DR CLDB; cl5185
DR ATCC; CRL-1998
DR BCRJ; 0283
DR BioSample; SAMN03151937
DR BioSample; SAMN03471274
DR CCRID; 3111C0002000000074
DR CCRID; 3142C0001000000023
DR ChEMBL-Cells; CHEMBL3307513
DR ChEMBL-Targets; CHEMBL614035
DR CLS; 300452/p765_ECV-304
DR Cosmic; 1466801
DR DSMZ; ACC-310
DR ECACC; 92091712
DR IZSLER; BS CL 137
DR JCRB; JCRB0744
DR JCRB; NIHS0220
DR Lonza; 264
DR PRIDE; PXD004340
RX PubMed=1378828;
RX PubMed=1690702;
RX PubMed=9290701;
RX PubMed=10508494;
RX PubMed=10653001;
RX PubMed=11669284;
RX PubMed=12197766;
RX PubMed=12453433;
RX PubMed=20143388;
RX PubMed=27554326;
WW http://www.atcc.org/support/faqs/d0b4d/ECV304%20%20ATCC%20CRL1998-1057.aspx
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-2.html
WW http://cellbank.nibiohn.go.jp/legacy/cellbank/qualitycontrol/identification/summary.htm
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=10508494, PubMed=12197766, PubMed=20143388). Was originally thought to originate from endothelial cells obtained from the umbilical vein of a healthy donor.
CC Doubling time: ~2 days (DSMZ).
CC Omics: Deep tyrosine phosphoproteome analysis.
CC Discontinued: ATCC; CRL-1998; true.
CC Discontinued: BCRJ; 0283; probable.
CC Discontinued: JCRB; NIHS0220; true.
ST Source(s): ATCC; CLS; DSMZ; ECACC; JCRB; PubMed=11416159
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 12
ST D16S539: 9
ST D18S51: 16,18
ST D21S11: 29
ST D3S1358: 16
ST D5S818: 10
ST D7S820: 10,11
ST D8S1179: 14
ST FGA: 17,22
ST Penta D: 11,15
ST Penta E: 7,10
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0554 ! T24
SX Female
CA Cancer cell line
//
ID ED(27)
AC CVCL_8345
SY ED27
DR BioSample; SAMN03151688
RX PubMed=1415390;
RX PubMed=11869090;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a WISH derivative (PubMed=11869090, PubMed=20143388). Originally thought to originate from a chorionic villus sample from a 35-year old woman.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_1909 ! WISH
SX Female
CA Cancer cell line
//
ID ED1
AC CVCL_M036
DR ECACC; 89040701
RX PubMed=3882559;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID ED1-19-1-6-5
AC CVCL_9173
DR CLO; CLO_0002883
DR ATCC; HB-90
OX NCBI_TaxID=10090; ! Mus musculus
OX NCBI_TaxID=10116; ! Rattus norvegicus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID Ed141.MEL
AC CVCL_GR69
DR TOKU-E; 4006
RX PubMed=11950413;
CC Characteristics: Early passage culture.
DI NCIt; C3224; Melanoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Ed147.BT
AC CVCL_GR70
DR TOKU-E; 4007
RX PubMed=11950413;
CC Characteristics: Early passage culture.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Ed149.BT
AC CVCL_GR71
DR TOKU-E; 4008
RX PubMed=11950413;
CC Characteristics: Early passage culture.
DI NCIt; C3058; Glioblastoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ED16
AC CVCL_M039
RX PubMed=2016566;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID ED17
AC CVCL_M040
DR ECACC; 95110627
RX PubMed=2016566;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID ED2
AC CVCL_M037
DR ECACC; 89040702
RX PubMed=3882559;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID ED3
AC CVCL_M038
DR ECACC; 89040703
RX PubMed=3882559;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID ED4
AC CVCL_M044
RX PubMed=2572659;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID ED7
AC CVCL_M041
DR ECACC; 95110624
RX PubMed=2572659;
CC Monoclonal antibody target: UniProtKB; Q9JI30; Rat Itgam/Cd11b.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID ED8
AC CVCL_M042
DR ECACC; 95110625
RX PubMed=2572659;
CC Monoclonal antibody target: UniProtKB; Q9JI30; Rat Itgam/Cd11b.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID ED9
AC CVCL_M043
DR ECACC; 95110626
RX PubMed=2572659;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID Eda Bel
AC CVCL_U679
DR ATCC; CRL-1190
CC Discontinued: ATCC; CRL-1190; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID Edi 1
AC CVCL_A233
SY Edi-1; EDI-1; CAMe001-A; EDe008-A
DR hPSCreg; EDe008-A
CC From: University of Edinburgh; Edinburgh; UK.
CC Registration: Swiss research registry; BAG-hES-IMP-0012.
CC Registration: UK Stem Cell Bank (UKSCB); R-06-005, Steering comm. appl. SCSC04-29.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Edi 2
AC CVCL_A234
SY Edi-2; EDI-2; CAMe002-A; EDe009-A
DR hPSCreg; EDe009-A
DR ISCR; 2210
WW http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/edi-2.aspx
CC From: University of Edinburgh; Edinburgh; UK.
CC Registration: Swiss research registry; BAG-hES-IMP-0032.
CC Registration: UK Stem Cell Bank (UKSCB); R-07-023, Steering comm. appl. SCSC07-12.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID Edi 3
AC CVCL_A235
SY Edi-3; EDI-3; CAMe003-A; EDe010-A
DR hPSCreg; EDe010-A
CC From: University of Edinburgh; Edinburgh; UK.
CC Registration: UK Stem Cell Bank (UKSCB); R-07-024, Steering comm. appl. SCSC07-12.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID Edi 4
AC CVCL_A236
SY Edi-4; EDI-4; CAMe004-A; EDe011-A
DR hPSCreg; EDe011-A
DR ISCR; 2211
WW http://www.nibsc.org/science_and_research/advanced_therapies/uk_stem_cell_bank/cell_lines/available_human_cell_lines/laboratory_grade/edi-4.aspx
CC From: University of Edinburgh; Edinburgh; UK.
CC Registration: UK Stem Cell Bank (UKSCB); R-07-025, Steering comm. appl. SCSC07-13.
OX NCBI_TaxID=9606; ! Homo sapiens
CA Embryonic stem cell
//
ID EDi001-A
AC CVCL_AW97
SY AST22; AST23
DR BioSamples; SAMEA3319992
DR EBiSC; EDi001-A
DR ECACC; 66540058
DR hPSCreg; EDi001-A
RX PubMed=21863007;
CC From: University of Edinburgh; Edinburgh; UK.
DI NCIt; C26845; Parkinson's disease
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID EDi002-A
AC CVCL_AW98
SY NAS2
DR BioSamples; SAMEA3333374
DR EBiSC; EDi002-A
DR ECACC; 66540059
DR hPSCreg; EDi002-A
RX PubMed=21863007;
CC From: University of Edinburgh; Edinburgh; UK.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Induced pluripotent stem cell
//
ID EDJ#22
AC CVCL_C260
DR ATCC; SCRC-1021
CC Breed/subspecies: 129S6/SvEvTac.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID Edmin337
AC CVCL_8364
SY Edmin 337; L-337
CC Caution: We are not certain that Edmin337 and L-337 are the same cell line.
OX NCBI_TaxID=9796; ! Equus caballus
CA Undefined cell line type
//
ID Edom-iPS-#r-23
AC CVCL_Y537
DR SKIP; SKIP000410
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L430 ! Edom22
SX Female
CA Induced pluripotent stem cell
//
ID Edom-iPS-#r-5
AC CVCL_Y536
DR SKIP; SKIP000409
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L430 ! Edom22
SX Female
CA Induced pluripotent stem cell
//
ID Edom-iPS-#r30
AC CVCL_Y538
DR SKIP; SKIP000411
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L430 ! Edom22
SX Female
CA Induced pluripotent stem cell
//
ID Edom-iPS-#r35
AC CVCL_Y539
DR SKIP; SKIP000412
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L430 ! Edom22
SX Female
CA Induced pluripotent stem cell
//
ID Edom-iPS-#r49
AC CVCL_Y540
DR SKIP; SKIP000413
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L430 ! Edom22
SX Female
CA Induced pluripotent stem cell
//
ID Edom-iPS-#S-31
AC CVCL_Y535
DR SKIP; SKIP000408
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L430 ! Edom22
SX Female
CA Induced pluripotent stem cell
//
ID Edom-iPS-1
AC CVCL_L431
SY Edom-iPS-1(#k-1)
DR SKIP; SKIP000405
RX PubMed=21637780;
RX PubMed=23631808;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L430 ! Edom22
SX Female
CA Induced pluripotent stem cell
//
ID Edom-iPS-2
AC CVCL_L432
SY Edom-iPS-1(#k-2)
DR SKIP; SKIP000406
RX PubMed=21637780;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L430 ! Edom22
SX Female
CA Induced pluripotent stem cell
//
ID Edom-iPS-3
AC CVCL_L433
SY Edom-iPS-1(#k-3)
DR SKIP; SKIP000407
RX PubMed=21637780;
WW http://nrichd.ncchd.go.jp/reproduction/hipscell.htm
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L430 ! Edom22
SX Female
CA Induced pluripotent stem cell
//
ID Edom22
AC CVCL_L430
DR JCRB; JCRB1581
RX PubMed=21637780;
RX PubMed=23631808;
ST Source(s): JCRB
ST Amelogenin: X
ST CSF1PO: 12
ST D13S317: 8,12
ST D16S539: 10,12
ST D5S818: 11
ST D7S820: 9,12
ST TH01: 7,9
ST TPOX: 11
ST vWA: 14,17
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Adult stem cell
//
ID EDS 100
AC CVCL_IM44
DR CLO; CLO_0002884
DR CLDB; cl1137
CC From: Dept. Scienze Biomediche e Biotecnologie; Universita degli Studi di Brescia; Brescia; Italy.
DI NCIt; C84736; Glycogen storage disease type III
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID EDS 101
AC CVCL_IM45
DR CLO; CLO_0002885
DR CLDB; cl1138
CC From: Dept. Scienze Biomediche e Biotecnologie; Universita degli Studi di Brescia; Brescia; Italy.
DI NCIt; C84736; Glycogen storage disease type III
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID EDS 105
AC CVCL_IM46
DR CLO; CLO_0002886
DR CLDB; cl1139
CC From: Dept. Scienze Biomediche e Biotecnologie; Universita degli Studi di Brescia; Brescia; Italy.
DI NCIt; C125701; Ehlers-Danlos syndrome, type VII
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID EE39C
AC CVCL_9978
SY EE39c
DR Cosmic; 902794
RX PubMed=1730573;
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9979 ! EE39LN
SX Female
CA Cancer cell line
//
ID EE39LN
AC CVCL_9979
RX PubMed=1730573;
CC Derived from metastatic site: Lymph node.
DI NCIt; C4349; Colon adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_9978 ! EE39C
SX Female
CA Cancer cell line
//
ID EEB
AC CVCL_8685
DR CLO; CLO_0051023
DR BioSample; SAMN03471963
DR RCB; RCB2345
ST Source(s): RCB
ST Amelogenin: X,Y
ST CSF1PO: 11
ST D13S317: 9,12
ST D16S539: 10,12
ST D5S818: 11
ST D7S820: 10
ST TH01: 7
ST TPOX: 8,9
ST vWA: 16,17
DI NCIt; C8923; Acute erythroid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID EEC145T
AC CVCL_0Q75
SY EEC 145T
RX PubMed=10027626;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
DI NCIt; C3014; Endometriosis
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID EEK
AC CVCL_8346
SY Embryonic Equine Kidney
DR BioSample; SAMN03151865
RX PubMed=14505435;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Misidentified/contaminated. Originally thought to be of horse origin but found to be a pig NSK derivative (PubMed=14505435, PubMed=20143388).
OX NCBI_TaxID=9823; ! Sus scrofa
HI CVCL_8378 ! NSK
CA Spontaneously immortalized cell line
//
ID EEL
AC CVCL_8347
SY Embryonic Equine Lung
OX NCBI_TaxID=9796; ! Equus caballus
CA Finite cell line
//
ID EelB
AC CVCL_AZ88
SY Eel Brain
RX PubMed=26714751;
CC Group: Fish cell line.
OX NCBI_TaxID=7938; ! Anguilla rostrata
SX Female
CA Spontaneously immortalized cell line
//
ID Een217
AC CVCL_X679
SY Een 217
DR NIH-ARP; 755-405
RX PubMed=2969774;
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID eEnd.1
AC CVCL_6273
RX PubMed=2736622;
RX PubMed=3345558;
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID eEnd.2
AC CVCL_6274
RX PubMed=2736622;
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID EES-1
AC CVCL_W468
RX PubMed=12237927;
CC Caution: Not to be confused with extraosseous Ewing sarcoma cell line EES1 (CVCL_T757).
CC Derived from metastatic site: Lung.
DI NCIt; C4817; Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EES1
AC CVCL_T757
RX PubMed=17077599;
CC Caution: Not to be confused with Ewing sarcoma cell line EES-1 (CVCL_W468).
DI NCIt; C7135; Extraosseous Ewing sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EFC-1
AC CVCL_AS06
SY Efc-1
RX PubMed=2129226;
RX PubMed=16244654;
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID EFC007
AC CVCL_9U91
RX PubMed=8639765;
RX PubMed=9108096;
CC Transformant: NCBI_TaxID; 1891767; Simian virus 40 (SV40).
OX NCBI_TaxID=10090; ! Mus musculus
CA Transformed cell line
//
ID EFE-184
AC CVCL_1191
SY EFE184
DR CLO; CLO_0002887
DR CLDB; cl1140
DR BioSample; SAMN03470928
DR CCLE; EFE184_ENDOMETRIUM
DR ChEMBL-Cells; CHEMBL3308103
DR ChEMBL-Targets; CHEMBL1075438
DR Cosmic; 924109
DR Cosmic; 1576452
DR Cosmic; 2030462
DR DSMZ; ACC-230
DR GDSC; 924109
DR GEO; GSM374971
DR GEO; GSM375430
DR GEO; GSM886997
DR GEO; GSM888066
RX PubMed=22460905;
RX PubMed=25984343;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 90 hours (PubMed=25984343); ~92 hours (DSMZ).
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 13
ST D16S539: 12
ST D18S51: 12,19
ST D21S11: 30,33.2
ST D3S1358: 14,17
ST D5S818: 11,13
ST D7S820: 10,11
ST D8S1179: 11,13
ST FGA: 21
ST Penta D: 10,13
ST Penta E: 16
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 15,16
DI NCIt; C7558; Endometrial carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EFK
AC CVCL_Y449
SY Equine Fetal Kidney
DR ATCC; CRL-6289
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6289; true.
OX NCBI_TaxID=9796; ! Equus caballus
SX Sex undetermined
CA Finite cell line
//
ID Efk3B
AC CVCL_GZ34
SY Efk-3B; Efk3 clone 3B; Eptesicus fuscus kidney 3B
RX PubMed=27639955;
WW https://www.kerafast.com/product/2849/eptesicus-fuscus-kidney-cell-line-efk3b
WW http://usask.technologypublisher.com/tech/Eptesicus_fuscus_(Big_Brown_Bat)_kidney_immortalized_cell_line
CC Group: Bat cell line.
CC Characteristics: Can be used to cultivate viruses from the Coronaviridae, Filoviridae, Herpesviridae, Paramyxoviridae and Rhabdoviridae.
CC Doubling time: 24 hours (Kerafast).
CC Transformant: Myotis polyomavirus large T-antigen (MyPVTag).
OX NCBI_TaxID=29078; ! Eptesicus fuscus
SX Male
CA Transformed cell line
//
ID EFM-19
AC CVCL_0253
SY EFM19
DR CLO; CLO_0002888
DR EFO; EFO_0002175
DR MCCL; MCC:0000144
DR CLDB; cl1141
DR BioSample; SAMN03471840
DR CCLE; EFM19_BREAST
DR ChEMBL-Cells; CHEMBL3308502
DR ChEMBL-Targets; CHEMBL1075439
DR Cosmic; 906851
DR Cosmic; 1603196
DR Cosmic; 2165019
DR Cosmic-CLP; 906851
DR DSMZ; ACC-231
DR GDSC; 906851
DR GEO; GSM344364
DR GEO; GSM344414
DR GEO; GSM350527
DR GEO; GSM783976
DR GEO; GSM847250
DR GEO; GSM847460
DR GEO; GSM843497
DR GEO; GSM886999
DR GEO; GSM888068
DR GEO; GSM1669754
DR IGRhCellID; EFM19
RX PubMed=6589426;
RX PubMed=19582160;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://colt.ccbr.utoronto.ca/cancer/get_cellline.pl?cellline=EFM-19
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~50-60 hours (DSMZ); 81 hours (PubMed=25984343).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9
ST D13S317: 8,12
ST D16S539: 11,12
ST D18S51: 13
ST D21S11: 28
ST D3S1358: 18
ST D5S818: 11
ST D7S820: 9
ST D8S1179: 13,14
ST FGA: 22
ST Penta D: 9,13
ST Penta E: 13,14
ST TH01: 7,8
ST TPOX: 8,12
ST vWA: 14
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EFM-192A
AC CVCL_1812
SY EFM192A; EFM192
DR CLO; CLO_0002889
DR EFO; EFO_0006568
DR BioSample; SAMN03471045
DR CCLE; EFM192A_BREAST
DR Cosmic; 1309000
DR Cosmic; 1995391
DR Cosmic; 2165004
DR Cosmic-CLP; 1290798
DR DSMZ; ACC-258
DR GDSC; 1290798
DR GEO; GSM344365
DR GEO; GSM344415
DR GEO; GSM350532
DR GEO; GSM847316
DR GEO; GSM847470
DR GEO; GSM843498
DR GEO; GSM886998
DR GEO; GSM888067
DR GEO; GSM1421429
DR GEO; GSM1669755
RX PubMed=19582160;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~9 days (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: CNV analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 9,14
ST D16S539: 8,13
ST D18S51: 17
ST D21S11: 32.2
ST D3S1358: 16
ST D5S818: 12,13
ST D7S820: 8,11
ST D8S1179: 9,15
ST FGA: 20,22
ST Penta D: 9
ST Penta E: 14,16
ST TH01: 7
ST TPOX: 8,10
ST vWA: 16
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1813 ! EFM-192B
OI CVCL_1814 ! EFM-192C
SX Female
CA Cancer cell line
//
ID EFM-192B
AC CVCL_1813
SY EFM192B
DR CLO; CLO_0002890
DR EFO; EFO_0006569
DR DSMZ; ACC-308
RX PubMed=25485619;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~4-5 days (DSMZ).
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 9,14
ST D16S539: 8,13
ST D5S818: 12,13
ST D7S820: 8,11
ST TH01: 7
ST TPOX: 8,10
ST vWA: 16
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1812 ! EFM-192A
OI CVCL_1814 ! EFM-192C
SX Female
CA Cancer cell line
//
ID EFM-192C
AC CVCL_1814
SY EFM192C
DR CLO; CLO_0002891
DR EFO; EFO_0006570
DR DSMZ; ACC-311
RX PubMed=25485619;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~4 days (DSMZ).
CC Omics: Deep RNAseq analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Derived from metastatic site: Pleural effusion.
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 9,14
ST D16S539: 8,13
ST D5S818: 12,13
ST D7S820: 8,11
ST TH01: 7
ST TPOX: 8,10
ST vWA: 16
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_1812 ! EFM-192A
OI CVCL_1813 ! EFM-192B
SX Female
CA Cancer cell line
//
ID EFM-30
AC CVCL_1B48
RX PubMed=6589426;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EFM-36
AC CVCL_1B49
RX PubMed=6589426;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EFM-40
AC CVCL_1B50
RX PubMed=6589426;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EFM-49
AC CVCL_1B51
RX PubMed=6589426;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EFM-55
AC CVCL_1B52
RX PubMed=6589426;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EFM-56
AC CVCL_1B53
RX PubMed=6589426;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EFM-61
AC CVCL_1B54
RX PubMed=6589426;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EFM-63
AC CVCL_W957
RX PubMed=6405069;
RX PubMed=6589426;
CC Derived from metastatic site: Visceral.
DI NCIt; C4872; Breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EFM-76
AC CVCL_1B55
RX PubMed=6589426;
CC Derived from metastatic site: Pleural effusion.
DI NCIt; C4017; Ductal breast carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EFN-R
AC CVCL_0I48
SY EFN
DR CCLV; CCLV-RIE 0086
RX PubMed=19941903;
OX NCBI_TaxID=9823; ! Sus scrofa
CA Finite cell line
//
ID EFO-21
AC CVCL_0029
SY EFO21; EFO 21
DR CLO; CLO_0002892
DR CLDB; cl1142
DR BioSample; SAMN03473384
DR CCLE; EFO21_OVARY
DR ChEMBL-Cells; CHEMBL3308730
DR ChEMBL-Targets; CHEMBL1075440
DR Cosmic; 911905
DR Cosmic; 1305325
DR Cosmic; 1707571
DR Cosmic-CLP; 911905
DR DSMZ; ACC-235
DR GDSC; 911905
DR GEO; GSM659374
DR GEO; GSM887000
DR GEO; GSM888069
DR GEO; GSM1669756
RX PubMed=6405069;
RX PubMed=12661003;
RX PubMed=22460905;
RX PubMed=23839242;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://www.proteinatlas.org/learn/cellines
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 42 hours (PubMed=25984343); ~40-60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (PubMed=12661003; Sanger).
CC Omics: Deep antibody staining analysis.
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Ascites.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 9
ST D16S539: 12,13
ST D5S818: 10,12
ST D7S820: 9
ST TH01: 6
ST TPOX: 8,9
ST vWA: 16
DI NCIt; C5228; Ovarian cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EFO-27
AC CVCL_1192
SY EFO27; EFO 27
DR BTO; BTO:0002033
DR CLO; CLO_0002893
DR EFO; EFO_0006571
DR CLDB; cl1143
DR BioSample; SAMN03473290
DR BioSample; SAMN03473370
DR CCLE; EFO27_OVARY
DR ChEMBL-Cells; CHEMBL3308134
DR ChEMBL-Targets; CHEMBL1075441
DR Cosmic; 906852
DR Cosmic; 1305326
DR Cosmic; 1707565
DR Cosmic-CLP; 906852
DR DSMZ; ACC-191
DR GDSC; 906852
DR GEO; GSM659375
DR GEO; GSM887001
DR GEO; GSM888070
DR GEO; GSM1669757
RX PubMed=3476184;
RX PubMed=6405069;
RX PubMed=12661003;
RX PubMed=22460905;
RX PubMed=23415752;
RX PubMed=23839242;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: 29 hours (PubMed=25984343); ~50-80 hours (DSMZ).
CC Microsatellite instability: Instable (MSI-high) (PubMed=12661003; Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: shRNA library screening.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Derived from metastatic site: Omentum.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 9,10,13,14 (Cosmic-CLP; PubMed=25877200)
ST CSF1PO: 9,10,13 (DSMZ)
ST D13S317: 12,13
ST D16S539: 11,13
ST D18S51: 12,18
ST D21S11: 27,30
ST D3S1358: 14,17
ST D5S818: 11,12
ST D7S820: 8,10
ST D8S1179: 13,15
ST FGA: 23,26
ST Penta D: 9
ST Penta E: 7,10
ST TH01: 6,8
ST TPOX: 8
ST vWA: 13,18
DI NCIt; C5243; Ovarian mucinous adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EFO-3
AC CVCL_D309
SY EFO3
RX PubMed=6405069;
DI NCIt; C7978; Ovarian serous cystadenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EFO-47
AC CVCL_D310
SY EFO47
RX PubMed=6405069;
DI NCIt; C40078; Ovarian clear cell adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID eFOP1-1
AC CVCL_W543
DR SKIP; SKIP000346
RX PubMed=24321451;
DI NCIt; C3040; Fibrodysplasia ossificans progressiva
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W541 ! GM00513
SX Female
CA Induced pluripotent stem cell
//
ID eFOP1-11
AC CVCL_W544
RX PubMed=24321451;
DI NCIt; C3040; Fibrodysplasia ossificans progressiva
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W541 ! GM00513
SX Female
CA Induced pluripotent stem cell
//
ID eFOP2-3
AC CVCL_W545
DR SKIP; SKIP000337
RX PubMed=24321451;
DI NCIt; C3040; Fibrodysplasia ossificans progressiva
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W542 ! GM00783
SX Male
CA Induced pluripotent stem cell
//
ID eFOP2-8
AC CVCL_W546
RX PubMed=24321451;
DI NCIt; C3040; Fibrodysplasia ossificans progressiva
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_W542 ! GM00783
SX Male
CA Induced pluripotent stem cell
//
ID eFOP3-2
AC CVCL_W547
DR SKIP; SKIP000342
RX PubMed=24321451;
DI NCIt; C3040; Fibrodysplasia ossificans progressiva
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W548 ! eFOP3-4
SX Male
CA Induced pluripotent stem cell
//
ID eFOP3-4
AC CVCL_W548
DR SKIP; SKIP000343
RX PubMed=24321451;
DI NCIt; C3040; Fibrodysplasia ossificans progressiva
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_W547 ! eFOP3-2
SX Male
CA Induced pluripotent stem cell
//
ID EG.Lu
AC CVCL_S390
DR ATCC; CRL-6560
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6560; true.
OX NCBI_TaxID=9764; ! Eschrichtius robustus
SX Female
CA Finite cell line
//
ID EGC/PK060399egfr
AC CVCL_8856
DR CLO; CLO_0002894
DR ATCC; CRL-2690
RX PubMed=11169131;
WW http://micro.magnet.fsu.edu/primer/techniques/fluorescence/gallery/cells/egc/egccells.html
CC Transformant: egfr-neu chimer.
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID EGC/PK240899egfr
AC CVCL_0E01
DR ATCC; CRL-2621
RX PubMed=11169131;
CC Transformant: egfr-neu chimer.
CC Discontinued: ATCC; CRL-2621; true.
CC Breed/subspecies: Sprague-Dawley.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID EGE-R
AC CVCL_0I52
SY EGE
DR CCLV; CCLV-RIE 0271
RX PubMed=19941903;
CC Group: Bird cell line.
OX NCBI_TaxID=34924; ! Pica pica
CA Finite cell line
//
ID EGFP-CEM-NKr
AC CVCL_1G54
SY EGFP-CEMNKR
DR NIH-ARP; 11698-328
RX PubMed=16884734;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
DI NCIt; C7953; Childhood T acute lymphoblastic leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_X622 ! CEM.NKR
SX Female
CA Cancer cell line
//
ID EGFP-K562
AC CVCL_1G55
DR NIH-ARP; 11699-327
RX PubMed=12505723;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0004 ! K-562
SX Female
CA Cancer cell line
//
ID EGFP-MBD-nls
AC CVCL_U952
DR RCB; AES0134
DR RCB; RCB2708
RX PubMed=17397393;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Discontinued: RCB; RCB2708; true.
CC Breed/subspecies: 129/Ola.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID EGFR-T17
AC CVCL_6D48
SY EGFR T17; EGFRT17; NIH EGFR-T17
DR CLO; CLO_0008170
DR CLDB; cl3699
RX PubMed=1550855;
RX PubMed=3500513;
CC Transfected with: HGNC; 3236; EGFR.
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Spontaneously immortalized cell line
//
ID EGG
AC CVCL_5739
DR CLS; 400171/p2056_EGG
CC Breed/subspecies: DBA.
DI NCIt; C21604; Mouse leukemia
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID EGI-1
AC CVCL_1193
SY Egi-1
DR CLO; CLO_0002895
DR BioSample; SAMN03473571
DR ChEMBL-Cells; CHEMBL3308731
DR ChEMBL-Targets; CHEMBL1075442
DR Cosmic; 906853
DR Cosmic; 927186
DR Cosmic; 1373548
DR Cosmic-CLP; 906853
DR DSMZ; ACC-385
DR GDSC; 906853
DR GEO; GSM1669758
RX CelloPub=CLPUB00275;
RX PubMed=27397505;
CC Doubling time: >45 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X,Y
ST CSF1PO: 12,13
ST D13S317: 11
ST D16S539: 12,13
ST D5S818: 13
ST D7S820: 9,13
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 17,19
DI NCIt; C4436; Cholangiocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID EGR-101
AC CVCL_0J01
DR RCB; AES0184
RX PubMed=22826106;
CC Transfected with: UniProtKB; P42212; GFP.
CC Breed/subspecies: C57BL/6N.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID EGR-G101
AC CVCL_0J00
DR RCB; AES0182
RX PubMed=22826106;
CC Transfected with: UniProtKB; P42212; GFP (with L-64, T-65 and L-231 = EGFP).
CC Breed/subspecies: C57BL/6NCr.
OX NCBI_TaxID=10090; ! Mus musculus
SX Male
CA Embryonic stem cell
//
ID EGV-10T
AC CVCL_5U38
SY EGV10T; EGV 10T; EGV10-T
RX PubMed=1971176;
RX PubMed=3319569;
RX PubMed=3470760;
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID EGV-3T
AC CVCL_5U39
SY EGV3T; EGV 3T; EGV3-T
RX PubMed=1971176;
RX PubMed=3319569;
RX PubMed=3470760;
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID EGV-4T
AC CVCL_5500
SY EGV4T; EGV 4T; EGV4-T
DR JCRB; JCRB0229
RX PubMed=3319569;
RX PubMed=3470760;
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID EGV-5T
AC CVCL_5U40
SY EGV5T; EGV 5T; EGV5-T
RX PubMed=1971176;
RX PubMed=3319569;
RX PubMed=3470760;
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID EGV-6T
AC CVCL_5U41
SY EGV6T; EGV 6T; EGV6-T
RX PubMed=1971176;
RX PubMed=3319569;
RX PubMed=3470760;
CC Transformant: ChEBI; CHEBI:21759; N-methyl-N'-nitro-N-nitrosoguanidine (MNNG).
CC Breed/subspecies: Fischer 344.
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Male
CA Transformed cell line
//
ID EH
AC CVCL_L804
DR BioSample; SAMN03151773
DR Cosmic; 1809509
RX PubMed=2827813;
RX PubMed=12592342;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HK derivative (PubMed=12592342, PubMed=20143388).
DI NCIt; C7402; Hairy cell leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_L805 ! HK
SX Male
CA Cancer cell line
//
ID EH-118MG
AC CVCL_T447
SY EH118MG; 118 MG-EH
RX PubMed=4312117;
RX PubMed=4337530;
CC Problematic cell line: Contaminated. Parent cell line (U-118MG) has been shown to be a U-138MG derivative.
DI NCIt; C60781; Astrocytoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0633 ! U-118MG
SX Male
CA Cancer cell line
//
ID EH-GB1
AC CVCL_IU73
SY Eastern Hepatobiliary surgery hospital - Gallbladder Cancer 1
RX PubMed=20403235;
CC Doubling time: 24 hours (PubMed=20403235).
CC Derived from metastatic site: Ascites.
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EH-GB2
AC CVCL_6899
SY Eastern Hepatobiliary surgery hospital - Gallbladder Cancer 2
RX PubMed=22134783;
CC Doubling time: ~48 hours (PubMed=22134783).
CC Derived from metastatic site: Liver.
DI NCIt; C3844; Gallbladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID EH/A44
AC CVCL_H578
DR CLO; CLO_0002896
DR CLDB; cl1145
RX PubMed=208448;
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/aeh-a44.htm
CC Transformant: NCBI_TaxID; 10298; Human herpesvirus 1 (HSV-1).
OX NCBI_TaxID=10036; ! Mesocricetus auratus
OI CVCL_H576 ! EHT
CA Transformed cell line
//
ID EH17a
AC CVCL_J896
DR CLO; CLO_0002897
DR ATCC; CRL-2209
DR BCRC; 60538
RX PubMed=1707872;
CC Monoclonal antibody target: UniProtKB; P04083; Human ANXA1.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID EH34A3
AC CVCL_Z865
DR DGRC; 7
RX DOI=10.1016/B978-012229460-0/50004-X;
RX PubMed=6825955;
CC Group: Insect cell line.
OX NCBI_TaxID=7227; ! Drosophila melanogaster
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID EH7a
AC CVCL_J897
DR CLO; CLO_0002898
DR ATCC; CRL-2194
DR BCRC; 60537
RX PubMed=1707872;
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_4032 ! P3X63Ag8.653
CA Hybridoma
//
ID eHAP A11
AC CVCL_5J32
SY eHAPA11; Engineered-HAPloid clone A11
RX PubMed=25373145;
CC Group: Haploid karyotype cell line.
CC Omics: Genome sequenced.
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y019 ! HAP1
SX Male
CA Cancer cell line
//
ID eHAP E9
AC CVCL_5J33
SY eHAPE9; Engineered-HAPloid clone E9
RX PubMed=25373145;
CC Group: Haploid karyotype cell line.
CC Omics: Genome sequenced.
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_Y019 ! HAP1
SX Male
CA Cancer cell line
//
ID EHEB
AC CVCL_1194
DR BTO; BTO:0003276
DR CLO; CLO_0002899
DR CLDB; cl1146
DR BioSample; SAMN03473424
DR CCLE; EHEB_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308163
DR ChEMBL-Targets; CHEMBL2366258
DR Cosmic; 906854
DR Cosmic-CLP; 906854
DR DSMZ; ACC-67
DR GDSC; 906854
DR GEO; GSM887002
DR GEO; GSM888071
DR GEO; GSM1374472
DR GEO; GSM1669759
DR NCBI_Iran; C494
RX PubMed=2159091;
RX PubMed=11705877;
RX PubMed=12592342;
RX PubMed=22460905;
RX PubMed=23297799;
RX PubMed=27397505;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Problematic cell line: Probably misidentified. Originally thought to be a leukemia cell line but is probably a B-lymphoblastoid cell line (PubMed=12592342).
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Part of: MD Anderson Cell Lines Project.
CC Doubling time: ~50-70 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 13
ST D16S539: 9,12
ST D5S818: 12
ST D7S820: 10,11
ST TH01: 6
ST TPOX: 8,9
ST vWA: 16
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID EHM
AC CVCL_E578
DR dbMHC; 48773
DR ECACC; 88052079
DR IHW; IHW9080
DR IMGT/HLA; 11630
WW http://bioinformatics.hsanmartino.it/ecbr/cl80.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID EHMES-1
AC CVCL_M207
RX CelloPub=CLPUB00241;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID EHMES-10
AC CVCL_M208
RX CelloPub=CLPUB00241;
RX PubMed=16542214;
DI NCIt; C3234; Mesothelioma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID Ehrlich-Lettre ascites strain E
AC CVCL_3873
SY Ehrlich-Lettre; Ehrlich Lettre; E-La; EAT; EAT strain E; Ehrlich ascites; Ehrlich
DR BTO; BTO:0001920
DR CLO; CLO_0002900
DR CLO; CLO_0050165
DR CLDB; cl1148
DR ATCC; CCL-77
DR CCRID; 3111C0001CCC000317
DR ChEMBL-Cells; CHEMBL3307669
DR ChEMBL-Targets; CHEMBL614641
DR CLS; 400169/p2044_EAT
DR ECACC; 87032503
DR JCRB; JCRB9090
DR KCLB; 10077
DR RCB; RCB0142
RX PubMed=5829538;
WW http://what-when-how.com/molecular-biology/ehrlich-cells-molecular-biology/
DI NCIt; C21678; Malignant neoplasms of the mouse mammary gland
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_5299 ! JTC-11
SX Female
CA Cancer cell line
//
ID EHS
AC CVCL_3506
SY Englebreth-Holm-Swarm
DR CLO; CLO_0002901
DR ATCC; CRL-2108
DR IFO; IFO50268
CC Discontinued: ATCC; CRL-2108; true.
CC Breed/subspecies: ST/Eh.
DI NCIt; C24018; Mouse chondrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_0J39 ! BAM [Mouse chondrosarcoma]
OI CVCL_0J38 ! EHSPEL
CA Cancer cell line
//
ID EHSPEL
AC CVCL_0J38
SY EHS parietal Endoderm-Like
RX PubMed=15172037;
CC Breed/subspecies: ST/Eh.
DI NCIt; C24018; Mouse chondrosarcoma
OX NCBI_TaxID=10090; ! Mus musculus
OI CVCL_0J39 ! BAM [Mouse chondrosarcoma]
OI CVCL_3506 ! EHS
CA Cancer cell line
//
ID EHT
AC CVCL_H576
DR CLO; CLO_0002902
DR CLDB; cl1150
RX PubMed=208448;
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/aeht.htm
OX NCBI_TaxID=10036; ! Mesocricetus auratus
OI CVCL_H578 ! EH/A44
CA Spontaneously immortalized cell line
//
ID EI
AC CVCL_F958
DR TKG; TKG 0693
RX PubMed=7669752;
RX PubMed=28196595;
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Omics: Protein expression by reverse-phase protein arrays.
ST Source(s): TKG
ST Amelogenin: X
ST CSF1PO: 13,14
ST D13S317: 12,13,14
ST D16S539: 8,9
ST D5S818: 12
ST D7S820: 10,11,12
ST TH01: 6
ST TPOX: 8,12
ST vWA: 14,21
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EIAV 12E8.1
AC CVCL_4519
DR CLO; CLO_0002903
DR CLDB; cl5186
DR ATCC; HB-8917
DR IZSLER; BS Hy 46
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2199 ! Sp2/0-Ag14
CA Hybridoma
//
ID EIIL
AC CVCL_W441
RX PubMed=7699285;
RX PubMed=8718550;
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_2529 ! Ishikawa
SX Female
CA Cancer cell line
//
ID EJ
AC CVCL_7039
DR TKG; TKG 0664
RX PubMed=12889855;
CC Caution: Not to be confused with bladder carcinoma cell line EJ (CVCL_2443).
ST Source(s): TKG
ST Amelogenin: X
ST CSF1PO: 12,13
ST D13S317: 9,12
ST D16S539: 10,11
ST D5S818: 11,14
ST D7S820: 10,11
ST TH01: 7,9
ST TPOX: 8,11
ST vWA: 16
DI NCIt; C7359; Endometrial adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EJ-1
AC CVCL_2893
SY EJ1
DR BTO; BTO:0003639
DR BioSample; SAMN03151938
DR JCRB; JCRB0710
DR TKG; TKG 0441
RX PubMed=9290701;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=20143388).
ST Source(s): JCRB; PubMed=11416159; TKG
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 12
ST D16S539: 9
ST D18S51: 16,18
ST D21S11: 29
ST D5S818: 10,12
ST D7S820: 10,11
ST D8S1179: 14
ST FGA: 17,22
ST TH01: 6
ST TPOX: 8,11
ST vWA: 17
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0554 ! T24
SX Female
CA Cancer cell line
//
ID EJ-28
AC CVCL_5983
SY EJ/28; EJ28
DR CLS; 300172/NA
RX PubMed=7490993;
RX PubMed=11207054;
RX PubMed=12127398;
CC Discontinued: CLS; 300172; true.
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EJ-6-2-Bam-6a
AC CVCL_5741
DR CLO; CLO_0002907
DR ATCC; CRL-1888
RX PubMed=7207618;
CC Breed/subspecies: NIH Swiss.
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0594 ! NIH 3T3
SX Male
CA Transformed cell line
//
ID Ej138
AC CVCL_2443
SY EJ138; EJ 138; MGH-U1; MGHU1; MGH-UI; MGH-U1 (EJ); EJ
DR BTO; BTO:0003553
DR CLO; CLO_0002905
DR CLO; CLO_0002906
DR CLDB; cl1152
DR CLDB; cl1154
DR BioSample; SAMN03151939
DR BioSample; SAMN03151949
DR ChEMBL-Cells; CHEMBL3307583
DR ChEMBL-Targets; CHEMBL614292
DR Cosmic; 760480
DR Cosmic; 925828
DR Cosmic; 1093986
DR Cosmic; 1927289
DR ECACC; 85061108
DR GEO; GSM827443
DR GEO; GSM1374473
DR NCBI_Iran; C429
RX PubMed=663932;
RX PubMed=864752;
RX PubMed=3708594;
RX PubMed=4027986;
RX PubMed=6244232;
RX PubMed=6823318;
RX PubMed=6826254;
RX PubMed=7185004;
RX PubMed=20143388;
RX PubMed=23401075;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a T24 derivative (PubMed=3708594, PubMed=6823318, PubMed=20143388).
CC Omics: Transcriptome analysis.
ST Source(s): PubMed=11416159
ST Amelogenin: X
ST D18S51: 16,18
ST D21S11: 29
ST D8S1179: 14
ST FGA: 22
ST TH01: 6
ST vWA: 17
DI NCIt; C4912; Bladder carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0554 ! T24
SX Female
CA Cancer cell line
//
ID EJ32B
AC CVCL_E579
DR dbMHC; 48774
DR ECACC; 95042756
DR IHW; IHW9085
DR IMGT/HLA; 11631
WW http://bioinformatics.hsanmartino.it/ecbr/cl85.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID EJG
AC CVCL_3817
DR CLO; CLO_0002908
DR CLDB; cl1155
DR ATCC; CRL-8659
DR ECACC; 93051803
RX Patent=US4670394;
RX PubMed=3927288;
CC Doubling time: 4.6 days (PubMed=3927288); 110 hours (ATCC).
OX NCBI_TaxID=9913; ! Bos taurus
SX Female
CA Spontaneously immortalized cell line
//
ID EJM
AC CVCL_2030
DR EFO; EFO_0006572
DR BioSample; SAMN03472928
DR CCLE; EJM_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR Cosmic; 720776
DR Cosmic; 742955
DR Cosmic; 2081379
DR Cosmic; 2367286
DR Cosmic-CLP; 1297447
DR DSMZ; ACC-560
DR GDSC; 1297447
DR GEO; GSM827296
DR GEO; GSM887003
DR GEO; GSM888072
DR GEO; GSM1669760
DR Lonza; 1540
RX PubMed=2117464;
RX PubMed=10087940;
RX PubMed=10557056;
RX PubMed=10936422;
RX PubMed=22460905;
RX PubMed=25485619;
RX PubMed=25984343;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: 40 hours (PubMed=25984343); ~50-60 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 11,12
ST D13S317: 13
ST D16S539: 11
ST D18S51: 15,17
ST D21S11: 31.2
ST D3S1358: 15,17
ST D5S818: 9,11
ST D7S820: 8
ST D8S1179: 14
ST FGA: 20,22
ST Penta D: 14
ST Penta E: 16
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 14
DI NCIt; C3242; Plasma cell myeloma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EK [Human B-cell]
AC CVCL_E580
SY EK(OH); OH/EK
DR dbMHC; 48775
DR ECACC; 88052054
DR IHW; IHW9054
DR IMGT/HLA; 10557
WW http://bioinformatics.hsanmartino.it/ecbr/cl54.html
CC Part of: 10th International Histocompatibility Workshop (10IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Transformed cell line
//
ID EK [Horse]
AC CVCL_Y450
SY Equine Kidney
DR ATCC; CRL-6290
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6290; true.
OX NCBI_TaxID=9796; ! Equus caballus
SX Male
CA Finite cell line
//
ID EK-1
AC CVCL_8348
SY Eel Kidney-1; Ek-1
DR CCLV; CCLV-RIE 0809
RX CelloPub=CLPUB00137;
RX DOI=10.3147/jsfp.28.27;
CC Group: Fish cell line.
OX NCBI_TaxID=7937; ! Anguilla japonica
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID EK-TOK
AC CVCL_E581
DR dbMHC; 48776
DR ECACC; 94061622
DR IHW; IHW9354
DR IMGT/HLA; 10558
WW http://bioinformatics.hsanmartino.it/ecbr/cl354.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Transformed cell line
//
ID EKL
AC CVCL_5742
DR CLO; CLO_0002909
DR CLDB; cl1156
WW http://www.rccc.cytspb.rssi.ru/ecellbank/animal/aekl.htm
OX NCBI_TaxID=9796; ! Equus caballus
SX Sex undetermined
CA Undefined cell line type
//
ID EKOP
AC CVCL_6755
DR CLO; CLO_0050527
DR RCB; RCB2150
RX PubMed=16198317;
CC Knockout cell: Method=KO mouse; MGI; MGI:1346865; Mapk14.
CC Transfected with: HGNC; 6876; MAPK14 (isoform Exip).
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_6753 ! KOP
SX Female
CA Spontaneously immortalized cell line
//
ID EKS3
AC CVCL_5283
RX PubMed=1693429;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=EKS3
DI NCIt; C3992; AIDS-related Kaposi sarcoma
OX NCBI_TaxID=9606; ! Homo sapiens
CA Cancer cell line
//
ID EKVX
AC CVCL_1195
DR BTO; BTO:0004077
DR EFO; EFO_0006786
DR BCRJ; 0298
DR BioSample; SAMN03471437
DR ChEMBL-Cells; CHEMBL3307626
DR ChEMBL-Targets; CHEMBL614487
DR Cosmic; 687781
DR Cosmic; 875848
DR Cosmic; 905970
DR Cosmic; 974288
DR Cosmic; 1092598
DR Cosmic; 1146952
DR Cosmic; 1175860
DR Cosmic; 1305343
DR Cosmic; 1312329
DR Cosmic; 1998440
DR Cosmic-CLP; 905970
DR GDSC; 905970
DR GEO; GSM50210
DR GEO; GSM50273
DR GEO; GSM206468
DR GEO; GSM434292
DR GEO; GSM750810
DR GEO; GSM794266
DR GEO; GSM799337
DR GEO; GSM799400
DR GEO; GSM846290
DR GEO; GSM843499
DR GEO; GSM1153407
DR GEO; GSM1181255
DR GEO; GSM1181350
DR GEO; GSM1669761
DR IGRhCellID; EKVX_02GEO
DR SKY/M-FISH/CGH; 2793
RX PubMed=2041050;
RX PubMed=17088437;
RX PubMed=19372543;
RX PubMed=22355448;
RX PubMed=23856246;
RX PubMed=23933261;
RX PubMed=24618588;
RX PubMed=25485619;
RX PubMed=27397505;
RX PubMed=27807467;
RX PubMed=28196595;
WW https://dtp.cancer.gov/discovery_development/nci-60/cell_list.htm
WW https://strap.nci.nih.gov/celline_detail.php?sample_id=9
WW http://tcpaportal.org/mclp/
CC Part of: MD Anderson Cell Lines Project.
CC Part of: NCI60 cancer cell line panel.
CC Characteristics: Produces a human cell infectious xenotropic murine leukemia virus (X-MLV).
CC Doubling time: 43.6 hours (DTP).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: Deep proteome analysis.
CC Omics: Deep RNAseq analysis.
CC Omics: DNA methylation analysis.
CC Omics: Protein expression by reverse-phase protein arrays.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
CC Omics: Virome analysis using proteomics.
CC Misspelling: 'ERVX' in Cosmic 875848.
ST Source(s): Cosmic-CLP; PubMed=19372543; PubMed=25877200
ST Amelogenin: X,Y
ST CSF1PO: 9
ST D13S317: 11
ST D16S539: 9,11
ST D18S51: 13,16
ST D19S433: 13
ST D21S11: 30,31 (PubMed=19372543)
ST D21S11: 31 (PubMed=25877200)
ST D2S1338: 17,19
ST D3S1358: 16,18
ST D5S818: 11,12
ST D7S820: 9,12
ST D8S1179: 15
ST FGA: 20,21
ST Penta D: 9
ST Penta E: 5
ST TH01: 9.3
ST TPOX: 8,11
ST vWA: 15
DI NCIt; C2926; Non-small cell lung carcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID EL 1
AC CVCL_3680
DR CLO; CLO_0002910
DR ATCC; CRL-9854
RX Patent=US5447861;
ST Source(s): ATCC
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 10,12
ST D16S539: 12
ST D5S818: 10,12
ST D7S820: 9,11
ST TH01: 6,9.3
ST TPOX: 8,11
ST vWA: 15
OX NCBI_TaxID=9606; ! Homo sapiens
CA Finite cell line
//
ID El Don
AC CVCL_3681
DR CLO; CLO_0002912
DR ATCC; CRL-1149
DI NCIt; C125701; Ehlers-Danlos syndrome, type VII
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Finite cell line
//
ID El Man
AC CVCL_X712
SY Elman
DR ATCC; CRL-1101
CC Discontinued: ATCC; CRL-1101; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID El San
AC CVCL_U688
DR ATCC; CRL-1222
RX PubMed=3860870;
CC Discontinued: ATCC; CRL-1222; true.
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID EL-4 6.1 C10
AC CVCL_0254
SY EL4 6.1 C10; EL461C10
DR MCCL; MCC:0000145
CC Breed/subspecies: C57BL/6N.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0255 ! EL4
CA Cancer cell line
//
ID EL-4-B5
AC CVCL_5I39
SY EL-4 B5; EL4-B5; EL4B5
RX PubMed=7691726;
WW https://www.kerafast.com/product/2291/cd40l-expressing-feeder-cell-line-el-4-b5
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C57BL/6N.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_5680 ! EL4.BU.1.OUAr.1.1
CA Cancer cell line
//
ID EL-4ad
AC CVCL_8603
DR JCRB; JCRB1352
RX PubMed=1505120;
CC Breed/subspecies: C57BL/6N.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0255 ! EL4
CA Cancer cell line
//
ID EL-E
AC CVCL_0C08
RX PubMed=7736387;
DI NCIt; C5214; Breast adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Cancer cell line
//
ID EL-NC-1S
AC CVCL_J898
SY anti NAP-1
DR CLO; CLO_0002920
DR ATCC; HB-9647
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_2155 ! P3/NS1/1-Ag4.1
CA Hybridoma
//
ID EL4
AC CVCL_0255
SY EL-4; EL 4; E.L.4
DR BTO; BTO:0003432
DR CLO; CLO_0002913
DR CLO; CLO_0050166
DR MCCL; MCC:0000146
DR CLDB; cl1158
DR CLDB; cl1159
DR CLDB; cl1160
DR ATCC; TIB-39
DR BCRC; 60179
DR CCRID; 3111C0001CCC000136
DR CCRID; 3131C0001000800003
DR CCRID; 3142C0001000000130
DR ChEMBL-Cells; CHEMBL3308380
DR ChEMBL-Targets; CHEMBL614293
DR ECACC; 85023105
DR JCRB; JCRB1350
DR KCB; KCB 2013027YJ
DR KCLB; 40039
DR Lonza; 760
DR NCBI_Iran; C114
DR RCB; RCB1641
DR TKG; TKG 0150
RX PubMed=4099030;
RX PubMed=14801344;
WW http://www.cells-talk.com/index.php/page/copelibrary?key=EL4
WW http://www.thermofisher.com/ch/en/home/technical-resources/cell-lines/e/cell-lines-detail-141.html
CC Breed/subspecies: C57BL/6N.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
CA Cancer cell line
//
ID EL4-luc2
AC CVCL_5J22
CC Transfected with: UniProtKB; P08659; Firefly luciferase (with optimized codon usage for mammalian expression).
CC Discontinued: PerkinElmer; Catalog number 124088.
CC Breed/subspecies: C57BL/6N.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0255 ! EL4
CA Cancer cell line
//
ID EL4-TK
AC CVCL_F943
DR TKG; TKG 0192
CC Breed/subspecies: C57BL/6N.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0255 ! EL4
CA Cancer cell line
//
ID EL4.BU
AC CVCL_3818
SY EL4 BU; E.L.4-BUdr
DR CLO; CLO_0002914
DR ATCC; TIB-40
RX PubMed=4099030;
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Breed/subspecies: C57BL/6N.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0255 ! EL4
CA Cancer cell line
//
ID EL4.BU.1.OUAr.1.1
AC CVCL_5680
DR CLO; CLO_0002915
DR ATCC; TIB-41
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
CC Breed/subspecies: C57BL/6N.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0255 ! EL4
CA Cancer cell line
//
ID EL4.BU.OU6
AC CVCL_3819
DR CLO; CLO_0002916
DR CLDB; cl1161
DR ECACC; 85121301
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
CC Breed/subspecies: C57BL/6N.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3818 ! EL4.BU
CA Cancer cell line
//
ID EL4.E1
AC CVCL_0256
SY EL4E1
DR MCCL; MCC:0000147
CC Breed/subspecies: C57BL/6N.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0255 ! EL4
CA Cancer cell line
//
ID EL4.IL-2
AC CVCL_5681
DR CLO; CLO_0002917
DR ATCC; TIB-181
DR BCRC; 60275
DR CCRID; 3131C0001000800021
DR CLS; 400425/p590_EL4IL-2
RX PubMed=6968789;
CC Breed/subspecies: C57BL/6N.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_0255 ! EL4
CA Cancer cell line
//
ID EL4.NOB-1
AC CVCL_0257
SY EL4NOB1; NOB-1
DR CLO; CLO_0002918
DR MCCL; MCC:0000148
DR CLDB; cl1162
DR ECACC; 87020408
WW http://www.cells-talk.com/index.php/page/copelibrary?key=NOB-1
CC Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC Selected for resistance to: ChEBI; CHEBI:472805; Ouabain.
CC Breed/subspecies: C57BL/6N.
DI NCIt; C21602; Mouse lymphoma
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_3819 ! EL4.BU.OU6
CA Cancer cell line
//
ID ELC1.We
AC CVCL_S379
SY ELC1We
DR ATCC; CRL-6495
CC Group: Bird cell line.
CC Part of: Naval Biosciences Laboratory (NBL) collection (transferred to ATCC in 1982).
CC Discontinued: ATCC; CRL-6495; true.
OX NCBI_TaxID=67771; ! Callipepla californica
SX Sex undetermined
CA Finite cell line
//
ID ElCo
AC CVCL_8686
DR BioSample; SAMN03151689
RX CelloPub=CLPUB00262;
RX PubMed=212193;
RX PubMed=1246601;
RX PubMed=6451928;
RX PubMed=9215216;
RX PubMed=20143388;
WW http://iclac.org/wp-content/uploads/Cross-Contaminations-v8_0.pdf
CC Problematic cell line: Contaminated. Shown to be a HeLa derivative (PubMed=1246601, PubMed=6451928, PubMed=20143388). Originally thought to originate from a breast carcinoma.
CC Transformant: NCBI_TaxID; 333761; Human papillomavirus type 18 (HPV18).
DI NCIt; C4029; Cervical adenocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
HI CVCL_0030 ! HeLa
SX Female
CA Cancer cell line
//
ID ELF-153
AC CVCL_2031
SY Elf-153; ELF153
DR BioSample; SAMN03473443
DR Cosmic; 787427
DR Cosmic; 975245
DR Cosmic; 1012064
DR Cosmic; 1281310
DR Cosmic; 1465954
DR Cosmic; 2306197
DR DSMZ; ACC-693
RX CelloPub=CLPUB00037;
RX PubMed=7519473;
RX PubMed=16408098;
CC Characteristics: CSF2 dependent.
CC Doubling time: 36 hours (PubMed=7519473); ~40-60 hours (DSMZ).
ST Source(s): DSMZ
ST Amelogenin: X
ST CSF1PO: 10
ST D13S317: 8
ST D16S539: 12,13
ST D5S818: 11
ST D7S820: 9,10
ST TH01: 6,9
ST TPOX: 8,11
ST vWA: 19
DI NCIt; C9154; Adult acute myeloid leukemia
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID Elf1
AC CVCL_C115
SY Elf-1; ELF-1
DR EFO; EFO_0005901
DR ISCR; 2212
RX PubMed=24623855;
WW http://grants.nih.gov/stem_cells/registry/current.htm?id=527
WW http://www.wicell.org/home/stem-cell-lines/catalog-of-stem-cell-lines/elf-1.cmsx
CC From: University of Washington; Seattle; USA.
CC Registration: NIH Human Embryonic Stem Cell Registry; NIHhESC-12-0156.
CC Omics: Transcriptome analysis.
ST Source(s): WiCell
ST Amelogenin: X
ST CSF1PO: 10,11
ST D13S317: 11,13
ST D16S539: 11
ST D18S51: 15,18
ST D21S11: 29,31
ST D3S1358: 16
ST D5S818: 11,13
ST D7S820: 8,10
ST D8S1179: 13,14
ST FGA: 24
ST Penta D: 13,14
ST Penta E: 5,12
ST TH01: 6,8
ST TPOX: 8,9
ST vWA: 17,18
OX NCBI_TaxID=9606; ! Homo sapiens
SX Female
CA Embryonic stem cell
//
ID ElFa
AC CVCL_CZ88
SY EIFa
RX PubMed=2720636;
RX PubMed=4038916;
RX PubMed=7153601;
DI NCIt; C4646; Gestational choriocarcinoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID ELGH
AC CVCL_W729
RX PubMed=24372271;
CC Group: Fish cell line.
OX NCBI_TaxID=310571; ! Epinephelus lanceolatus
SX Sex undetermined
CA Spontaneously immortalized cell line
//
ID Elijah
AC CVCL_M653
SY ELIJAH; ELI-BL; ELI BL; Eli BL; ELI; Eli
DR Cosmic; 2297022
DR GEO; GSM115809
RX PubMed=2824665;
RX PubMed=2898508;
RX PubMed=2943927;
RX PubMed=2985508;
RX PubMed=16960149;
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC Misspelling: Occasionally 'Elija'.
DI NCIt; C27694; Epstein-Barr virus-related Burkitt lymphoma
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Cancer cell line
//
ID elkRK13
AC CVCL_0A22
RX CelloPub=CLPUB00223;
RX PubMed=22673102;
CC Transfected with: UniProtKB; P67986; Elk prion protein.
OX NCBI_TaxID=9986; ! Oryctolagus cuniculus
HI CVCL_3155 ! RK 13
CA Spontaneously immortalized cell line
//
ID ELM-D
AC CVCL_X174
RX PubMed=2460423;
RX PubMed=8355701;
CC Transformant: NCIt; C17262; X-Ray.
CC Breed/subspecies: C3H/HeNSIc.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
SX Female
CA Cancer cell line
//
ID ELM-I-1
AC CVCL_2032
DR CLO; CLO_0002919
DR CLDB; cl1163
DR DSMZ; ACC-44
RX PubMed=2319808;
RX PubMed=2460423;
RX PubMed=8355701;
CC Doubling time: ~20-40 hours (DSMZ).
CC Transformant: NCIt; C17262; X-Ray.
CC Breed/subspecies: C3H/HeNSIc.
DI NCIt; C21895; Mouse erythroid leukemia
OX NCBI_TaxID=10090; ! Mus musculus
HI CVCL_X174 ! ELM-D
SX Female
CA Cancer cell line
//
ID ELON
AC CVCL_E582
DR dbMHC; 48777
DR ECACC; 94022528
DR IHW; IHW9236
DR IMGT/HLA; 10559
WW http://bioinformatics.hsanmartino.it/ecbr/cl236.html
CC Part of: 12th International Histocompatibility Workshop (12IHW) cell line panel.
CC Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
OX NCBI_TaxID=9606; ! Homo sapiens
SX Sex undetermined
CA Transformed cell line
//
ID ELT10
AC CVCL_4615
SY ELT-10; ELT 10
RX PubMed=7539981;
CC Breed/subspecies: Long-Evans.
DI NCIt; C60426; Rat leiomyoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID ELT3
AC CVCL_4616
SY ELT-3; ELT 3
DR BTO; BTO:0003253
RX PubMed=7539981;
CC Breed/subspecies: Long-Evans.
DI NCIt; C60426; Rat leiomyoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID ELT4
AC CVCL_4617
SY ELT-4; ELT 4
RX PubMed=7539981;
CC Breed/subspecies: Long-Evans.
DI NCIt; C60426; Rat leiomyoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID ELT5A
AC CVCL_4618
SY ELT-5A; ELT 5A
RX PubMed=7539981;
CC Breed/subspecies: Long-Evans.
DI NCIt; C60426; Rat leiomyoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_4619 ! ELT5B
SX Female
CA Cancer cell line
//
ID ELT5B
AC CVCL_4619
SY ELT-5B; ELT 5B
RX PubMed=7539981;
CC Breed/subspecies: Long-Evans.
DI NCIt; C60426; Rat leiomyoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
OI CVCL_4618 ! ELT5A
SX Female
CA Cancer cell line
//
ID ELT6
AC CVCL_4620
SY ELT-6; ELT 6
RX PubMed=7539981;
CC Breed/subspecies: Long-Evans.
DI NCIt; C60426; Rat leiomyoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID ELT9
AC CVCL_4621
SY ELT-9; ELT 9
RX PubMed=7539981;
CC Breed/subspecies: Long-Evans.
DI NCIt; C60426; Rat leiomyoma
OX NCBI_TaxID=10116; ! Rattus norvegicus
SX Female
CA Cancer cell line
//
ID Em Ar
AC CVCL_3682
DR CLO; CLO_0002921
DR ATCC; CRL-1168
OX NCBI_TaxID=9606; ! Homo sapiens
SX Male
CA Finite cell line
//
ID EM-2
AC CVCL_1196
SY EM2
DR BTO; BTO:0005904
DR CLO; CLO_0002922
DR EFO; EFO_0002176
DR CLDB; cl1164
DR BioSample; SAMN03472895
DR CCLE; EM2_HAEMATOPOIETIC_AND_LYMPHOID_TISSUE
DR ChEMBL-Cells; CHEMBL3308889
DR ChEMBL-Targets; CHEMBL2366281
DR Cosmic; 787491
DR Cosmic; 906855
DR Cosmic; 994175
DR Cosmic; 1026572
DR Cosmic; 1078728
DR Cosmic; 1498416
DR Cosmic-CLP; 906855
DR DSMZ; ACC-135
DR GDSC; 906855
DR GEO; GSM887004
DR GEO; GSM888073
DR GEO; GSM1374474
DR GEO; GSM1669762
DR IGRhCellID; EM2
RX CelloPub=CLPUB00038;
RX PubMed=3332852;
RX PubMed=3856862;
RX PubMed=22460905;
RX PubMed=27397505;
CC Part of: Cancer Cell Line Encyclopedia (CCLE) project.
CC Doubling time: ~35-40 hours (DSMZ).
CC Microsatellite instability: Stable (MSS) (Sanger).
CC Omics: Deep exome analysis.
CC Omics: DNA methylation analysis.
CC Omics: SNP array analysis.
CC Omics: Transcriptome analysis.
ST Source(s): Cosmic-CLP; DSMZ; PubMed=25877200
ST Amelogenin: X
ST CSF1PO: 10,12
ST D13S317: 9,12
ST D16S539: 11,12
ST D18S51: 13,15
ST D21S11: 30
ST D3S1358: 14,16
ST D5S818: 8,12
ST D7S820: 10
ST D8S1179: 14
ST FGA: 21,22
ST Penta D: 13,14
ST Penta E: 7,16
ST TH01: 9.3
ST TPOX: 8,12
ST vWA: 14,17
DI NCIt; C3174; Chronic myelogenous leukemia, BCR-ABL1 positive
OX NCBI_TaxID=9606; ! Homo sapiens
OI CVCL_2033 ! EM-3
SX Female
CA Cancer cell line
您正在向 biovector.net 发送关于产品 细胞株Cell Lines 17-BioVector NTCC质粒载体菌种细胞蛋白抗体基因保藏中心 的询问
- 公告/新闻
